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ABSTRACT
STUDIES ON PNEUMOCOCCI ISOLATED FROM CHILDREN IN THE 
SHEFFIELD AREA. By Richard Howden.
The isolation of the pneumococcus (Streptococcuspneumoniae) was improved, and gave large mucoid colonies, when incubated in an anaerobic environment containing extra C 0 2. Both reduction of oxygen tension, with a reduction in the formation of peroxides, and a variable requirement for C 0 2 were necessary for optimal recovery of strains from children.
During a four year period 1736 pneumococci isolated from samples at the Children’s Hospital, Sheffield were 
serotyped, their requirement for C 0 2 and sensitivity to antibiotics were collated with patients details. This information was analysed for patterns both in health and
disease as a background to clinical management and there-introduction of vaccination in high risk patients. Serotyping of strains by co-agglutination of sensitised protein-A particles, was quicker and as sensitive ascrossed immuno-electrophoresis (CIE), without requiring the complex CIE equipment.
The increased and more active growth obtained under anaerobic conditions enhanced detection of pneumococcal enzymes, including sugar fermentation. New specific substrates, e.g. the APIZYM system, and those linked to nitrophenyl compounds were found to be applicable to thepneumococcus. A second new area of investigation, the 
differentiation of the pneumococcus by its sensitivity to a range of dye substances, was discovered and developed. Further unique differences were seen in the shape and colour of colonies on Mitis-salivarius agar, C 0 2requirement, haemolysins and sensitivity to tetracycline. 
Another antibiotic, mecillinam, was found for the practical recognition of penicillin-tolerant strains as an 
alternative to the use of cloxacillin for this purpose.Much of the work in this study has not previously beenreported and should form the basis of a number of newapproaches and may lead to a scheme, at present not available, for the differentiation and characterisation of the pneumococcus beyond the capsular serotype.
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Streptococcus pneumoniae is the most frequent bacterial 
cause of pneumonia, otitis media, and bacteraemia and is 
the third most common cause of meningitis in infants and 
children (Klein, 1981). It is difficult to obtain accurate 
figures of the extent of pneumococcal pneumonia because the 
pneumococcus is a normal part of the naso-pharnygeal flora 
of at least 30% of children under 10 years old (Locja et 
a l » r 1975 and Dowling et al., 1971). Assuming a 5% 
mortality rate for the cases producing the 1700 deaths in 
children, under 5 years old, from acute respiratory 
infections and pneumonia (Registrar General's report for
1978); this would represent approximately 34,000 infected 
children per year. The pneumococcus was thought by Heffron 
in 1939 to be the cause of two thirds of respiratory 
infections in children and forty years later general 
practioners in the United Kingdom still reported 55,000 
pneumococcal pneumonia cases, in patients of all ages 
(Vogel, 1982) . Diagnosis in children is also complicated by 
the difficulty in obtaining a full clinical history, a 
suitable bacteriological sample either because children 
tend to swallow their respiratory secretions or because 
they have received prophylactic antibiotic therapy. 
However, with more stringent criteria, Austrian (1975) 
reported an estimated 420,000 cases of pneumococcal 
pneumonia in persons over 18 years old. The pneumococcus 
remains the only infective agent in the 10 leading causes 
of death (Austrian, 1975) and accounts for 27% of all
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deaths occurring after the first month of life in those 
under 5 years of age (Court, 1968). In the Newcastle 
Family Survey (Miller et a l ., 1960), 80% of illness in
children under five years of age was infective and of these 
60% were respiratory infections. This group • of patients 
has also the highest pneumococcal carriage rate (Hendley et 
a l ., 1975), which is known to be a contributary factor in
the production of pneumococcal disease (Hodges and MacLeod, 
1946). Spread of the organism from the respiratory tract 
into the eustachian tiabe is presumed to result in 
pneumococcal otitis media (Austrian, 1975), which persists 
as one of the most common infections of children in 
developed countries. The attack rate of this infection is 
estimated at between 15 and 20 cases per 100 children in 
the first two years of life and by three years of age 70% 
of children have had at least one attack of otitis media 
(Teele et al., 1980) which, although rarely fatal, is the 
cause of life long handicap through deafness (Austrian et 
a l ., 1977 and Kamme et al., 1970). The incidence of
pneumococcal otitis media reaches a peak at between 6 and 
12 months, while in pneumonia cases this happens early in 
the child's second year and has an attack rate of greater 
than 32 per 100,000 children (Broome and Facklam, 1981). 
Early childhood is a vulnerable age for pneumococcal 
infections when loss of initially protective maternal 
antibodies leads to systemic infections (Klein, 1931) . 
However Bortolussi et al. (1977) reported in four newborn 
infants that sepsis arose within the first 24 h of birth,
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probably acquired during passage along the mothers genital
tract. Pneumococcal meningitis has a peak occurence at
between three to five months of age and has been estimatedet
to attack 1.4-2.2 people per 100,000 (Fraser 1973 and 
1974). Approximately 8 cases of pneumococcal bacteraemia 
per 100,000 population, based on hospital findings, has 
been reported but actual numbers are expected to be much 
higher (Johnstone, 1981). Recognition of bacteraemia 
depends on a number of factors, including the decision to 
perform a venepuncture at the right time of the disease and 
before the start of antibiotic therapy. Some bacteraemic 
patients do not present as hospital admissions (MacGowan et 
a l « f 1973 and Braddon et al ., 1977) and it is probable that 
if blood cultures were more frequently performed in 
respiratory illnesses the number of isolates would 
increase. Whether this would affect the treatment of the 
patient is unknown (Jacobs et a l ., 1979). Untreated
pneumococcal pneumonia and the concomitant bacteraemia are 
fatal in 40% of cases (Witt and Hamburger, 1963) and in 
untreated meningitis the chances of survival are virtually 
nil (Austrian, 1968).
Two methods have been employed to help the patient combat
this organism, firstly vaccination or serum therapy to
provide antibodies to enhance phagocytosis of the 
bacterium, and later replaced by the administration of
antibiotics to limit the growth of the organism. The
history of pneumococcal serology goes back to 1891 when 
Metchnikoff cited the agglutination of the organism, and in
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1897 Bezancon and Griffin suggested the antigenic diversity 
of the pneumococcus. Neufeld's description of the now 
classic quellung reaction, the apparent swelling of the 
organism's capsule when mixed with specific rabbit 
antisera, in 1902 preceded the differentiation of the
pneumococcal serotypes. Its true importance was overlooked 
until rediscovered by Armstrong and by Logan and Smeall in 
1932, and now forms the basis of the serotyping of 
isolates. Preventative therapy, dates from 1911, when Sir 
Almroth Wright prevented pneumonia in South African gold 
miners by injections of a vaccine prepared from whole 
killed organisms (Wright et al., 1914). In the next 40 
years, following the recognition of the majority of the 
pneumococcal capsular serotypes and their application to 
immunisation (Franc is and Tillett, 1930; Sutliff and
Finland, 1931 and Finland and Brown, 1938), nearly half a 
million people received polyvalent vaccines composed of 
either whole pneumococcal cells or their capsular 
polysaccharides without serious untoward reactions, but 
with uncertain benefit in some cases (Austrian, 1975) . 
Pneumococcal pneumonia had been a major preoccupation of
medicine up to the 1940's and it was ironic that the 
development of safe and effective multi-factorial vaccines 
(Heidelberger et al., 1948) coincided with the introduction 
of effective antimicrobial agents. For the next twenty 
years there was almost no professional interest in 
prevention of the disease. A licence to supply polyvalent 
polysaccharide vaccines by E.R. Squibb and Sons in 1950,
5
was revoked without prejudice shortly afterwards because of 
lack of its use and at about this time also, the 
accompanying bacteriological techniques of mouse 
inoculation and pneumococcal serotyping fell into 
widespread disuse and with it the impetus for pneumococcal 
studies. If the amount of interest in the pneumococcus can 
be measured by the number of papers published on that 
subject the figure for 1939 was 120 but by 1955 this had 
fallen to 29 titles at a period when the total number of 
papers listed in Index Medicus had begun the spiralling 
increase over pre-war levels. The exquisite sensitivity of 
this organism to antibiotics seriously raised the question 
whether or not it mattered if it was isolated at all, 
particularly from pneumonia patients. The picture was 
different in meningitis for, although sulphonamides had 
reduced the death rate to around 60% in the late 1930's 
(MacLean et al., 1939) and penicillin in the 1940's had
reduced this still further, a fatal outcome for both
meningitis and bacteraemia, even in England and the USA,
remained at 20-30% (Communicable Disease Reports (CDR), 
29/1975, 25/1978, 10/1981, 71/1984 and Broome and Facklam,
1979) and many of the survivors, particularly children, 
showed residual neurological damage. It is worth 
remembering that the other main causes of meningitis are 
much less likely to be fatal, Haemophilus influenzae at 
2.9% and the meningococcus at 8%, and with less likelihood 
of severe sequalae (CDR, 25/1978). Pneumococcal infection 
continued at a much higher level, and was more often fatal
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in less favoured areas; in Nigeria, for example, between 
1971 and 1976, 51% of patients with pneumococcal systemic 
infections died (Baird et al. , 1976) and still, in 1984, a 
small survey of 28 patients with pneumococcal meningitis 
showed that 14 had died, eight were known to have survived 
and the fate of the other six was unknown (Kumasi, 
unpublished data). Survival curves of patients with 
pneumococcal meningitis and bacteraemia showed that most 
deaths occurred within the first five days of illness 
(Austrian and Gold, 1964). These findings suggested that 
for many patients irreversible physiological changes had 
already taken place by the time of admission to hospital. 
This continuing high mortality of pneumococcal systemic 
infection is a salutary example of the failure of 
antibiotics to cure infectious disease unaided. The 
outcome of all infection is dependant on the ability of the 
victim to combat the effects of the invader and this is 
most clearly seen in pneumococcal disease. Victims of 
pneumococcal infection fall broadly into two groups. 
Firstly those in whom trauma has physically damaged 
protective membranes and allowed penetration of the 
organism into the body, e.g., meningitis is a common 
sequelae of fracture to the skull or cribriform plate. The 
other much larger group consists of those in whom the 
immune system is either not developed, as in the infant, or 
is or has become incompetent because of age, predisposing 
diseases or drug therapy. Children under five years old 
and especially those under two years appear unable to make
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sufficient or effective anti-polysaccharide antibodies 
(Howie et al., 1976; Borgono et al., 1978 and Riley and
Douglas, 1981). Surveys of the results of vaccination in 
infants, under one year old, have shown low antibody levels 
after one or two injections and when examined at two years 
of age the levels were identical to the unvaccinated group 
( Sell et a l ., 1978). Patients whose defences have been 
reduced include those suffering from sickle cell disease 
(Seeler et al., 1972), malignancy and other disease in 
which treatment results in immunosuppression (Allen and 
Weiner, 1981), alcoholism (Brayton et a l ., 1970), poor
nutritional conditions and being one of or descended from 
the indigenous natives of America (Herbert et a l ., 1967 and 
Davidson et a l ., 1976), Africa (Johnson, 1981), Australia 
and New Guinea (Douglas and Riley, 1979). Ethnic origin 
and any of the other factors when combined exaggerate some 
inherited tendancy for pneumococcal infection in those 
peoples (Johnson, 1981). That is except for otitis media 
which is more common in white children, probably because of 
anatomic differences in the eustachian tube (Doyle, 1977) . 
In sickle cell disease, in which the spleen can be
destroyed or need to be surgically removed, the infection 
results from lack of the spleen which would otherwise
selectively clear the blood of pneumococci and generate the
early antibody response (Singer, 1973 and Wara, 1981) . 
This loss in combination with sluggish antibody production 
and a decreased turnover of the alternative complement 
pathway components, a source of non-specific opsonising
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immunoglobulin (Pearson, 1977), is often fatal. Another 
large group of victims, even in the so-called developed 
countries, is the elderly patient in whom the immune system 
is naturally in decline and may not produce sufficient 
antibody until it is too late. The natural course of 
pneumococcal disease is a race to produce sufficient 
antibodies in the host to remove the organism before the 
effects of the infection exhaust the patient's strength. 
The above groups of patients all suffer from the combined 
disadvantages of a lack of prompt immune reponse and a 
reduced capacity to cope with the stress of infection. If 
pneumococcal antibody production reaches the crucial level 
by the third to the fifth day of overt illness the fever is 
resolved by crisis, the patient's temperature drops 
dramatically and survivors suffer prolonged weakness. In
the 1930's, when both pneumonia and poor nutritional
\conditions were common, convalescent pneumococcal patients 
occupied more than two thirds of the beds on medical wards, 
for a month or more during six months of each year 
(Finland, 1981). At this time the other major cause of bed 
occupancy was typhoid fever whose season of high incidence 
dove-tailed into the rest of the year. Typhoid fever is 
largely a disease of the past, in developed countries, but 
pneum onia is still as common a cause of admission as it 
was then (Finland, 1981). The order of events from onset 
of infection to crisis is incompletely understood and 
varies both with the host and the type of pneumococcus 
involved (Austrian, 1975). The first line of defence
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against invading organism is the mucosal surface of the
respiratory tract to which the pneumococcus must attach
without being opsonised and then avoid or overcome the
alveolar macrophages (Tylewska et al., 1980; Andersson et
al., 1981 and Rosenberg, 1981). In vaccinated persons
sufficient opsonising antibody is present at the lung
surface to induce the macrophages to phagocytose the et U
bacteria (Hof,^1980 and Coonrod and Yoreda, 1981). If the 
pneumococci are not consumed invasion can spread into the 
interstitial spaces of the lung, to the hilar nodes and 
thence into the blood stream resulting in meningitis, 
peritonitis , endocarditis or myocarditis by metastatic 
spread (G'ad'aleanu , 1980 and Johnston, 1981).
Pneumococci are able to effect infiltration of the lungs 
not by overwhelming the victim with toxins but, by stealth, 
avoiding activation of the opsonising system. The 
pneumococcal capsule protects the organism from 
phagocytosis by wandering macrophages and proteases are 
released from the organism capable of destroying secretory 
IgA (Kilian et a l ., 1979 and Mulks et a l ., 1980), a
phagocytosis-enhancing immunoglobulin present in the mucus.
Certain strains reduce the probability of opsonisation 
further by not activating the alternative complement system 
(Guckian et a l ., 1975* and Edwards and Stark, 1977). Once a 
focus of infection has been established in the lung tissue 
the combination of any of the potentially reactive 
constituents of the pneumococcus and the immune system, 
e.g. capsular polysaccharide with antibody, C substance
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with C-reactive protein (CRP) or bacterial cell wall with 
the alternative complement pathway, leads to the release of 
potent mediators of inflammation (Tomasz, 1981). The more 
virulent organisms are less readily phagocytosed, require a 
greater degree of complement binding for opsonisation and 
would therefore be expected to have increased persistence 
in the lung, which would cause excessive release of the 
acute inflammatory mediators. Interaction of C-reactive 
protein and pneumococcal carbohydrate can start the 
complement fixation series by initiating release of the Cl 
component (Mortensen et a l ., 1976). The release of the C5 
factor of complement and its derivatives enhances 
chemotaxis of neutrophils, monocytes and macrophages and 
stimulates the release from the neutrophils of granule 
enzymes and toxic oxygen metabolites into the lung (Webster 
et al ., 1980). Anaphylatoxins (Dias da Silva and Lepow,
1967) and C567 complexes (Ward et a l ., 1966) also formed by 
activation of the complement system cause permeability 
changes and cell wall damage of the host's own tissue. The 
degree and extent of the changes seen in the pneumonic lung 
may be produced by the body^.s over-reaction to invasion as 
much as by direct aggressive action of the organism. None 
of a number of pneumococcal products e.g. haemolysin, 
purpura-producing principle, virulin, leukocidin and 
neuraminidase has been proven to be the pathogenic 
principle in pneumonitis (Johnston, 1981 and Tomasz, 1981).
At the time of death the extent of the pneumonitis is 
insufficient to cause anoxia and the mass of bacterial
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particles is not significant in relation to the size of the 
host (Perry and Cluff, 1963). Injection of large numbers 
of killed pneumococci fails to cause death therefore the 
mediators of imflammation probably contribute largely to
the fatal outcome and may explain the waves of spreading 
oedema surrounded by a fringe of polymorphonuclear white 
blood cells, a characteristic feature of the histology of 
pneumococcal pneumonia. Factors that weaken the natural 
resistance of the respiratory system to infection, such as 
temperature variations and viral infections, assist in the 
establishment of pneumococcal disease. The question 
whether chilling facilitates invasion of the lower
respiratory tract has been disputed (Douglas and Riley,
1979) but the frequency of pneumonia is clearly related to 
the effect of temperature changes on certain types of 
occupation. Exposure to inclement weather and subjection 
to extremes of heat gave attack rates of 13 and 12.6 cases 
per 1000 men per year respectively; in factory workers, 
with only small temperature changes, this rate was 3.9 per 
1000 per year (Brundage and Bloomfeld, 1932). Experimental 
evidence (Green and Kass, 1965) indicates that cold
immersion lowers pulmonary antibacterial activity 
presumably by its effect on the alveolar macrophage, but 
this could also be by a reduction in pulmonary blood flow 
(Gwaltney et al., 1975). A strong correlation was shown 
between weekly mortality from bronchopneumonia in infants 
and low temperatures at the time of onset of the illness 
(Payling-Wright and Payling-Wright, 1945). These mortality
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rates were related to poverty and poor housing and rose 
sharply when the temperature fell below 4°C. Lunn et al., 
in Sheffield (1967), and Douglas and Blomfield (1958) found 
a significant excess of respiratory infections in children 
related to social class, pollution and living in a family 
with an adult with chronic respiratory infection. Seasonal 
variation in the carriage of pneumococci and transmission 
on the incidence of pneumonia is also associated with colds 
and overcrowding (Brimblecombe et a l ., 1958); conversely 
lowest carrier rates and infections are both seen in the 
summer months (Loga et al., 1975). The seasonal incidence 
of pneumonia parallels the seasonal variation of viral 
infections of the respiratory tract, largest numbers of 
isolations being in the winter and spring months. Onset of 
pneumococcal pneumonia in >90% of cases is preceded, a week 
or two before, by "cold-like" symptoms (Finland, 1981). 
The interval, between start of the viral illness and 
emergence of the symptoms of pneumococcal infection, gives 
time for pneumococcal antibody production to have begun, 
and to be present in therapeutic levels only 3-5 days after 
severe illness has been recognised. A gradually 
accelerating cyclic process can be envisaged, following in 
the wake of viral supression of the bodies defences (Hodges 
and MacLeod, 1946; Harford et al., 1949; Fiala, 1969 and
cvftA. Cc-rr usco
Ferdandez-Peuntes,j^l980) when persistence of pneumococci in 
the lung causes increasing production of inflammatory 
mediators. This increases the inflammatory response and 
physiological damage which finally gives rise to clinical
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disease, 7-12 days later, at which time the process may 
have advanced too far for effective treatment. Although 
doubt has been expressed as to which viruses are involved, 
rhinovirus, parainfluenza and particularly influenza virus 
are the prime suspects (Lepow et al., 1968). The increased 
incidence of pneumococcal bacteraemia following severe 
pneumonia is a further indicator of influenza virus in the 
community. The 1957 A 2 influenza virus outbreak increased 
the incidence of pneumococcal bacteraemia by 300% in the 
peak month of the epidemic (Austrian, 1968). These gloomy 
portents receeded as the actual number of deaths from 
infectious diseases ‘ from all causes fell by 60% from the 
late 1950's to the mid 1970's, although deaths from 
respiratory diseases stayed the same (Cockburn, 1979). In 
children however, within five years of the introduction of
sulphonamides (Kanof et al., 1943), pneumococcal
bacteraemia no longer was the common companion of childhood 
illnesses. Other problems appeared more pressing, notably 
outbreaks of hospital acquired sepsis produced by 
entero-pathogenic Escherichia coli (Kauffman, 1969) and 
multi-resistant staphylococci (Williams, 1959). It was a 
case of "out of sight, out of mind" and, although Dowling 
and Lepper in 1951 and Austrian and Gold in 1964 
demonstrated that pneumococcal bacteraemia still carried a 
significant mortality rate regardless of antibiotics, it 
was not until the late 1960's and early 1970's that the 
pneumococcus was brought back into the mainstream of 
microbiological and clinical attention. The spectre of
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clinical pneumococcal isolates resistant to antibiotics 
first appeared as sporadic reports of strains tolerant to 
penicillin from Australia, New Guinea and South Africa 
(Hansman and Bullen, 1967; Hansman, 1972 and Gratten et 
a l ., 1980) and progressed to a world wide phenomenon 
(Hansman, 1977; Watanakukorn et a l ., 1980; Hansman, 1980) 
with examples emerging in America (Heiber and Nelson, 1977 
and Cooksey et a l ., 1978), England (Howie and Mitchell,
1976), Canada (Dixon, 1974), Finland (Zacchrisson and 
Brorsen, 1981), South Africa (Ward et al., 1979), Italy (De 
Bac et al., 1981) and Japan (Oguri and Kosakai, 1981),
showing resistance to an increasing array of antibacterial 
agents (Jacobs et a l ., 1978 and Landesman et a l ., 1979).
When the first penicillin tolerant strains were recognised
the resistance of S. pneumoniae to tetracycline was 
widespread (Percival et al., 1969 and Howard et a l . , 1978)
and had reached 13% of isolated strains in Evans and 
Hansman1s paper (1963). Occasional strains resistant to 
erythromycin (Dixon, 1967) and chloramphenicol (Applebaum 
et al., 1977 and Garau et a l ., 1981) had also been seen. 
The danger of the situation was made apparent when Jacobs 
et a l . (1978) reported strains of pneumococci from
hospitals at two South African centres, Johannesburg and 
Durban, resistant to all of a range of antibiotics,
including the penicillins, cephalosporins, erythromycin, 
tetracycline, clindamycin, sulphonamides rifampicin, 
streptomycin and chloramphenicol. Because of the exquisite 
sensitivity of the pneumococcus to penicillin, testing of
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isolates for antibiotic susceptibility was only rarely 
performed until the pneumococcus unexpectedly showed, after 
thirty years exposure to antibiotics, a capability for 
developing multiple-resistance and thereby posing a major 
threat as a hospital and possibly, a community, pathogen 
(Ward et a l . , 1979 and Mylotte <>n<\ SatM\ , 1981) . The
pneumococcus has revealed many similarly unusual and 
fascinating features over the last hundred years, not least 
of which is the ability, after languishing on the mucus 
membranes in a commensal role for various lengths of time 
(Straker et al., 1939; Clifton et al., 1955 and Hendley et 
a l., 1975) , before suddenly becoming pathogenic and often 
rapidly fatal, without the reason for this change or the 
cause of death being known, despite extensive and intense 
study. This paradox was evident from the first record of 
pneumococcal isolations in 1881 when the injection of human 
saliva into rabbits, independently, by Sternberg and by 
Pasteur produced septicaemia and death of the animals. The 
isolation by Fraenkel in 1886 of the coccus, originally 
named Diplococcus pneumoniae, from the sputa of patients 
with pneumonia, indicated its role in human disease. 
However controversy raged over whether the diplococci, 
reported by Fraenkel, or the bacilli, stained in sections 
of lung by Gram, from Freidlander's fatal cases of 
pneumonia were the actual cause of pneumonia (Austrian, 
1960). Weichselbaum1s extensive study, in 1886, of the 
bacteriology of pneumonia resolved this heated issue but 
differences between the presence of organisms in
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Gram-stained films and their growth in vitro has continued 
at the root of more recent problems with the pneumococcus 
(Barrett-Connor, 1970 and Merrill et al., 1973). The
laudable, but often indiscriminant, use of antibiotics
before bacteriological specimens have been obtained has 
clouded the issue, since even a single dose of penicillin 
can reduce the vitality of the infecting strain (Crofton, 
1970; Murray and Hampton, 1980 and Adenyi-Jones et al., 
1980) . Such interference with growth can produce negative 
culture reports, in vitro, despite positive Gram film 
results (Lepow et a l ., 1968; Spencer and Philips, 1973;
Rein et al., 1978 and Sarachik, 1979). Some authors have 
shown only 40-60% of the isolates expected from the results 
of Gram-stained smears, even in samples from patients 
without prior antibiotic therapy (Williams and Kauffman, 
1978; Fiala, 1969; Barrett-Connor, 1971 and Boerner and
Zwadyk, 1982). Animal inoculation for the recovery of the 
pneumococcus by its differential pathogenicity was, and by 
some authors still is, considered to be the better
isolation method, particularly when the specimen may 
contain other bacteria (Austrian, 1959; Rathbun and Govani, 
1967 and Converse and Dillon, 1977). However the cost and 
logistic problems of maintaining a large population of 
animals has contributed to the decline of this approach. 
The method should also be abandoned because of the
bacteriological problems associated with extrapolating 
results from animal experiments to human disease. MacLeod 
(1952) and others have shown that certain serotypes of the
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pneumococcus, including type 14, an invasive type of human 
infection (Heffron, 1939) are non-pathogenic for mice, and 
in general the higher the serotype number the less likely 
are they to be demonstrated in the animal (Morch, 1943) . 
Unfortunately the alternative procedure of culture on 
artificial media, as routinely employed in many
laboratories, and quoted in the papers regarding Gram films 
and poor performance culture results, suffers from a number 
of weaknesses which may explain the differences in results.
Conventional culture, by aerobic incubation on enriched 
blood-containing agar plates, produces a small indented ( 
so-called "draughtsman") colony showing a degree of 
greening or change in the surrounding medium. This 
appearance can easily be overlooked especially when the
sample includes other greening streptococci and if the 
plate is the subject of an inexperienced or hurried 
examination. To avoid these pitfalls it is recommended 
that careful scrutiny of the plate, by a microscope at low 
power or a hand lens (Austrian, 1971), followed by the 
testing of at least three colonies from each culture is 
necessary to maximise the recognition and identification of 
pneumococci. Recovery rates are increased (Auger, 1939, 
Kempner and Schlayer, 1942) without markedly enhancing 
colony size, if the plates are incubated in an atmosphere
containing extra C 0 2; for example in a candle jar (at 2%)
or C 0 2 incubator (at 5-10%). Carbon dioxide appears to 
have two advantages for the artificial culture of 
pneumococci, firstly in reducing the lag period of growth
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following transfer of the organism from the host to a new 
environment (Valley and Rettger, 1927; Walker, 1932;
Broquest and Snell, 1951 and Repaske et a h , 1974)', and 
also because growth of certain strains is dependent upon 
levels of C O 2 above the normal atmospheric value of 0.03% 
v/v, i.e. these cultures are carboxyphilic (Austrian and 
Collins, 1966, Sebest^ny, 1978). Sir Alexander Fleming, in 
1941, recommended the advantage of incubating all cultures 
from the respiratory tract with added C 0 2 after repeated 
attempts to grow a coccus seen in Gram-stained films failed 
until C O 2 was added to the culture environment from a Kipps 
apparatus. A further handicap to successful recovery, 
evident as intense greening or bleaching around colonies on 
blood containing agars, especially when the catalase 
content of the blood has been reduced by heating, is 
produced by the toxic accumulation of hydrogen peroxide 
(MacLeody^ 1922 and Holt, 1962). The formation of hydrogen 
peroxide and therefore the need for a peroxide handling 
enzyme system by the organism would be minimised if 
cultures were performed in an anaerobic environment. It is 
often overlooked that the natural habitat of the 
pneumococcus, the respiratory tract, besides being an area 
with a high C 0 2 level is in fact a reduced environment 
since the oxygen content of the mucu^ is removed by the 
metabolism of the bacteria harboured within the secretions.
The adaption of the pneumococcus to a reduced environment 
with an increased C 0 2 concentration is further seen when 
the focus of infection in tuberculosis of the lung and
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pneumococcal pneumonia is contrasted. Tuberculosis, 
produced by the aerobic mycobacteria, starts in the well 
oxygenated upper lobes of the lung and the pneumococcus, a 
facultative anaerobe, invades the lower lobes, an area of . 
high CO 2 and relatively low 0 2 tension. Early papers by 
Bolognesi (1907) and Smith (1936) reported anaerobic 
pneumococcal strains but the advantage of using both 
anaerobiosis and increased C 0 2 as the atmosphere for their 
clinical isolation was not appreciated.
A preliminary report (Howden, 1976) confirmed the enhanced 
effect of the combined atmosphere. Culture in an anaerobic 
atmosphere, containing extra C 0 2, significantly increased 
the isolation rate, size of the pneumococcal colony and 
minimised peroxide production, indicated by a lack of 
greening when grown anaerobically on heated blood agar.
Both animal inoculations and artificial culture methods 
suffer from the practical disadvantage of reliance on 
suitable samples being obtained before antibiotic therapy 
is started, followed by speedy transfer to and processing 
in the laboratory. A number of techniques for the 
detection of bacterial antigens, directly from a patient's 
sample, avoiding the uncertainties of culture and prior 
antibiotics (Tugwell and Greenwood, 1975) began to be 
applied to pneumococcal disease (Dorff et al., 1971; Coonrod 
and Rytel, 1972 and Whittle et a l ., 1974). The first to 
come into vogue was crossed-immunoelectrophoresis (CIE), in 
which pneumococcal antigen, in the patient's sample, was 
made to migrate in a buffer system across an agar gel
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towards pneumococcal capsular antibodies migrating in the 
opposite direction and observed for precipitation lines 
(Anhalt and Yu, 1975; El-RafA»<£, and Dulake, 1975 and
Silverman et al,, 1977). In comparisons of media, direct
Gram-stained smears and rapid antigen methods, the latter 
appeared the most sensitive indicator of pneumococcal 
infection (Olcen, 1978; Fossiek and Fedorko, 1979 and
Edwards et al., 1980). But the bacteriological isolation
procedures used were aerobic culture only, either with or 
without extra C 0 2. The co-agglutination technique, in 
which the pneumococcal antigen is agglutinated with 
specific antibody, previously attached to staphylococcal 
cells, was next applied to pneumococcal work both for
serotyping isolates (Kronvall, 1972) and later for the 
detection of antigen in patient's samples (Edwards et a l ., 
1980). Other rapid diagnostic methods, enzyme-linked 
immunosorbent assay (ELISA) (Barrett et al., 1980 and Drow 
and Manning ,, 1980), fluorescent antibody technique (FAT)
(Clausen, 1981), pneumococcal antibody labelled latex 
particles (Coonrod and Bauer, 1976) radio-immuno assay 
(Leinonen, 1980) were introduced during the course of my 
study, each appear to have merit for the study of 
pneumococcal disease but were not investigated due to lack 
of time and the necessary equipment. Antibody coated latex 
particles, a similar principle to co-agglutination, has 
been reported to be more sensitive than CIE (Kumar et a l .,
1980) .
The antigen detection methods were developed for rapid
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diagnosis of infection but can also be used to serotype the 
increased number of isolates produced by anaerobic
incubation with extra C 0 2. An extended survey of the 
strains obtained by this new culture method to determine 
the serotypes involved was indicated, as the strains may 
include previously unknown types whose distribution may 
differ from other reports. The pattern of serotypes 
recovered may have relevance to the effective use of 
pneumococcal vaccines, especially in this hospital which 
includes a Regional Centre for children with malignant 
disease, a high risk group for pneumococcal infections. 
Many surveys of the frequency of serotype distribution both 
in time and place have shown significant differences 
(Finland and Barnes, 1977 and Broome and Facklam, 1981) 
including the types associated with childhood and adult
illness (Austrian, 1959; Gray et al., 1979; Riley and
Douglas, 1981 and Klein, 1981). Morch in a 1944 Danish
study, found types 06, 14, 19 and 23, in 59.9 per cent of 
isolates from children aged 2 years or less and in only
12.1 per cent of strains from those aged 12 years and more 
(Morch, 1944). Serotypes responsible for bacteraemia in 
adults and children differed from those isolated from focal 
infections such as otitis media (Kamme et al., 1970; Loda
et al., 1975 and Gray et al., 1979). Other reports
confirmed serotypes 06, 14, 19 and 23 as responsible for 
most cases of bacteremia or meningitis in children and also 
included serotype 18 in that group of strains (Seigel et 
al., 1978). Serotype 03 was given as the principal cause
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of invasive disease in general and serotype 19 as the 
leading cause of otitis media (Kamme et al., 1970; Austrian 
et al., 1977 and Gray et al., 1979). Although serotype 03 
was often seen in otitis media it was an infrequent cause 
of sepsis or meningitis in children. Frequency of 
particular serotypes, notably serotype 02, changed from the 
dominant isolate, up to the late 1930's (Griffiths, 1928 
and Heffron, 1939), to being a rare finding by 1945 
(Austrian, 1968); most other serotypes have not shown such 
dramatic change (Finland and Barnes, 1977). There has been 
concern that the introduction of pneumococcal vaccination 
into an area would affect the distribution of strains but
MacLeod, (1949) and Austrian et al. (1976) showed that the
carriage of non-vaccine serotypes was not altered in 
populations after vaccination. Variation has also been 
seen with serotypes responsible for the bulk of infections 
differing from one part of the world to another (Lund,
1959; Hansman 1977a; De Bac et al., 1979; Gausta^., 1979; 
Jacobs et al., 1979 and Kalin et al., 1980). Serotypes 02 
and 25 seldom cause bacteraemia or pneumonia in the United 
States but are common causes of disease in Papua New Guinea 
(Riley and Douglas, 1981) and in South Africa (Austrian,
1981), and a survey of pneumonia and meningitis in Nigeria 
and Senegal indicated that serotypes 01 and 05 were the 
most frequent types (Greenwood et al., 1980) . Frequency of 
occurence is not always a direct indication of the
incidence of disease, pneumococcal serotypes have widely 
different invasive potential in and between man and animals
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and there is an inverse correllation between case rates and 
carriage (Riley and Douglasf 1981). For example, 60% of 
carriers of serotypes 01 or 05 developed pneumococcal 
pneumonia when they developed an upper respiratory 
infection, whereas only 5% of carriers of serotype 20 did 
so (Hodges and MacLeod, 1946). Although the proportion of 
cases caused by each serotype has changed over the years 
the same twelve types are reponsible for the majority of 
bacteraemic infections (Tilghan and Finland, 1937 and 
Austrian and Gold, 1964) and eight serotypes account for 
70% of ear infections (Kamme et al., 1970 and Douglas and 
Riley, 1979). Severity of the disease can also be a 
product of the serotype, bacteraemic infections caused by 
type 01 have a fatality rate of 6% when treated with 
penicillin, similarly treated infections caused by 
pneumococcus type 03 are accompanied by a mortality of 48% 
(Austrian, 1968) . This difference in the prognosis caused 
by different serotypes provides an additional reason for 
identifying the capsular type of the organisms causing 
infection. Even within a serotype virulence is greater for 
certain strains (Griffith , 1981) than others and
satisfactory rapid differential markers beyond the 
organisms capsular polysaccharide are required. 
Recognition of these aggressive variants is essential to 
our understanding and possible treatment at an early stage 
of this life-threatening infection. Differentiation of 
pneumococci at present is limited to identifying the 
serotype of the strain's capsular polysaccharrides by its
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reaction with the 46 type or group antisera covering the 83 
known serotypes. Sera are available only in the Danish
Serum Institute to recognise the antigens of which each 
type is composed because of stability problems of the 
highly absorbed antisera and the complexity of the number 
of antigens represented in each type. Antisera for 
serotype 06, for example, is a group reagent which contains 
antibody to detect sub-types 06A and 06B, which have the 
antigenic formulae 06a, 06b and 06a,06c respectively; some 
other groups have much more complicated antigen 
compositions. Therefore, under most situations, relatively 
crude strain to strain differences only can be detected. 
Essentially a differential scheme should preferably be 
simple to perform, reproducible and perhaps relate to the 
infective process under review. All typing systems depend 
on the genetic stability of the markers chosen and it is 
theoretically impossible to devise a perfect system for 
epidemiology (Elek and Higney, 1970). Study of the 
pneumococcus urgently needs a simple distinguishing test or 
group of tests to provide suitable strain markers. Much of 
the work on the pneumococcus was performed before modern 
characterisation techniques were available and a
re-examination of some of these, for example enzyme 
detection, derived from the old carbohydrate fermentation 
tests, may have merit (Morch, 1943) . Unique pneumococcal 
enzymes have been recognised (H'Oltje and Tomasz, 1975; 
Glasgow et al., 1977 and Kobata gKJ j' , 1978) which could 
form the starting point for differentiation by
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characteristic enzyme patterns. The enzyme profile tests, 
such as the APIZYM strip, a commercial source of prepared 
substrates have been applied to detecting enzymes in cells 
and bacteria (Humble et al., 1977 and Tharragonnett et a l ., 
1977) including the non-haemolytic streptococci (Waitkins,
1977) , and may be applicable to the pneumococcus. 
Alternatively indicator labelled substrates, e.g. 
nitrophenyl or methylumberiferryl derivatives, provide an 
inexpensive, rapid and sensitive indicator of enzyme 
activity. Production of haemolysins has also been used 
as a factor to recognise pathogenicity in the streptococci 
and the Clostridia and if more reliably produced in the new 
anaerobic culture method could find application in the 
pneumococci. Other observations, made early in the study, 
on growth inhibition by the pH indicator, bromothymol blue, 
and the Eh indicator, methylene blue, were expanded into 
investigations of these and other dyes as differential 
indicators of individual strains. These new aspects 
confirm that, nearly 100 years after its first recgnition, 
there are still many fascinating and potentially rewarding
facets to the association of man and the pneumococcus.
The aims and objectives of this thesis therefore will be:-
i) to serotype, over a four year period, the pneumococci 
isolated by the combined atmosphere culture method from 
routine hospital laboratory specimens;
ii) to examine methods for this serotyping and the
detection of pneumococcal antigen in the patient;
iii) to examine factors affecting the recovery of
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pneumococci under different gaseous and cultural 
conditions;
iv) to attempt to recognise differential properties of the 
strains by their enzyme patterns and by their production of 
haemolysins, and to assess the suitability of dye 
inhibition in distinguishing among the pneumococci; a 
number of different pneumococcal strains would be examined 
during the study in order that recent clinical isolates be 
tested in preference to laboratory maintained cultures 
which may have lost their viruleunce during storage;
v) to test for antibiotic resistance;
vi) to collect and process epidemiological information on 
the patients and strains seen during the study.
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2.1 PATIENTS
The patients were children aged between 1 day and 16 
years who attended the Children's Hospital, Western Bank, 
Sheffield, for a variety of reasons not always directly 
related to pneumococcal infections. Children were either 
referred to the Hospital's Out-patient departments 
initially by their General Practitioner, admitted for a 
pre-arranged operation, admitted as medical or surgical 
emergency admissions to the wards at Western Bank or the 
Thornbury Annexe (approximately 1.5 miles away) or came to 
the Accident and Emergency Department. Several children 
were referred from other Sheffield hospitals, e.g. Jessop 
Hospital for Women (Maternity) and a further group of 
children were transferred from other hospitals in the Trent 
Regional Health Authority, i.e. Rotherham, Doncaster, 
Chesterfield, Scunthorpe, Grimsby and Lincoln, most 
commonly because of complications following meningitis and 
spina bifida.
2.1.1 Samples
Specimens were obtained from the patients by medical 
or nursing staff by routine procedures.
i) Swabs. A sterilised cotton wool swab on a wooden stick 
(Hospiswabs MW130, Medical Wire) was used to obtain 
material from the throat, nose, mouth, eyes, ears, burns, 
operative and accidental wounds, vaginal secretions, skin 
(finger, face and other sites), parotid duct or peritoneum
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of the patient as appropriate. Swabs were also used to 
sample the lung surface, oesophagus, middle ear and 
bronchial airways at autopsy. After sampling the swab was 
returned to its plastic container for transfer to the 
laboratory.
ii) Sputum was obtained with the help of a physiotherapist 
or by suction after passing a catheter into the trachea of 
an intubated child and collected into a sterile disposable 
plastic bottle.
iii) Cerebrospinal fluid (CSF) was aspirated from the 
lumbar spinal region by the attending doctor. Occasionally 
the fluid was taken from the ventricular space in the brain 
or from the valve chamber or reservoir of a CSF shunt 
system inserted in patients with hydrocephalus to reduce 
the intercranial pressure.
(iv) Blood culture was performed by the medical staff after 
skin disinfection of the venepuncture site with 
Chlorhexidine (Hibitane, ICI). Approximately 2 ml of blood 
was divided between two bottles of commercially prepared 
"Bloodgrow" culture broth (MW 900, Medical Wire). The 
bottles were incubated at 37°C for one week with daily 
observation for growth. Gram-stained films were made from 
bottles thought to show growth and if positive subcultures 
made on two blood agar plates, one each for aerobic and 
anaerobic culture and on MacConkey agar for aerobic 
culture; all were incubated at 37°C for up to 48 h. After 
7 days, apparently negative bottles were subcultured on to 
a heated blood agar plate which was incubated at 37°C for
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18 h aerobically with 10% C 0 2.
v) Sinus-antral washouts. Sterile normal saline was
instilled via a catheter to free the mucus and pus 
obstructing the nasal sinuses. A sample of the washings 
was removed by suction and placed in a sterile plastic 
bottle.
vi) Urine. A midstream specimen of urine was collected , 
after cleansing the external genitalia, and transferred
into a screw capped glass 25 ml bottle.
vii) Pleural Effusion Fluid from an empyema or pleural 
effusion was obtained by the medical staff from the pleural 
cavity with a syringe and needle and transferred to a 25 ml 
glass bottle.
viii) Bladder Discharge. The contents of the bladder in
spina bifida patients with a non-functional bladder were
obtained by washing out the bladder with sterile saline 
into a 25 ml glass container.
2.1.2 Transport of specimens to the Laboratory
During normal laboratory hours, specimens were sent 
routinely from the ward with minimum delay to reduce loss 
of bacterial viability. Outside these hours, swabs were 
placed into Amies transport medium (Oxoid), held at room 
temperature and cultured the next day.
2.2 ISOLATION MEDIA AND CULTURAL CONDITIONS
All the pneumococcal strains were routine isolates 
using the procedure developed in this laboratory (Howden,
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1976). The media used were Blood agar (CBA) and heated
blood agar (HBA). Blood agar was Columbia agar base 
(Oxoid) autoclaved at 15 lbs/sq in for 15 min and allowed 
to cool to 55°C before the addition of 7% (v/v)
defibrinated horse blood (LabM). Heated blood agar was 
prepared by similar methods except that the complete medium 
was heated to 90°C until its colour changed to dark brown. 
The agar media were dispensed in 15 ml volumes in petri 
dishes, allowed to set and the surfaces were dried for 10 
min at 37°C. If the plates were not required on the day of
preparation they were stored at 4°C for up to 2 days.
Specimens were spread evenly over approximately 20% of the 
area of a CBA or an HBA plate and spread with a sterile 
nichrome wire loop in three stages to obtain discrete 
colonies. Plates were incubated at 37°C for 18 h, the HBA 
plate aerobically in an atmosphere enriched with 5-10% C 0 2
(Distillers Co.) and the CBA plates anaerobically as
described in the gaseous environment, Section 2.4.1.
2.3 IDENTIFICATION OF ISOLATES
Gram-stained films and a catalase slide test were 
performed on suspected pneumococcal colonies.
Gram-positive diplococci that were catalase negative were 
identified by tests for bile solubility and optochin 
sensitivity.
i) The rapid bile solubility test (Howden, 1979) was 
carried out by placing a loopful of a 10% (w/v) aqueous 
sodium deoxycholate solution, pH 7.0 on the suspected
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colony. After incubation at 37°C for 10 min pneumococcal 
colonies had dissolved and non-pneumococcal colonies 
remained entire. If a doubtful result occurred, the rapid
test was confirmed by overnight bile solubility and 
optochin sensitivity tests.
ii) Overnight bile solubility. To 1 ml of an overnight 
culture was added 1 ml of 10% (w/v) sodium deoxycholate
solution. After incubation at 37°C for 10 min, the fluid
was examined; clearing of the culture was a positive result 
and a negative result was when the culture remained turbid.
iii) Optochin test (Lund, 1959). The test culture was 
spread on to half of a blood agar plate and an optochin 
paper disk (Mast Laboratories) added; the plate was 
incubated in air plus 10% C 0 2 at 37°C for 18 h. A zone of 
inhibition >18 mm in diameter was a positive result.
2.4 EFFECTS OF GASEOUS ENVIRONMENT ON GROWTH
2.4.1 Incubation conditions for the clinical specimens
The cultures were incubated under the standard 
anaerobic conditions used in the laboratory. The
inoculated plates were placed, with the lid uppermost, in 
an anaerobic jar (Baird and Tatlock) equipped with a 
palladium catalyst (Oxoid). The air was evacuated to a 
vacuum of 660 mm Hg and replaced with a gas mixture of 90% 
H 2 and 10% C 0 2. Reaction of the oxygen remaining in the 
jar and the added hydrogen under the influence of an active
catalyst produced a secondary vacuum of 20 mm Hg within 10
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min which was equalised with more of the gas mixture. The 
jars were incubated at 37°C for 18 h. A nutrient agar plate 
streaked with a culture of Pseudomonas aeruginosa was 
included in each jar as a control. The Pseudomonas, an 
obligate aerobe, would not grow if all the oxygen had been 
removed and the vessel remained airtight.
2.4.2 Culture of pneumococci to determine the optimum 
conditions for growth
Pneumococcal cultures were incubated in seven
distinct gaseous atmospheres given below:
a) 90% hydrogen (H2) and 10% carbon dioxide (C02);
b) 100% H 2;
c) 100% nitrogen (N2);
d) 5% H 2, 85% N 2 and 10% C 0 2;
e) 5% C 0 2 in a C 0 2 incubator;
f) aerobic without extra C 0 2;
g) candle jar container;
For suppliers of the gases see Appendix A.
The routine laboratory procedure as described in
2.4.1 was followed for all gases with the exception of 
nitrogen which required an extra stage. After evacuating 
the jar to 660 mm of Hg nitrogen was added, followed by a 
further evacuation to 660 mm Hg and a second introduction 
of the gas. A secondary vacuum was not produced by the 
nitrogen gas and the jar was immediately placed in the
incubator. The candle jar conditions were obtained by
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placing a lighted candle in the jar which burns until 
approximately 3% of the 0 2 has been consumed and 
approximately 2.5% C 0 2 has been produced.
All cultures were incubated at 37°C unless otherwise 
specified.
2.4.3 Comparison of aerobic and anaerobic incubation for 
the isolation of pneumococci from routine nasal swabs
During a three month period routine nasal swabs were 
cultured on to two CBA plates, one incubated anaerobically 
with C 0 2 and the other aerobically with C 0 2. The swabs 
were then broken off into 7 ml of Todd-Hewitt broth (T-H), 
containing 1% (w/v) liver digest (T-HL), in a 150 X 12 mm 
loose capped glass test tube. After 18 h at 37°C the 
plates were examined for pneumococcal colonies and the 
broths subcultured on two CBA plates/ incubated and 
examined as the original plates. A total of 89 specimens 
were tested.
2.4.4 The growth of pneumococci under different gaseous 
conditions.
To further compare the effect of gaseous conditions 
on pneumococcal growth eight recently isolated strains were 
cultured in an extended range of gas mixtures. The culture 
method was in two stages, firstly the test strain was grown 
anaerobically with C 0 2 on CBA for 18 h at 37°C, a single 
colony transferred to 5 ml of T-H broth, incubated for 4 h 
at 37°C, centrifuged, washed in sterile distilled water and
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finally resuspended in 1 ml of sterile distilled water. 
Each suspension was seeded on seven freshly prepared CBA 
plates using the standard loop method (McGeachie and 
Kennedy, 1963). Since it is known that small numbers of 
bacteria are more exacting in their in vitro growth 
requirements the suspension was diluted 1 in 100 in sterile 
distilled water and subcultured using the standard loop 
method. All plates were incubated at 37°C for 18 h in the 
atmospheres given in Section 2.4.2.
The loss of viability after diluting the supension 1 in 100 
was investigated using a strain each of serotypes 6 and 18 
grown and washed in sterile water as in the above
experiment, diluted 1 in 10, 1 in 50 and 1 in 100 in 
sterile distilled water, PBS and T-H broth; each dilution 
was subcultured on to CBA and incubated anaerobically with 
C 0 2 and aerobically at 37°C for 18 h.
Four cultures were tested by a modified procedure for 
gaseous requirement, the second stage dilution was 1 in 100 
in PBS. After 18 h at 37°C the viable count was recorded.
2.4.5 Direct isolation and gaseous environment
To study the need for different atmospheres, on
primary isolation, nasal swabs were obtained from four
patients suspected of carrying pneumococci. The organisms 
were washed from the swabs into 0.5 ml of PBS and the 
standard loop method used to inoculate seven CBA plates; 5 
ml of T-H was added to the remaining suspension. All 
cultures were incubated at 37°C for 18 h with one of each
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of the seven seeded plates incubated under the seven 
conditions given in Section 2.4.2.
2.4.6 The requirement for C 0 2
It is generally accepted that certain pneumococci 
require extra C 0 2 (Austrian, 1965) for artificial culture, 
nd comparisons were made of growth on CBA under the 
following conditions
Anaerobically in H 2, C 0 2 level approximately nil
Aerobically, C 0 2 level approximately 0.03%
Candle jar, C 0 2 level approximately 2.50%
Carbon dioxide incubator, C 0 2 level approximately 5.0%
Four strains, one each of serotypes 03, 09, 19 and 33, 
recently isolated from clinical samples were cultured under 
each of the above conditions at 37°C for 18 h.
Repeat nasal samples were obtained from two patients 
previously shown to carry pneumococci. The organisms were 
washed from the swabs into 0.5 ml of sterile distilled 
water and a loopful of the suspension plated on to 4 CBA 
plates and 4 heated CBA plates (HBA). One plate of each 
medium was incubated aerobically, aerobically plus 5% C 0 2, 
anaerobically and anaerobically plus 10% C 0 2.
A simple method was developed to assess the requirement for 
C 0 2 by recently isolated cultures. A light suspension of 
the strain was made in PBS, subcultured on to two CBA 
plates by the standard loop procedure; one plate was 
incubated in the aerobic incubator and the second in the 
C 0 2 incubator, both at 37°C for 18 h.
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Absence of growth on the aerobic and growth on the C 0 2
plate was taken to indicate C 0 2 dependence. The test was
repeated on all dependent strains to confirm the need for 
C 0 2.
2.5 IDENTIFICATION OF CAPSULAR SEROTYPES
Four methods were used for capsular typing of 
isolates.
2.5.1 Capsule swelling test
The test strain was mixed with a loopful of each of 
the Pooled antisera (Statens Seruminstitute, Copenhagen) on 
a glass slide and observed for apparent increase in
capsular size. The pooled antisera consisted of an 
Omniserum, containing antibodies raised against all
pneumococcal antigen types, and nine sera that contained 
antibodies to a smaller group of serotypes; by these sera 
the unknown strain could more readily be assigned to a 
single serotype group.
2.5.2Immunodiffusion
Prior to obtaining electrophoresis equipment capsular 
antigen was detected in pneumococcal broth cultures by 
immunod i f f us i o n .
A glass microscope slide (6.5 x 2.5 cm) was placed on a 
level platform and 2 ml of molten Nobel agar in half 
strength Veronal buffer (Table 2.1) pH 8.6, poured on to 
it. When the agar was set, wells, 1.5 mm diameter with
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inter-well gaps of 3 mm, were cut in the agar. This 
pattern of holes allowed four antigens to be tested against 
the 10 pooled antisera. The respective solutions were 
added to the wells using glass capillary tubes and the 
slide placed in a moist chamber for 18 h at room 
temperature. If a precipitation line, observed against a 
dark background, formed between an antigen and antiserum 
well, the antigen was retested with the individual antisera 
of that pool. A permanent preparation was made by staining 
the precipitation lines after the soluble proteins 
remaining in the gel had been removed by immersing the 
slide in physiological saline for 24 h at 37°C followed by 
4 h in tap water. The gel was stained with the Amido Black 
solution (Table 2.2) for 30 min and the excess colour 
removed by decolourisation in 1% (v/v) glacial acetic acid 
containing 1% (v/v) glycerol. The agar was finally dried
at 37°C and examined for black stained precipitation lines. 
Four methods of pneumococcal antigen extraction were 
compared :-
i) T-H broth culture supernate, after 18 h at 37°C;
ii) Alcohol extraction of T-H culture broth. Two volumes 
of 74 OP ethyl alcohol mixed with 1 volume of culture at 
4°C for 18 h; supernate removed and the deposit made up to 
0.1 volume;
iii) T-H culture, lysed by 1% of a 10% (w/v) solution of 
sodium deoxycholate at 37°C for 2 h, followed by alcohol 
precipitation as for method ii);
iv) Protein reduced lysed T-H culture by boiling with 1% of
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50% (v/v) acetic acid, cooling, neutralising with sodium 
hydroxide before proceeding as for method iii).
2.5.3 Immuno-electrophoresis
Pneumococcal antigen was obtained from the supernate 
of an overnight culture in Todd-Hewitt liver digest broth 
(T-HL). On a glass slide on a level surface, 2 ml of 1% 
(w/v) molten agar in either Veronal buffer, pH 8.6, or Tris 
buffer, pH 8.1 (Table 2.1), were poured and allowed to set.
Parallel rows of wells, 2 mm in diameter, were cut 5 mm 
apart. The holes in one row were filled with the test 
antigen and the opposite row with pneumococcal antisera. 
The slide was placed on the central platform in the 
electrophoresis chamber and paper wicks were led from the 
edge of the agar into the buffer chamber containing the 
same buffer. Tris buffer was diluted 1 in 9 in distilled 
water for use. A constant current or constant voltage was 
applied from the the power pack to the electrophoresis tank 
for a time specified in the experiments described below. 
The heat produced by current passing across the slide was 
absorbed by placing a plastic platten containing ice 
beneath the slide before each electrophoretic run. Lines 
of precipitation were first observed against a dark 
background. The gel, washed overnight in physiological 
saline, was transferred to tap water for 4 h, and stained 
in coomassie blue (Table 2.2). The dye solution, diluted 1 
in 20 in 12.5% (w/v) trichloroacetic acid (TCA), was left 
on the slide for 15 rain, the excess stain removed in TCA
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TABLE 2.1
Buffer and staining solutions used in electrophoresis
Veronal buffer (pH 8.6)
Sodium barbitone 10.00 g
Sodium acetate 6.50 g
Distilled water 1.00 1
Thymol (5% (w/v) aqueous) 5.0 ml
The buffer was brought to pH 8.6 with HC1
Tris buffer (pH 8.1)
Tris (hydroxymethyl) aminomethane 0.60 g 
Glycine 2.90 g
HC1 (1 N) 0.5 ml
Distilled water 100 ml
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TABLE 2.2
Staining solutions used in electrophoresis 
Amido Black Stain
Amido Black 
Acetic acid (glacial)
Distilled water to
Decolourising Solution I
Ethyl Alcohol (66 OP)
Acetic acid (glacial)
Distilled water
Decolourising Solution II
10% (w/v) aqueous Trichloracetic acid
Coomassie Blue Stain
Brilliant Blue R 1 g
Distilled water 100 ml
90 ml 
20 ml 
900 ml
i g
7 ml 
100 ml
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before the slide was dried in air.
Crossed immunoelectrophoresis or electroendosmosis, a rapid 
but more complicated technique than immunodiffusion, 
required a series of experiments to select the most
suitable method. The supernate from 100 ml of an 18 h
Tryptone soya broth (TS) culture, at 37°C, of a
pnuemococcal strain found to react with pool H antiserum by 
the immunodiffusion method was used throughout the first
series of tests:-
i) Agar/agar and indubriose in Veronal buffer were compared 
at a constant current of 10, 20 or 30 ma for 30 min and at 
250 mv constant voltage.
ii) A repeat of series i) with Tris buffer replacing the 
Veronal buffer.
iii) Repeat testing in agar/agar gel in Tris and Veronal 
buffers at a 100 mv.
iv) Agar/agar and indubriose gels were repeated in Tris 
buffer at 50 ma constant current.
v) Indubriose gel in Tris buffer at 100 mv for 30 min; the 
reaction temperature was . reduced by a frozen platten 
beneath the slide during electrophoresis.
vi) Fresh group H antigen prepared in Todd-Hewitt broth was 
tested under the conditions used in v ) .
vii) Source of the precipitation artefact was investigated 
by obtaining antigen as supernate from both TS and T-H 
broths with and without 1% (w/v) liver digest and/or 1% 
(w/v) haemoglobin solution and passing a constant current
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of 100 mv for 1 h in indubriose agar and Tris buffer.
viii) New antigen was prepared from whole culture, whole 
culture lysed with sodium deoxycholate and the culture 
supernate, both with and without alcohol precipitation, and 
compared under the conditions used in vii).
ix) The Veronal buffer system was retested with antigens 
from cultures of serotypes 06, 23 and group E identified by 
slide agglutination. A constant current of 20 ma was
applied for 30 min on the antigens against Omni, pool B,
pool H, pool E, serotype 06 and serotype 23 antisera in
indubriose and agar/agar gels.
x) Sensitivity of each system was assessed with neat, 1 in 
3, 1 in 6, 1 in 12 and 1 in 24 dilutions of serotypes 06 
and 23 antigens in both gels under the conditions used in
vii) .
Cultures of pneumococci in T-H, previously tested by 
immunodiffusion and stored at 4°C, were tested by 
electrophoresis at 20 ma per slide for 30 min in Veronal
buffer against their respective pool and component sera; 
strains non-reactive by immunodiffusion were tested with 
the sera against the pool and serotype 06, 19, 23 and 18 
antigens.
The interwell gap in the initial tests, 5 mm, was compared 
with gaps of 2 and 3 mm using 10 strains of groups A, D and 
F in agar/agar, Veronal buffer at 100 mv for 30 min. 
Agar/agar and indubriose gel were both tested at pH 8.6 and 
pH 6.6, using antigens from ix), at 30 ma constant current 
for 30 min.
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Sensitivity of the pH 6.6 gel for pool antisera was tested 
using antigens of groups A, B, C, F, G and H, neat and 
diluted 1 in 12 phosphate buffered saline (PBS),
xi) Detection of pneumococcal antigen in the following body 
fluids was attempted in agar/agar with Veronal buffer at 30 
ma for 30 min:~
a) CSF was centrifuged at 2000 rpm for 10 min and the 
supernate used as the antigen;
b) Sputum was liquified with an equal volume of 2% (w/v) 
N-acetyl cysteine (Airbron), centrifuged at 2000 rpm for 15 
min and the supernate used as the antigen;
c) Whole blood was allowed to clot in a sterile glass 
bottle and the serum obtained after centrifugation at 2000 
rpm for 10 min used as the antigen.
2.5.4 Co-agglutination
The method used was essentially that of Kronval 
(1973). A freeze dried ampoule of Staphylococcus aureus 
Cowan Type 1 (NCTC 8530) was obtained from the National 
Collection for Type Cultures, Colindale, London,
i) Preparation of Protein-A suspension. The organism was 
grown for 18 h at 37°C either
a) in a cotton wool plugged flask (17cm base diameter) 
containing 150 ml of Casein-Cysteine-Yeast broth (CCY, 
Table 2.3) (Ardvison et al., 1971) from which the contents 
were harvested by centrifugation at 2000 rpm for 20 min in 
universal containers, or
b) as lawns on the surface of eight petri dishes containing
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TABLE 2.3
Casein-Cystine-Yeast medium for the culture of 
Staphylococcus aureus
Basal medium 
Casein 8 g
Yeast extract 2 g
Sodium lactate 1.5 ml
N a 2HP0„.2H20 0.2 g
KHjPO* 0.08 g
(NHJ 2S O h 0.2 g
Tryptophane 0.016 g
L-cystine 0.02 g
Distilled water 200 ml
To the medium, autoclaved at 10 lbs/sq in for 15 min, when 
cool were added 2 ml of Supplements A and B (given below) 
Supplement A Vitamin solution
Thiamine 0.02 g
Nicotinic acid 0.04 g
Distilled water 100 ml
Supplement B Mineral solution
MgSO^.THaO 0.2 g
MnS0*.4H20 0.1 g
FeSO^.7H20 0.06 g
Citric acid 0.06 g
Distilled water 100 ml
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15 ml of Columbia base agar (LabM). The growth from each 
plate was removed with the edge of a sterile microscope 
slide into 10-15 ml of PBS and the suspension centrifuged 
at 2000 rpm for 20 min in universal containers.
The deposit from either method was formalised by suspending 
in 25 ml of PBS containing 0.5% (v/v) formaldehyde solution 
BP 36% (v/v) (Evans Medical) for 3 h at room temperature. 
After washing four times in PBS, the concentration of 
treated cells was adjusted to 10% (v/v) and placed in a 100 
ml beaker. A 2 metre length of sterile silicone tubing 
(internal diameter 0.5 cm) and peristaltic pump were 
arranged to pass the suspension continously through an 80°C 
water bath for 3 h.
ii) Modification to the CCY broth method was sought to 
enhance growth and speed harvesting of the staphylococci:-
a) CCY agar plates were prepared, covered with a sterile 
semi-permeable membrane (cellophane jam pot cover) seeded 
with the staphylococcus, incubated for 48 h at 37°C.
b) Alternatively the agar was seeded without membranes and 
the growth removed by scraping into PBS;
iii) Preparation of protein-A co-agglutination reagent 
(PCR). To 0.035 ml of the formalised heat treated 
protein-A preparation was added 0.007 ml of pneumococcal 
capsular antiserum. After 30 min at room temperature this 
was diluted 1 in 4 with PBS containing 0.1% (w/v) sodium
azide before use.
iv) Testing of an unknown pneumococcal isolate.
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Pneumococcal antigen was obtained by either emulsifying an 
anaerobically cultured colony in a loopful (0.005 ml) of 
saline or as the supernate from a T-HL culture. A loopful 
of each of the PCR pools in turn was mixed with the antigen 
on a glass slide and observed for aggregation of the 
suspension (co-agglutination) for up to 1 min. If 
co-agglutination was obtained with a pool PCR, the PCR of 
each of the individual serotypes of that pool were tested. 
To investigate certain pneumococcal strains which, when 
grown in T-H broth, gave no or slow agglutination with pool 
PCR reagents two strains showing this effect were grown in 
TS, RCM, CCY and T-H broths with and without 10% (v/v) 
serum at 37°C for 18 h.
Extraction and concentration of the antigen released into 
T-H broth was attempted by acetone and alcohol 
precipitation both with and without prior boiling to remove 
protein.
v) Modification in the preparation of PCR reagents was 
necessary to cause stronger reactions with certain strains.
At the dilution previously used for all reagents, 1 in 28, 
although more concentrated than Kronvall's recommended 1 in 
100, Omni, pool D and serotype 03 PCR reagents gave weak or 
negative pool reactions with some of their specific 
antigens. The volume of antiserum added to the prepared 
protein-A and the amount of PBS for the in-use dilution was 
varied for each of the screening reagents. Sensitising 
dilutions (SD) were made at 1 in 2 (SDl), 1 in 7 (SD2) and 
1 in 14 (SD3) for each of the antiserum pools and serotype
48
03 in 10% (v/v) treated protein-A for 30 min and further
diluted for use (UD) to 1 in 2 (UD2), 1 in 3 (UD3) and 1 in
4 (UD4) and examined for co-agglutination of the test 
strains indicated below:-
a) Omni serum was tested with strains of serotypes 03, 04,
06, 09, 11, 14, 15, 19, 21 and 23 at SDl, neat and UD2, SD2
and SD3;
b) Pool B: strains of serotypes 03, 06, 08 and 19 were
tested at SDl and SD2 and UD4;
c) Pool H: strains were tested of serotypes 13, 14, 15, 23
and 28 at SDl, SD2, SD3 and UD4;
d) Pool E: with serotypes 10, 21 (two strains) and 33 at
SDl, SD2, SD3, UD2, UD3, UD4;
e) Pool D: serotypes 09 (two strains), 11 (two strains), 16 
and 37 at SDl, SD2, SD3 and UD2;
f) Pool F: serotypes 17 (three strains) at SDl, SD2, SD3
and UD2;
g) Pool G: serotypes 34 and 35 (four strains) at SDl, SD2
and SD3;
h) Pool A: serotypes 01 (two strains), 04 and 18 at SDl,
SD2 and U D 3 ;
i) Pool C: serotypes 07, 27 and 31 at SDl, SD2 and O D 2 ;
j) Pool I: two strains "x" and "y" (not individually
serotyped) at SDl, SD2 and UD2;
k) Serotype 03: three strains termed "M", "N" and "R" at 
SDl, SD2 and SD3, the antigen from strain R was diluted 1 
in 25, 1 in 100, 1 in 150, 1 in 250 and 1 in 625.
vi) Alternative methods of antigen extraction of a serotype
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03 culture, incubated on 10 CBA plates anaerobically with 
C 0 2 at 37°C for 18 h were performed as follows:-
a) growth from three plates was scraped into sterile
distilled water, lysed with 1% (w/v) sodium deoxycholate
and boiled to remove protein; when cool the polysaccharide 
was precipitated with 2 volumes of cold 74 OP ethyl 
alcohol;
b) as for a) except that cold acetone was the precipitant;
c) colonies from 2 plates were lysed in situ with the 
deoxycholate solution and washed off and treated as a ) ;
d) as for c) except that acetone was used to extract the
polysaccharide.
Growth in RCM broth at 37 °C for 18 h was similarly treated 
as follows:-
e) 10 ml of culture as in a) precipitated with alcohol;
f) 10 ml of culture as in b) with acetone;
g) 10 ml of culture boiled and precipitated with alcohol 
but without prior lysis;
h) as in g) except that acetone was used.
After 18 h at 4°C the extracts were centrifuged, the 
supernate removed, the precipitate reconstituted in 2 ml of 
distilled water and titred against serotype 03 PCR reagent,
vii) Loss of antigenicity was noted for certain strains 
after storage in T-H broth when compared to growth of the 
same scraped from blood agar culture. This effect was 
examined by growing a strain each of serotypes 01, 03, 06, 
17, 19, 20, 22, 23, 33, 35 and group I at 37°C for 18 h in 
T-H broth and on CBA plates. Half of each broth was stored
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at 4°C and RT; a suspension from each plate was also made 
in PBS and stored at 4°C. The reaction of each strain was 
confirmed against its pool and component reagents at that 
time and again after 7 days.
2.6 THE EFFECTS OF MEDIA ON PNEUMOCOCCAL GROWTH
The ability of certain media to actively support 
pneumococcal growth for isolation and antigen and enzyme 
testing was investigated. Media were prepared from 
Todd-Hewitt broth, formulated for the production of 
streptococcal toxins, Re-inforced clostridial medium broth, 
an anaerobic culture medium, and Tryptone soya broth, a 
blood culture medium.
2.6.1 Reinforced Clostridial broth
The commercial Reinforced clostridial medium (RCM) 
was prepared as three variants, in 5 ml volumes
i) BRCM, a 1% (w/v) solution of methylene blue was added at
1% (v/v) to RCM from which the agar had been removed by
filtration.
ii) BRC, RCM prepared by removal of the agar (without the 
addition of methylene blue);
iii) R C M , prepared with agar but without the dye.
A series of broths was seeded with 0.2 ml of a faintly 
turbid suspension in PBS of each of 5 strains (one culture 
of serotypes 06, 08 and 14, and two of serotype 03), 
incubated at 37°C for 18 h.
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2.6.2 Liver digest
Liver digest powder (LD, Oxoid), a source of growth 
factors, was added to three commercial media (LabM), 
tryptone soya broth, RCM and Todd-Hewitt broth at a 
concentration of 1% (w/v). Doubling dilutions of these 
media in their respective broths was made down to 0.03%. 
To each dilution and a control tube, without LD, was added 
0.1 ml of a light suspension of a serotype 03 culture in 
PBS; incubation was at 37°C for 18 h.
2.6.3 Growth at different pH values
Three cultures (serotypes 01, 03 and 33) were
examined in the following eight media:-
a) THA78 : prepared by solidifying T-H broth with 1% (w/v) 
Agar No.3 (Oxoid), pH 7.8;
b) THA73: prepared from THA78, after adjusting the pH of 
the medium to 7.3 with N HC1, with the addition of 1% (v/v) 
of a 0.2% (w/v) bromocresol purple solution (BCP);
c) LTGA68: prepared from 1 g, Lab Lemco , 2 g tryptose, 0.2 
g glucose and lg of Agar No.3 in 100 ml of distilled water, 
final pH 6.8;
d) THTA78: prepared by adding 1% (v/v) of a 0.2% (w/v)
bromothymol blue solution (BTB), 0.2% (w/v) sodium
bicarbonate and 0.04% (w/v) disodium phosphate to THTA, pH
7.8,;
e) RCMA68: prepared by adding 0.8% (w/v) Agar No. 3 to RCM 
broth;
f) RCMA73: by adding 0.2% (w/v) sodium carbonate to RCMA,
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adjusting the pH of the medium to 7.3, and 1% (v/v) BCP;
g) RCMA78: with sodium bicarbonate at 0.2% (w/v), disodium 
phosphate at 0.04% (w/v) and BTB at 1% (v/v), final pH 7.8;
h) CBA, pH 7.3;
Each of the media, after being autoclaved at 15 lbs/sq in, 
were spread with the three strains, serotypes 01, 03 and
31, and incubated, anaerobically with C 0 2, for 18 h at 
37°C.
2.6.4 Viability and turbidity
Three pneumococcal strains, serotypes 06, 19 and 23 
were cultured in 5 ml of T-H broth, aerobically and on a 
CBA plate incubated, anaerobically with C 0 2. After 18 h at 
37°C the broths were centrifuged and the deposits made up 
to 5 ml in PBS; the growth from the plate was scraped with 
a sterile glass slide into 5 ml PBS. Viable counts were 
performed on each sample by a standard loop method. The 
turbidity of each suspension was measured in a 
spectrophotometer at 660 nm, and at 260 nm, after the 
suspension had been lysed with bile for 1 h at 37°C.
2.6.5 The effects of cysteine and sodium bicarbonate on 
growth in Todd-Hewitt broth
T-H broth, suitable for the production of capsular 
material for serotyping, had the disadvantage that 
viability of the culture was rapidly lost and the formulae 
could not be used for other studies. The action of 
cysteine and/or sodium bicarbonate to improve growth in
53
this medium was investigated in the following manner:-
i) Cysteine hydrochloride. A 0.05% (w/v) aqueous sterile 
solution was diluted 1 in 10 in T-H and then double diluted 
in 5 ml of T-H to give 2 rows of five tubes at 
concentrations from 0.05 to 0.003% (w/v). A control tube, 
5 ml of T-H without.cysteine, was included in each row. 
Into each tube was mixed 0.2 ml of a light suspension of a 
serotype 03 strain, prior to incubation at 37°C.
ii) Sodium bicarbonate was added, after 5 h incubation, as 
0.2 ml of a 0.2% (w/v) sterile aqueous solution to each of 
one row of the above, including a control tube, before 
incubation for a futher 16 h.
iii) Adjustment of the cysteine solution to pH 7.0 was 
made, with 0.1N NaOH, and four media produced:-
a) T-H only;
b) T-H plus 0.025% (w/v) neutralised cysteine (T-HC);
c) T-H plus 0.025% (w/v) neutralised cysteine plus 0.1% 
(w/v) sodium bicarbonate (T-HCB);
d) T-H plus 0.1% (w/v) sodium bicarbonate (T-HB).
Three further cultures, serotypes 08, 19 and 23 strain,
were cultured in the four media at 37°C. After 24 h the 
turbidity was noted and viable counts were made by the 
standard loop method.
A further six cultures, of serotypes 03, 06, 11, 14, 15 and 
a non-capsulate strain, were cultured in the cysteine broth 
(T-HC); the cysteine and bicarbonate broth (T-HCB), and T-H 
with liver digest and haemoglobin solutions at 1% (w/v) 
(T-HLH) for 18 h at 37°C.
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2.6.6 Selective agents for pneumococcal isolation
The practical advantages of selective culture methods 
for the recovery of pneumococci from clinical samples was 
examined in three ways:-
i) Broth cultures. Six mixed cultures were prepared with 
the Oxford strain of Staph, aureus (SOX) and six recent 
pneumococcal isolates to examine the selective effect of 
sodium azide or gentamicin in T-H broth. The strains, 
serotypes 03 (three cultures), 04 (one culture) and 14 (two 
cultures), cultured on CBA anaerobically with C 0 2 at 37°C 
for 18 h, were suspended in 5 ml of PBS, and to each was 
added 0.2 ml of a suspension of a fresh culture of SOX, 
suspended in PBS. Three media were prepared in 5 ml 
volumes: Todd-Hewitt broth containing 1% (w/v) liver digest 
(T-HL), T-HL containing 0.01% (w/v) sodium azide (AT-HL) 
and T-HL containing a 2 ug gentamicin disc (0.4 ug/m 1) 
(GT-HL). A 0.1 ml volume of the pneumococca1/SOX 
suspension was added to each of the three media, incubated 
at 37°C for 18 h and subcultured on CBA agar for 18 h at 
37°C. Control tubes of each of the pneumococci and the SOX 
were made in T-HL and similarly incubated.
ii) Antibiotic discs placed on plate cultures were assessed 
for their inhibition of respiratory isolates. Nine 
pneumococcal and four non-haemolytic streptococcal (NHS) 
isolates from respiratory specimens were examined for 
inhibition by commercial discs of 2 ug gentamicin, 10 ug 
fucidin, 30 ug kanamycin and 200 ug nitrofurantoin.
55
A light suspension of the test organism, in PBS, was spread 
on to lysed blood sensitivity agar plates by the 
comparative zone method (Stokes, 19 68); SOX acted as the 
control organism. After 18 h aerobic incubation without 
extra C 0 2 at 37°C the zone diameters produced by the test 
and control cultures were measured,
iii) Gentamicin containing blood agar.
a) The amount of gentamicin necessary for inclusion in agar 
plates for selective culture was assayed by measuring the 
minimal inhibition concentration (MIC) of gentamicin for 
pneumococci. Plates of heated blood sensitivity agar were 
prepared containing:- gentamicin sulphate at 0.12, 0.25, 
0.5, 1, 2, 4 and 8 ug/ml. A loopful of the nine
pneumococcal suspensions and the SOX control were seeded on 
to each of the dilutions, incubated at 37 °C for 18 h and 
the presence or absence of growth recorded. The plate 
containing the first concentration not permitting growth 
was taken as the MIC.
b) Throat and nasal swabs from a total of 59 patients were 
cultured on to three plates, two containing 5 £ig/ml 
gentamicin in CBA (GCBA) and the third a CBA plate without 
gentamicin. One GCBA was incubated aerobically, the other 
in the C 0 2 incubator and the CBA plate anaerobically with 
C 0 2; all were incubated at 37°C for 18 h.
c) A short series of 12 routine swabs was cultured on CBA 
aerobically with and without C 0 2, anaerobically with and 
without C 0 2 and on GCBA anaerobically with C 0 2.
d) With eight further swabs a light suspension was made of
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the growth obtained anaerobically with C 0 2 on CBA in 1 ml 
of PBS cultured aerobically and anaerobically both with C 0 2 
onGCBA plates for 18 h at 37°C.
2.7 Enzyme Studies
A number of approaches were made to demonstrate 
pneumococcal enzymes to investigate potential differential 
characters.
2.7.1 Carbohydrate fermentation
Enriched serum-free media were examined for 
suitability and speed of reaction in the detection of 
carbohydrate fermentation as an alternative to the serum 
water sugars usually used with the pneumococcus:
i) CTA medium (BBL), recommended for fermentation studies 
of fastidious organisms, was prepared in 7 ml volumes in 
sealed bijoux bottles, with and without 1% (w/v) liver 
digest. A bottle of each medium was seeded with seven 
pneumococcal cultures, serotypes 13 (T52), 03 (T69), 23 
(T109), 06 (four strains, T122 and W154, from different 
patients, and T123 and T124, from the same patient) and a 
strain of Streptococcus faecalis. Repeat cultures of the 
same strains were tested in the media supplemented with 20% 
(v/v) egg yolk emulsion and CTA with yeast extract, 0.3% 
(w/v). Each series was incubated at 3 7 °C for 48 h.
ii) Defined Gonnococcal broth (Difco), described for the 
cultivation of Neisseria gonorrohoea without serum, was 
prepared in three forms i.e. as the base only, as the base
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containing supplements and as the base containing 0.5% 
(w/v) mannitol. The above eight strains were cultured for 
48 h at 37°C in each of the three formulae and the growth 
and approximate final pH noted.
iii) Modified Todd-Hewitt broth was prepared, without 
glucose, to contain Lab Lemco lOg; tryptone 20g; sodium 
bicarbonate 2g; sodium chloride 2g; disodium phosphate 0.4g 
in a litre of distilled water. Four media were made from 
this base by the addition of 0.5% (w/v) of either glucose, 
mannitol, salicin or sucrose and tested with four 
pneumococcal strains and a Staph. aureus (SOX) culture 
incubated at 37°C; the broths were examined after 18 and 42 
h incubation.
iv) Columbia agar base was prepared with 0.75% (w/v)
sucrose and 1% (v/v) bromocresol purple indicator solution 
and with 10% (v/v) horse serum or with 10% (w/v) finely
powdered chalk. Cultures of seven pneumococci and a S . 
faecalis were spread on the three media and growth and acid 
production recorded after 18 h incubation at 37°C.
2.7.2 Basal sugar testing medium
Alternative serum-free media for carbohydrate studies 
were assessed for use with the pneumococci.
i) Trypticase-yeast-liver-succinate broth (TYLS). The 
suitability of TYLS for carbohydrate fermentation studies 
was tested with pneumococci grown in the new medium with 
and without haemoglobin and cystein, and in Columbia base 
broth (CB) and RCM broth. TYLS was prepared from:-
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Trypticase 1.00 g
Liver digest 0.50 g
NaCl 0.50 g
Yeast extract 0.30 g
Sodium succinate 0.25 g
Distilled water 100 ml
(final pH 7.2)
Columbia broth (CB) was obtained by suspending 3.9 g of 
Columbia agar base in 100 ml of distilled water, allowing 
the agar to settle for 30 min and decanting the clear fluid 
above the agar into a flask for sterilisation. 
Supplemented formulae of TYLS and CB were made by adding to 
each 10 ml of the basic medium 0.1 ml of separately 
sterilised haemoglobin (500 mg/ml) and cystein HC1 (3.7%) 
solutions prior to use. Six cultures, serotypes 03 
(T1279), 06 (T1093), 09 (T1512), 17 (W801), 19 (T1453) and 
33 (W787), each suspended in 0.5 ml of PBS, were added in
0.1 ml volumes to 3 ml of each of the five broths and a 
loopful spread on to two CBA plates. One plate was 
incubated aerobically without extra C 0 2 and the other 
aerobically with C 0 2; cultures T1093, T1512 and W801 had 
been shown to be carboxyphilic (Section 2.4.6).
ii) Streptococcal basa l  medium for carbohydrate
fermentation
a) Streptococcal basal broth (SB), an alternative new 
medium for carbohydrate testing was made from:-
Tryptose 1.00 g
Proteose peptone 0.50 g
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Yeast extract 0.30 g
Liver digest 1.00 g
NaCl 0.50 g
Cystein HC1 0.04 g
Distilled water 100 ml
(final pH 7.2)
Suspensions from eight isolates, serotypes 06 (T2907 and
T2908, from the throat and nasal swabs of the same 
patient), 09 (T2860), 16 (T2744), 19 (T2645 and W1799), 23
(T2894 and T2901), were each made in 1 ml of PBS and a 0.2
ml volume transferred to 5 ml of SB, RCM and T-H broths,
incubated at 37°C for 18 h.
b) Streptococcal basal Agar (SBA) was SB solidified with 1%
(w/v) agar No.l. Plates of SBA and CBA were used for the
subculture of the above strains grown in SB under aerobic, 
aerobic with C 0 2 and anaerobic with extra C 0 2 conditions 
for 18 h at 37°C.
c) Attempted enhancement of growth in SB: the value of
,dditives to SB was assessed by preparing the basal broth 
formula to contain one of the following
sodium acetate 0.30% (w/v)
sodium bicarbonate 0.20% (w/v)
ornithine 0.50% (w/v)
arginine 0.50% (w/v)
choline 0.50% (w/v)
glucose 0.50% (w/v)
sodium succinate 0.25% (w/v)
haemoglobin solution 1.00% (w/v)
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agar No.l 0.05% (w/v)
phosphate buffer (KaHPO* 1.21 g/L and KH2P0^ 0.34 g/L).
A 0.2 ml volume of suspensions of four cultures, serotypes 
14 (T2989), 15 (T2860 and W2077) and 19 (T2645) in 2.5 ml
of PBS were added to each of the 10 broths, plus a control 
without additives and into T-H and RCM broths, and 
incubated at 37°C for 18 h.
Growth was recorded and the broths subcultured on to CBA 
incubated anaerobically with added C 0 2 for 18 h. Tests for 
residual glucose in the broth after incubation was made 
with glucose indicator strips (Clinistix, Ames).
d) Assimilation studies using SB agar were prepared by 
spreading a light suspension of the organism, in PBS, over 
the surface of the agar, cutting six wells, 7 mm in 
diameter, and adding a sterile 0.1% (w/v) solution of one 
of the following 
glutamic acid 
pyruvic acid 
thiamine 
L-histidine 
tryptophan 
aneurin
Four pneumococci of serotypes 15 (T2860 and W2077), 14 
(T2989) and 19 (T2645), were tested by this method,
incubated at 37°C for 24 h aerobically and for a further 24 
h anaerobically with added C 0 2.
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2.7.3 Microtitre plate method for carbohydrate fermentation
testing
The rapid demonstration of carbohydrate fermentation 
of high concentration substrates in microtitre plates has 
been successfully applied to organisms difficult to test by 
conventional methods, e.g. the Bacteroides group,
i) Preliminary studies of this method was performed on 
eight pneumococcal suspensions, serotypes 03 (T1279), 06
(W765), 09 (T1512), 16 (T1093), 17 (W801), 19 (T1453), 23
(W372) and 33 (W787), obtained by scraping the growth
resulting from anaerobic culture on a CBA plate into 1 ml 
of bacteroides basal medium (BM) broth. The carbohydrate 
substrates were 20% (w/v) solutions of fructose, inulin, 
maltose, raffinose, rhamnose, sucrose, trehalose and
xylose. Inulin and trehalose gave saturated solutions at 
this level and were prepared at 6% (w/v). Two drops of 
each suspension, two drops of each test solution and two 
drops of a 2% (v/v) Andrade's solution, in BM, were added
to a well in a microtitre plate. Aesculin hyrolysis was
similarly tested for each strain. The plate, sealed in a 
plastic bag, was incubated at 37°C for 4 h and examined for 
colour changes in the pH of the medium.
ii) The effect of suspending broth on microtitre 
carbohydrate reactions of three strains, serotypes 06 
(T4269), 09 (T4257) and 17 (T4273), was examined by
culturing the strains on three CBA plates anaerobically 
with C 0 2, for 18 h at 37°C. The growth from the three 
plates was scraped into 4 ml of PBS and 0.1 ml of the
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suspension added to each of 30 microtitre wells in three
rows of 10 wells. To the first row 0.1 ml of double
strength Columbia broth was added; to the second 0.1 ml of 
double strength SB broth and to the third 0.1 ml of double
strength BM broth; each medium contained 2 ml of Andrades
solution/100 ml. Across each row 0.1 ml of "sugar" 
solution was added prior to sealing the plates and 
incubating at 37°C for 4 h; the final well of each row 
contained the media and organism only as a negative 
control. The nine solutions tested were fructose, inulin, 
melibiose, raffinose, rhamnose, sucrose, trehalose, xylose 
and aesculin.
iii) Further tests, based on the results obtained from ii) 
above, were performed on five cultures, serotypes 06 
(T4269), 14 (T4334), 17 (T4273), 19 (W2856), and 23 (T4329) 
suspended in SB broth, in the substrates and method used in
ii) •
iv) An extended series of fermentable substances, at 20% 
(w/v) concentrations, was tested with a further eight 
isolates, serotypes 03 (T1453), 04 (W787), 09 (T1093), 14 
(T1512 and W801), 19 (T1279), and 23 (T795 and W372), in SB 
by the microtitre plate method. The substrates were 
arabinose, dulcitol, fructose, galactose, inulin, mannose, 
maltose, melibiose, raffinose, salicin, sorbitol and 
trehalose. It was only possible to obtain solutions at 5% 
(w/v) for dulcitol and 6% (w/v) for mannose; salicin 
crystallised out of solution on storage at 4°C. The growth 
from a CBA plate, cultured anaerobically for 18 h, was
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scraped into 1.5 ml of SB broth and 0.1 ml of the 
suspension added to 0.1 ml of substrate in a microtitre 
plate. The microtitre plate was incubated in the C 0 2 
incubator for 4 h before the colour changes were recorded.
2.7.4 The APIZYM system
The commercially available APIZYM freeze dried enzyme 
substrates (API Products, Table 2.4*) were used to detect 
pneumococcal enzyme profiles.
The basic method consisted of adding a suspension of the 
test organism to each of the 19 enzyme substrate and the 
negative control cupules of the APIZYM strip, followed by 
incubation at 37°C for 4 h before the development of enzyme 
products with two indicator reagents.
It was therefore necessary to standardise the preparation 
and concentration of pneumococcal suspension, the length of 
and gaseous conditions incubation prior to applying the 
method for pneumococci,
i) Growth standardisation.
$a) bacterial mass was measured by centrifuging the growth 
from 5 ml of an 18 h T-H culture at 37°C, removing 4.5 ml 
of the supernate, resuspending the deposit in the 
remainder, heating to 60°C for 30 min and centrifuging in 
an Haematocrit centrifuge at 10,000 rpm for 5 min.
b) Photometric estimation of the growth of two strains was 
made both in T-H broth, after 18 h culture at 37°C, divided 
and examined as whole broth and as centrifuged supernate 
and from the colonies, from the well of a CBA plate scraped
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TABLE 2.4
The APIZYM substrates
2-naphthyl phosphate;
2-naphthyl butyrate;
2-naphthyl caprylate;
2-naphthyl myristate; 
L-leucyl-2-naphthylamide; 
L-valyl-2-naphthylamide; 
L-cystyl-2-naphthylamide; 
N-benzoyl-DL-arginine-2-naphthylamine; 
N-glutaryl-phenylalanine-2-naphthylamine; 
2-naphthyl phosphate; 
Naphthol-AS-BI-phosphodiamide; 
6-Br-2-naphthyl-alpha D-galactopyranoside; 
2-naphthyl-beta D-galactopyranoside; 
Naphthol-AS-BI-beta D-glucuronic acid; 
2-naphthyl-alpha D-glucopyranoside; 
6-Br-2-naphthyl-beta D-glucopyranoside;
1-naphthyl-N-acetyl-beta D-glucosaminide;
6-Br-2-naphthyl-alpha D-mannopyranoside;
2-naphthyl-alpha L-fucopyranoside.
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into 2 ml of PBS. Absorbance of all samples was measured 
on the Cecil spectrophotometer from 380-700 nm.
An area, 3 cm square, from a lawn of growth on a CBA plate, 
incubated anaerobically with C 0 2, was scraped into 2 ml of 
PBS, lysed by 0.2 ml of 1% (w/v) sodium deoxycholate
solution. The lysate, was scanned in the visible and 
ultra-violet wavelengths from 200-700 nm against a blank of 
2 ml PBS plus 0.2 ml of deoxycholate.
d) Repeat spectrophotometric assays of lysed and whole 
suspensions were made at 350 and 660 nm respectively. The 
suspension was also cultured on CBA anaerobically with C 0 2 
for 18 h at 37°C for viable count neat and when diluted 1 
in 25 and 1 in 625 in PBS.
e) Further estimations were performed to compare readings 
at 660 and 260 nm for suspensions prepared from plates and 
for T-H and RCM broths. Growth in 5 ml of each broth was 
washed three times in PBS before resuspending in 2 ml prior 
to lysis and measurement.
f) Standardisation of bacterial dose of strain 55, grown on 
CBA anaerobically, scraped into PBS, and read at 660 nm was 
adjusted to 1.0 absorbance unit. This suspension, neat and 
at 1 in 2 and 1 in 4 dilutions was added in 0.1 ml portions 
to each cupule of three APIZYM strips and incubated at 37°C 
in a moist chamber for 4 h. The colour of the enzyme 
products in each cupule, developed by a drop of reagents A 
and B (API Products) was scored from 0 to 5 against the 
colour chart for that enzyme (Appendix B ) . The turbidity 
of the same strain, grown under the same conditions, was
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adjusted to 1.0 absorbance unit, and part of this 
suspension concentrated by centrifugation to a turbidity 
equivalent to 2.0 and 2.5 absorbance units. The three 
suspensions were added to three API strips and treated as 
for the dilute suspensions.
ii) Gaseous environment. The effect of the gaseous 
environment on the APIZYM results was studied with 
suspensions of four pneumococcal strains, obtained as in
f), and adjusted to 2.0 absorbance units. Three strips 
were filled for each strain and incubated under aerobic 
conditions with and without added C 0 2, and anaerobically 
with C 0 2 for 4 h at 37°C.
iii) Length of incubation. The length of time for 
incubation of the substrate strips before development of 
the reaction colours was examined in the same four strains 
similarly prepared and added to three strips. One strip of 
each strain was developed after 4, 5 and 6 h incubation at 
37°C.
iv) Testing of pneumococcal isolates by a standardised 
APIZYM method. From the results (Section 4.2.5) obtained
ffrom the above studies (Section 2.7.4, i, ii and iii) a 
standard method was adopted for the testing of pneumococci 
in the APIZYM substrate strip as follows:- The bacterial 
dosage for the strips was prepared from a lawn of growth 
produced by subculture of three colonies of the test strain 
on a CBA plate, incubated anaerobically with 10% C 0 2 for 18 
h at 37°C. The growth removed from the plate with a wire
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loop, was suspended in 2.2 ml of PBS and a 0.2 ml volume 
diluted in 0.8 ml of PBS. The turbidity of the diluted 
sample was measured in a spectrophotometer (Cecil 
Instruments, model CE 393) at 660 nm. The concentration of 
the remaining suspension was adjusted by dilution with PBS 
or concentration after centrifugation and removal of part 
of the supernate, to give a turbidity equivalent to 2.5 
absorbance units. For the test, a 0.1 ml volume of the 
adjusted suspension was placed into each of the 19 test and 
the single control cupules of the APIZYM strip and 
incubated in a moist chamber tray at 37 °C for 4 h. The 
degree of enzyme activity was read 5 min after adding one 
drop of reagent ZYM A (API Products, tris aminomethane 
250g, 37% hydrochloric acid 110 ml, laurylsulphate lOOg and 
distilled water up to 1 L, pH 7.6-7.8) and one drop of 
reagent ZYM B (API Products, fast blue BB, Sigma No. F 
0250, 3.5 g and 2-methoxyethanol up to 1 L) to each cupule.
A photographic spotlight was held 10 cm above the tray for 
10 sec to eliminate any yellow colour produced by an excess 
of unreacted Fast blue.
The colour of each cupule was compared with a standard 
colour chart supplied with the kit and graded from 0 to 5 - 
the higher the score the more intense was the colour. This 
method was used to test 101 routine clinical pneumococcal 
isolates.
2.7.5 Nitrophenyl enzyme substrates
Nitrophenyl substrates when cleaved by enzyme release
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the yellow coloured nitrophenyl group and can be used as a 
simple rapid alternative to the conventional sugar media 
and the APIZYM system to detect enzyme activity. The 
presence of enzyme activity was investigated using four 
nitrophenyl enzyme substrates (Koch-Light Laboratories) at 
their optimum reaction pH 5.4: 
p-nitrophenyl-alpha-D-glucosaminide; 
p-nitrophenyl-alpha-D-galactosaminde; 
p-nitrophenyl-N-acetyl-beta-D-glucosaminide; 
o-nitrophenyl beta D-galactosaminide;
To obtain the optimum reaction pH the substrates were made 
up in citrate phosphate buffer, pH 5.4, prepared from:- 
27.8 ml of Solution B (0.2 M disodium phosphate 71.7 g/L) 
and 22.2 ml of Solution C (0.1 M citric acid 18.2 g/L) 
mixed with 50 ml of distilled water. Four methods were 
used to examine the suitability of this approach:-
i) Glass capillary tubes, 3 cm in length, were half filled 
with the test substrate and an equal volume of the
4
pneumococcal suspension, in PBS, incubated at 37°C for up 
to 2 h and examined for colour change.
ii) Paper discs, impregnated with the substrate, were
placed on the pneumococcal colonies, produced on a CBA
plate by anaerobic culture for 18 h, incubated for up to 2
h at 37°C and examined for colour change.
iii) Spectrophotometric assay was made, from 300-600 nm, of 
the enzyme products from beta-galactosaminide substrate 
reacted with a pneumococcal culture. The sensitivity of 
the method was assessed by adding one volume of
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pneumoccocal suspension (containing approximately 10H cfu) 
to 3 volumes of ortho nitro-phenyl galactopyranoside 
solution, incubated at 3 7 °C for 1 h. The substrates were 
diluted to 1 in 2, 1 in 4 and 1 in'8 and tested against a 
suspension of the same strain (containing approximately 10® 
cfu) under the same conditions.
iv) Alpha-galactosidase, alpha-glucosidase and N-acetyl 
glucosaminidase activity was tested in precipitation tubes 
in 0.2 ml volumes against four strains at 37°C; colour 
changes were noted at 2 h and 18 h.
2.7.6 Neuraminidase
The ability of pneumococci to produce neuraminidase 
(Receptor Destroying Enzyme; RDE), was demonstrated by two 
methods:-
i) Pan-agglutinability of human blood group 0 red cells 
with blood group AB antiserum can occur after exposure to 
neuraminidase. This effect was tested for by adding 2 ml 
of either an overnight T-H broth culture or 2 ml of the 
broth culture, previously lysed with 0.4% (w/v) sodium
deoxycholate, to 2 ml of a 1% (w/v) suspension of group O 
Rh negative red cells in a 0.85% (w/v) sodium chloride
solution containing 0.1% (w/v) calcium chloride. A control 
tube of 2 ml T-H broth and 2 ml of 1% (v/v) red cells was 
included and all tubes incubated at 37°C for 30 min. After 
centrifugation at 2000 rpm for 2 min, the supernate was 
discarded and a volume of the deposit mixed with a volume 
of AB serum on a microscope slide and observed for
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agglutination for 2 min.
ii) The World Health Organization (WHO) method for
influenza A virus neuraminidase serum inhibitors was 
applied to Todd Hewitt broth cultures of three pneumococcal 
cultures (W, T and C) incubated for 18 h at 37°C. The
neuraminidase substrate was fetuin, an ammonium sulphate 
precipitate of foetal calf serum; the full list of reagents 
is given in Table 2.5. For the test 0.05 ml volumes of 
broth culture, phosphate buffer and fetuin were mixed with
0.5 ml of saline and incubated at 37°C for 18 h. When 
cooled to 20°C 0.1 ml of periodate reagent was added and
incubation continued at 20°C for exactly 20 min before 1 ml
of arsenite reagent and 2.5 ml of thiobarbituric reagent 
were added. After thorough mixing, the tubes were placed 
in a boiling water bath for 15 min, allowed to cool and 4 
ml of Warrenhoff's reagent added. The colour of the upper 
layer produced by vigorous shaking on a mechanical mixer 
for 2 min and centrifugaton at 1000 rpm for 5 min was 
removed and read at 54 9 nm in the spectrophotometer. The 
value obtained was compared with the turbidity of the 
original culture measured at 660 nm in the same instrument.
2.7.7 Proteinase
Production of proteinase, after stimulation in a 
milk-containing broth, was recognised as zones of clearing 
produced on milk agar.
i) Proteinase stimulation in each of four broths prepared 
as follows
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TABLE 2.5
Reagents for the neuraminidase assay
1. Periodate reagent
Sodium meta-periodateDistilled waterSyrupy o-phosphoric acid
Stored in a glass stoppered bottle.
2. Arsenite reagent
Sodium meta-arsenite Anhydrous sodium sulphate Distilled water Concentrated sulphuric acid
3. Thiobarbituric acid
Thiobarbituric acid 
Anhydrous sodium sulphate
The above reagents were each made up, once a 
and dissolved in a boiling water bath.
4. Warrenoff reagent
N-butanol Concentrated HC1 This reagent was made up fresh as required.
5. Phosphate buffer
A. Sodium dihydrogen orthophosphate(Na2P 0 J
B. Disodium hydrogen orthophosphate(Na2H P 0 J
For use 19 ml of solution B was mixed with 81 ml of solution A (final pH 5.9).
4.28 g 38 ml 62 ml
10 g 7.10 g 100 ml 0.3 ml
1.2 g 14.2 g
week,
100 ml 5 ml
0.4 M 
0.4 M
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a) Tryptose liver digest broth (TL): 1% (w/v) tryptose, 1% 
(w/v) liver digest and 0.5% (w/v) sodium chloride in 
distilled water;
b) PTL: the TL formulae without salt and dissolved in PBS;
c) Todd-Hewitt broth (T-H);
d) RCM.
The broths, dispensed in 10 ml volumes, were autoclaved, at 
15 lbs/sq in for 15 min, and allowed to cool before 1 ml of 
separately autoclaved 10% (w/v) skimmed milk in distilled 
water was added when required. Three strains of 
pneumococci, serotypes 03, 06 and 23, and a clinically
isolated culture of Serratia marsescens were incubated in 
each of the broths and a control broth, TL without milk, at 
37°C. After 2 days incubation, 0.05 ml of each broth was 
added to a 5 mm well cut in a 2% (v/v) sterile skimmed milk 
Columbia agar plate and incubated aerobically at 37°C for a 
further 18 h. All the broths were subcultured on CBA 
aerobically and anaerobically with C 0 2 at 37°C for 18 h.
ii) Milk containing agar plates, prepared from the TL and 
PTL broths, by the addition of 1% (w/v) agar No.l, were
spread with the previous cultures, together with a second 
control culture, Clostridium perfringens; all plates were 
incubated anaerobically with C 0 2 for 2 days at 37°C. After 
growth in TL and PTL broths tests for proteinase production 
were repeated on 2% (v/v) milk TL and PTL agars, under the 
same conditions as in i).
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2.7.8 Haemolysis
Preliminary culture of pneumococci on azide blood 
agar showed that immediately after anaerobic incubation in 
C 0 2 at 37°C colonies were not haemolytic but if these 
plates were left at 4°C for 3 h, 10 of the 14 strains 
tested showed haemolysis. The other four strains were also 
haemolytic after a further 3 h at room temperature. 
Haemolysis was not seen with the same strains if cultured 
on CBA and experiments were undertaken to examine the cause 
of this effect.
i) Four horse blood containing media, Columbia agar base, 
with and without 0.02% (w/v) sodium azide and tryptose 
blood agar base (the base for azide blood agar) with and 
without 0.02% (w/v) sodium azide, were seeded with eight 
pneumococcal strains and incubated anaerobically with C 0 2 
at 37°C for 18 h. The plates were removed from the 
anaerobic culture jar, placed at 4°C for 3 h and examined 
for zones of haemolysis against an illuminated background.
ii) Reductions in the azide content of azide blood agar 
(Difco) were sought to increase the size of colonies
produced on the medium without loss of the haemolysis
zones. The eight test strains were cultured as in
experiment i) but on three formulations of azide blood 
agar, containing either 0.02%, 0.01% or 0.005% (w/v) sodium 
azide, and 5% (v/v) horse blood.
iii) Todd-Hewitt medium, recommended for the production of 
haemolysins by the beta-haemolytic streptococci, was 
prepared as two forms of Todd-Hewitt agar with 1% (w/v)
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agar No.l, 5% (v/v) horse blood and with (AzT-H) and
without (T-H) 0.005% (w/v) sodium azide. The above eight
strains were cultured on the T-H, AzT-H media, azide blood
agar and CBA under anaerobic conditions with C 0 2at 37°C for 
18 h.
iv) Haemolysis of sheep and horse red cells; Tryptose base 
agar plates, with and without 0.005% (w/v) sodium azide, 
and containing 5% (v/v) of sheep or horse blood and CBA 
with 5% (v/v) horse blood were seeded with 12 pneumococcal 
strains and incubated anaerobically with C 0 2 at 37°C for 18 
h. Cultures were made of six further strains on the five 
media under aerobic conditions with and without C 0 2 and 
anaerobically with C 0 2 for 18 h at 37°C. The strains were 
of serotypes 03, 06, 09, 14, 23 and a non-capsulate
isolate.
v) Haemolysis of human and horse red cells: human blood
group O plates were prepared, with and without 0.005% (w/v)
sodium azide and also plates of the same basal medium but 
containg 5% (v/v) horse blood, to examine the type of 
haemolysis formed by three strains, serotypes 19, 23 and
on-capsulate isolate (strains T705, W338 and W317
respectively), incubated under the standard double zone 
haemolysis conditions.
vi) Camp reaction. Four strains of beta-haemolytic 
streptococci (Lancefield group B) obtained from the Jessop 
Hospital (strains RSll, Q90, G64 and 149) were used in the 
Camp reaction test on Tryptose blood agar prepared with 5% 
(v/v) group 0 negative human blood and the same medium
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previously spread with 1 ml of 0.05% (w/v) sterile sodium 
azide solution. Three strains of pneumococci, serotypes 04 
(W155), 06 (W148) and 19 (T328) and a control strain of Cl. 
perfringens were streaked on to two plates of each medium 
and two of the Group B isolates streaked, 5 cm apart, 
across the plates at right angles to the pneumococcal 
inocula. Three further strains, serotypes 18 (W261), 19 
(T345) and 23 (T587) with the control were cultured on to 
two similar sets of plates with the other two Group B 
isolates spread at right angle. All plates were incubated 
at 37°C, one set anaerobically with added C 0 2 and the other 
aerobically with C 0 2.
2.8 DYE INHIBITION STUDIES
Some pneumococci were found to be inhibited by 
methylene blue (Section 3.3) and bromothymol blue (Section 
3.5.2), the effects of these and other "dyestuffs" were
studied in an attempt to demonstrate differential
sensitivity patterns to growth inhibitors and therefore 
recognise variations between strains.
2.8.1 Inhibition of broth cultures by bromocresol purple, 
toluidine blue and methylene blue
The ability of serotype 33 pneumococcal strain to 
grow in T-H broths containing bromothymol blue (0.2% 
(w/v)), bromocresol purple (0.2% (w/v)), toluidine blue
(0.1% (w/v)) and methylene blue (0.1% (w/v)) each diluted
to 1 in 100, 1 in 1000 and 1 in 10000 in the medium was
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tested as a preliminary study. The twelve dye broths and a 
control T-H broth were lightly seeded with the pneumococcus 
and incubated for 18 h at 37°C.
2.8.2 Inhibition of growth on dye-containing agar slopes
The method was used to provide a concentration 
gradient of potential inhibitory agents to simplify 
selection of suitable dyes and concentrations,
i) Sixteen dyes tested against four strains. Stock 
solutions were prepared, in distilled water, from
bromothymol blue (BTB), bromocresol purple (BP), congo red 
(CR), methyl red (MR), and phenol red (PR) at
concentrations of 0.2 % (w/v); cresol red (RR), neutral red
(NR), janus green (JG), nile blue (NB), crystal violet
(CV), methylene blue (MB), toluidine blue (TB) and 
phenolphthalein (PP) at 0.1 % (w/v); saffronin (SF) and
coomassie blue (CB) at 0.5 % (w/v) and from malachite green 
(MG) at 0.02 % (w/v). For use the dye solutions were
diluted 1 in 10 in sterile water and 1 ml was mixed with 9
ml of molten T-H agar. Plates were poured and allowed to
set at an angle to form a slope whose thinnest edge just
reached the raised edge of the base. When the dye agar had 
set the plate was returned to the level and 9 ml of T-H 
agar, without dye, was poured on top. Four test strains, 
serotypes 09 (T891), 16 (T895) and 34 (T904 and T918), were 
streaked across the agar, from the highest to the lowest 
dye concentration area. The seeded plates were incubated 
at 37°C for 18 h anaerobically with C 0 2. The presence of
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growth and its length across the plate was noted.
ii) Testing of nine of the above sixteen dyes and a further 
nine dyes against six pneumococcal strains by the agar 
slope method.: solutions of the dyes MB, TB, NR, NB, CB,
CV, orange G (OG), luxol fast blue (LB), Best's carmine
(BC), celestin blue (CEB), brilliant blue (BB) and
rhodamine blue (RB) were made at 0.1% (w/v) concentrations 
in distilled water. Acridine orange (AO), alcian blue 
(AB), MG and JG were prepared at 0.2% (w/v) and BTB and
eosin-yellowish (EY) as 0.05% (w/v) solutions. A 1 in 10 
dilution of these solutions, in 10 ml of sterile molten
agar, was sloped in a petri dish and 10 ml of plain agar
poured as the reverse slope. The six test strains, four 
from the previous experiment and strains T966 (serotype 33) 
and strain W984 (serotype 14), were streaked along the 
gradient, incubated anaerobically for 18 h at 37°C and the 
length of growth produced measured.
iii) Inhibition studies by the agar slope method of ten 
dyes selected from those previously tested. Dye solutions 
were prepared at 0.1% (w/v) for NB, TB, BTB, JG and EY; at 
0.00002% (w/v) for MG; at 0.05% (w/v) for MB; at 0.2% (w/v) 
for AB; 0.05% (w/v) for AO and at 0.002% (w/v) for CV. 
These dye solutions were diluted 1 in 10 in agar and sloped 
plates prepared. The six strains, previously used, were 
seeded on to the plates, incubated at 37°C for 18 h, and 
the extent of growth inhibition along the line of the 
streak measured.
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2.8.3 The effects of aerobic and anaerobic culture on dye
inhibition of growth
Pairs of CB plates were seeded with the four test 
strains, serotypes 09 (T891), 16 (T895) and 34 (T904 and
T918), and nine wells, 5 mm in diameter,were cut in the 
agar and carefully filled with solutions of the dyes at the 
concentrations used in Section 2.8.2, ii. The dyes tested 
were BTB, MB, TB, NR, JG, NB, MG, CB and CV. All plates 
were incubated at 37°C for 18 h, one from each pair under 
aerobic conditions and the other anaerobically, both with 
added C 0 2. Zones of growth inhibition around the wells
were measured.
2.8.4 Paper strip method for dye inhibition studies
Dye impregnated paper strips were prepared by adding 
0.3 ml of a 0.1% (w/v) dye solution to a 3 x 1 cm square of 
Whatman's No.l filter paper. The strips, when dry, were
placed at right angles to each of the six pneumococcal test 
strains streaked across CBA plates, before incubation under 
anaerobic conditions at 37°C for 18 h. The cultures and 
the dyes tested were those used in Section 2.8.2 ii
together with luxol fast blue, nigrosin, naphthol yellow, 
orange G, rhodamine B, saffron, Best's carmine, celestin 
blue, brilliant blue, acridine orange, alcian blue and 
eosin yellowish.
79
2.8.5 Inhibition studies by the agar plate containing
method
A progressive series of 19 biological titrations was 
performed in stages starting with the ten dyes selected 
following the agar slope results. The testing was
performed on batches of eight to ten dyes but the
concentration used and the number of each stage are
presented in Tables 2.6 to 2.9 for clarity, and the 
pneumococcal strains tested in Table 2.10. Two of the ten 
dyes, eosin-yellowish and alcian blue, not included in the 
tables only featured in the early tests and were then
discarded. Eosin yellowish was tested in Stage 1 at 1.0 
and 0.5 ml of a 0.4% (w/v) solution and in Stage 2 at the
same volumes from a 0.033% (w/v) solution; alcian blue was
tested in Stage 1 at 1.5 and 1.0 ml of a 0.4% (w/v)
solution.
The test procedure for all experiments was to include the 
dye in 15 ml of T-H agar, to spread the organism over
approximately 1 c m 2 of the plate and then to incubate 
aerobically with added C 0 2 for 18 h at 37°C. Growth was 
recorded as presence, absence or as reduced colony size,
ii) Batch testing for reproducibility of inhibition results 
(Stage 17): using the dye concentrations given in Tables
2.8 and 2.9 four plates were poured for each dye solution 
by adding 12 ml of the diluted dye to 48 ml of T-H agar. A 
series of four experiments were performed on consecutive 
days.
Day 1: baseline testing of the dyes by the standard method
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TABLE 2.6
Dye concentrations and volumes added to Todd-Hewitt agar
plates in the dye inhibition Stages 1-8. A
Dye, concentration (%) and volume (ml) addedStage
No. Bromothymol Nile Acridine Crystal
blue blue orange violet
1
(1
0.02 .0, 0.5) 0.10 (1.0, 0.5) 0.10 (1.5, 1.0) 0.01 (1.0, 0.5)
2 0.02(1.0 and 0.20 0.5 ml was 0.033 taken from
0.033 
each dye)
3
(0
0.02 .8, 0.6) 0.10 (0.3, 0.1) 0.033 (0.8, 0.6)
0.01 (0.8, 0.5)
4 0.01 (1.0 0.025 ml was taken
0.04 from each
0.002
dye)
5 0.01(0.8)
0.10
(0.3)
0.04(1.04) 0.002(0.8)
6 0.01(0.9)
0.025(0.4) 0.04(0.4) 0.002(1.2)
7 0.0033 (3.0 ml 0.0035 0.008 0.001 was taken from each dye)
8 0.0033(3.4)
0.0035(3.6) 0.008(3.4)
0.001(3.4)
In stages 1-6 the volume of dye solution was added to 15 ml of Todd-Hewitt agar. In stages 7 and 8 the volume of dye solution was added to 12 ml of the agar.
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TABLE 2.7
Dye concentrations and volume added to Todd-Hewitt agar
plates in the dye inhibition Stages 1-8. B
Stage
No.
Dye, concentration (%) and volume (ml) added
Janusgreen Methyleneblue Malachitegreen Toluidineblue
1 0.01 0.10 0.002 0.10
(l.,0, 0.5) (0.5, 0.2) (1.5, 1.0) (0.5, 0.2)
2 0.20 0.01 0.002 0.01(1.0 and 0.5 ml was taken from each dye)
3 0.02 0.01 0.002 0.01.o00.o (1.5, 1.2) (0.7, 0.5) .o00.o
4 0.02 0.01 0.00002 0.01(0.8) (0.7) (1.0) (0.8)
5 0.01 0.01 0.00002 0.01
d.O) (0.9) (0.7) (1.0)
6 0.02 0.01 0.00002 0.01(0.4) (0.4) (0.8) (0.4)
7 0.0028 0.0014 0.000005 0.0020(3 .0 ml was taken from each dye)
8 0.0028 0.0014 0.000005 0.0020(3.4) (3.4) (2.6) (3.4)
In Stages 1-6 the volume of dye solution was added to 15 ml 
of Todd-Hewitt agar. In Stages 7 and 8 the volume of dye solution was added to 12 ml of the agar.
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TABLE 2.8
Dye concentrations and volume added to Todd-Hewitt agar
plates in each dye inhibition Stages 9-19. A
Dye and concentration (%) added
No. Bromothymol blue Nileblue Acridine orange Crystalviolet
9 0.003 0.003 0.013 0.0008
10 0.00375 0.001 0.000325 0.0008
11 0.005 0.0015 0.0044 0.00026
12 0.005 0.0015 0.0046 0.0004
13a 0.005 0.0015 . 0.0043 0.0006b - - 0.0046 0.0004
14a 0.005 0.0015 0.0043 0.00044b - 0.0010 0.00325 0.00026
15 0.0043 0.00107 0.00406 0.00296
16 0.0043 0.00107 0.00406 0.00296
1718 0.0043 0.00107 0.00406 0.0024519
In all of the above stages 3 ml of the dye solution wa;added to 12 ml of Todd-Hewitt agar.
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TABLE 2.9
Dye concentrations and volume added to Todd-Hewitt agar
plates in the dye inhibition Stages 9- 19. B
--------------
Stage
No.
Dye and concentration (%) added
Janusgreen
Methylene
blue Malachitegreen Toluidineblue
9 0.0027 0.0013 0.000005 0.0013
10 0.0038 0.00043 0.000005 0.000325
11 0.00348 0.00052 0.000010 0.00026
12 0.0036 0.00059 0.000025 0.00028
13a 0.0038 0.00059 0.000025 0.000325b 0.0036 0.00052 0.000050 0.00028c 0.00348 - - 0.00026
14a 0.00348 0.00059 0.000035 0.000236b 0.0027 - 0.000050 0.000216
15 0.00225 0.00060 0.000040 0.000163
16 0.00225 0.00060 0.000040 0.000163
1718 0.00290 0.00060 0.000040 0.00016319
In all of the above stages 3 ml of the dye solution was added to 12 ml of Todd-Hewitt agar.
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TABLE 2.10
Pneumococci tested in the agar plate 
dye inhibition stages.
Stage Serotype (number of strains)
No.
12 04, 06, 09, 14, 16, 33 and 34 (2)
3
4 01, 03*(3), 06 (6), 07, 09 (5), 14 (2), 15 (2),16 (3), 19 (4), 22, 23 (3), 31 (2), 33 (2),
34 (3), a pool I a non-capsulate variant
5 03 (3), 14 (2), 16, 19(2), 23 and pool I
6
7 01, 03, 06, 09, 14 (2), 16, 19, 23, pool I and
a non-capsulate variant
8 03, 14 (2), 16, 19, 23 and pool I
9, 10 11, 1213, 14 03, 04, 09, 14 (2), 19 and 23 (2)
15, 1617
18 03 (3), 06 (4), 09 (2), 11, 14 (4), 19 (9)
and 23 (4)
19 03 (5), 06 (4), 08, 09 (2), 11, 14 (8), 15 (2),
19 (5) and 23 (8)
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with the eight test strains;
Day 2: two series of plates were produced: a) the diluted
dye solutions were autoclaved in the T-H agar: b) the dye 
solutions were added after sterilisation of the agar;
Day 3: repeat testing of the standard strains as on Day 1.
iii) Testing of pneumococcal strains for sensitivity to the 
dyes and potassium tellurite (Stages 16 and 18). Potassium 
tellurite agar was prepared for both experiments by adding
1.2 ml of a 0.1% (w/v) solution of potassium tellurite and
1.8 ml of sterile distilled water to 12 ml of T-H agar.
iv) Dye inhibition testing and colonial appearance on 
Mitis-salivarius agar of 36 strains (Stage 19). These 
strains were cultured on the dyes given in Tables 2.9 and
2.10. They were also tested for colonial effects when 
grown on Mitis-salivarius agar (Section 2 8.9) and for C 0 2
requirement by the routine method (Section 2.4.6).
2.8.9 Colonial appearance on Mitis-salivarius agar.
Originally described as a selective medium for S. 
mitis and S. salivarius and the differentiation of dextran 
producing strains preliminary studies with this medium in 
the selective isolation of pneumococci gave novel colonial 
forms.
i) Mitis-salivarius agar (M-S) (Difco) and TYC agar (LabM), 
a similar formula for the isolation of dextran producing 
organisms, were seeded with 10 isolates, serotypes 01, 14, 
17, 19 (three strains), 23 (three strains) and 34, cultured 
aerobically and anaerobically at 37 °C for 18 h and examined
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for colonial size and appearance. A MOC (made in the 
U.S.S.R) plate microscope was used to examine the culture 
plate by oblique trans illumination at 12.5 x 0.6 and 12.5 
x 2 magnifications.
ii) The effect of sucrose on the production of the colonial 
forms of six strains, serotypes 09, 14, 19 (two isolates) 
and 23 (two isolates), was examined on M-S and M-S prepared 
without sucrose (S-M-S), cultured anaerobically at 37°C for 
18 h.
iii) The effects of base medium and trypan blue on the 
eolony types were investigated in twenty four strains grown 
on M-S, S-M-S, T-H containing 1% of 0.75% (w/v) trypan 
blue, RCM with 1% of 0.75% (w/v) trypan blue and CB agars, 
anaerobically at 37°C for 18 h. The pneumococci were of 
serotypes 01, 06 (three strains), 08, 09, 14 (four
strains), 17, 19 (five strains), 23 (six strains), 34 and
serogroup I.
iv) The next 70 routinely isolated pneumococcal strains 
were tested for colonial appearance on M-S, at 37°C for 18 
h.
v) To examine the basis for the irridescence effect two 
positive and a negative strain were grown in M-S broths and 
on M-S agar at 37°C for 18 h. The growth in the broth was 
centrifuged and a drop of the deposit observed under the 
plate microscope on a glass slide. Colonies, scraped 
directly from the M-S agar and as a heavy suspension in PBS 
were similarly observed under the microscope.
vi) A further 60 isolates were tested on M-S agar under
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the same conditions, two years after the original 
irridescence experiments.
vii) M-S agar, containing potassium tellurite is the 
recommended formula for selective streptococcal culture. 
Plates of M-S were prepared to include 1 ml of 1% potassium 
tellurite/litre of medium of both the Oxoid and Difco
formulae, and tested for growth inhibition of the eight 
cultures used in the dye inhibition studies (Section 2.8.5) 
incubated anaerobically at 37°C.
2.9 SENSITIVITY TESTS
The increased reports of antibiotic resistance in the 
pneumococcus warranted a reappraisal of laboratory
sensitivity testing procedures for this organism.
Tetracycline and co-trimoxazole resistance has become 
common but strains tolerant to chloramphenicol and the 
penicillins are still rare in Britain. To facilitate the 
early recognition of antibiotic tolerant strains it was 
necessary to investigate aspects of the in-vitro tests for 
pneumococcal susceptibility.
i) Media and atmosphere effects on the interpretation of 
sensitivity results were investigated for two strains, by 
the disc diffusion method, against penicillin, 2 units; 
tetracycline, 10 ug; trimethoprim, 2.4 \iq, and
co-trimoxazole, 25 ug. These were tested on Isosensitivity 
agar (IS), IS plus blood heated as for HBA (CIS) and on IS 
plus 7% horse blood (BIS) under anaerobic and aerobic 
conditions with added C 0 2 at 37°C for 18 h.
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ii) Sensitiviy testing of 22 pneumococcal isolates by the
antibiotic disc and agar containing methods using lysed 
blood sensitivity agar (LIS) was as follows:
a) Discs of tetracycline (5 ug) and trimethoprim (2.5 ug) 
were placed on LIS previously Seeded with the test strain.
b) Antibiotic plates containing 1 ug/ml trimethoprim and a 
second series containing 1 ug/ml of tetracycline were 
prepared by adding the drug when the agar had cooled to 
approximately 55°C. A loopful of a dilute suspension of 
the test culture , in PBS, was spread over 1 sq cm of these 
plates and incubated at 37°C for 18 h. The performance of 
the antibiotics and the agar was controlled by Staph. 
aureus (NCTC 6571, SOX).
c) Plates containing trimethoprim at 2.5, 1.0 and 0.75 
Ug/ml were poured and a loopful of a PBS suspension of 20 
of the above pneumococcal isolates spread over 1 sq cm of 
the agar and incubated at 37°C for 18 h.
Repeat tests were performed by the above method on the 
resistant cultures after incubation in RCM broth for 4 h.
iii) Extended series of antibiotic disc susceptibility 
tests. A known penicillin tolerant culture obtained from 
the Microbiology department at the Royal Hallamshire 
Hospital, Sheffield and 12 test strains from this 
department were allowed to grow in T-H broth for 4 h at 
37°C in the C 0 2 incubator. Each strain was spread on to 
BIS and LIS agars with a rotary plating machine; SOX served 
as the control organism. Commercial antibiotic discs were 
placed at the junction of the two seeded areas; the
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antibiotics and concentrations used are given in Table
2.11. Zone diameters were measured after incubation at 
37°C for 18 h.
The tests for mecillinam and cloxacillin were repeated for 
six further recent clinical isolates, the previous 
resistant strain and two resistant cultures supplied by the 
Streptococcal Reference Laboratory, Colindale.
iv) Sensitivity to Tetracycline and Trimethoprim by the 
disc diffusion method of 50 pneumococcal strains was 
performed on heated blood sensitivity agar against 
tetracycline, 5 ug r and trimethoprim, 2.5 ug» The test 
strain was applied to the central 6.5 cm diameter area of 
the plate on a rotary plater, the control organism SOX was 
spread on the remainder of the plate and the discs placed 
on the junction of the two seeded areas. After incubation 
at 37°C for 18 h the inhibition zones of the test strains 
were measured.
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TABLE 2.11
The antibiotics tested
Paper discs impregnated with antibiotics in the following 
concentrations were supplied by Mast (except where 
indicated).
Penicillin 1.5 units
Tetracycline 10 ug
Trimethoprim 2.5 ug
Co-trimoxazole 25 ug
Sulphadimidine 200 ug
Mezlocillin 30 ug
Azlocillin 75 ug
Chloramphenicol 2 ug
Erythomycin 5 ug
Cefotaxime 30 ug
Ticarcillin 75 ug
Cefuroxime 30 ug
Mecillinam 10 ug
Ceftazidime 10 ug
Cloxacillin 5 ug
Cefamandole 75 Ug (Oxoid)
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2.10 COLLECTION OF EPIDEMIOLOGICAL DATA
A daybook register of the samples positive for 
pneumococci was generated in the laboratory and contained 
the following information:-
a) Patient’s name, sex, registration number, date of 
birth, ward and consultant;
b) The type of sample, and its laboratory number 
together with clinical details of the patient were taken 
from the laboratory request form;
c) To these were added the sensitivity pattern, 
capsular type and requirement for C 0 2.
To complete the patients' details omitted from the 
laboratory request form, patients' medical records were 
obtained from the Medical Records Department, Accident and 
Emergency Department and the post mortem files from the 
Histology Department, Children's Hospital, Sheffield (with 
the permission of the Consultants responsible for the 
patient). The patients' home address and the reason for 
their admission or visit to the hospital were taken from 
these notes.
The details of those patients who had been admitted to the 
Children's Hospital or the Thornbury Annexe were processed 
by the Medical Records Department for analysis of bed 
occupancy and usage, using the Trent Regional Computer. A 
print out of each admission was produced and the 
appropriate episode matched with the laboratory details. A 
special computer file for this project and the material to 
be entered was coded on to specially produced computer
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input documents; Document A for In-patients and Document B 
for Out-patients, Accident and Emergency patients and post 
mortem cases (Appendix C ) . Document B had an extended 
patient details section for the information comparable to 
that on files for the In-patients (Document A).
The two groups of information were merged into one file for 
subsequent analysis of laboratory and patient data.
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3.1 GASEOUS ENVIRONMENT AND GROWTH
The clinical recovery of the pneumococcus can be 
affected by the gaseous atmosphere used as much as by the 
growth media. A number of investigations were undertaken 
to examine the factors involved.
3.1.1 Comparison of anaerobic and aerobic culture for the 
isolation of pneumococci from nasal swabs
Anaerobic culture with added C 0 2 when compared to 
aerobic culture without C 0 2 gave a 100% increase in 
pneumococcal isolations (Howden, 1976) . It was, therefore, 
necessary to examine the differences between aerobic and 
anaerobic culture when both atmospheres contained added 
C 0 2. Of the 89 specimens tested in the present study, 
pneumococci were isolated from both anaerobic and aerobic 
culture of 14, and in eight of these 14 samples the broth 
cultures also yielded pneumococci. Two further broths were 
positive for pneumococci but the parallel direct plate 
cultures were negative. The number of colonies seen under 
both conditions were similar however, those produced 
anaerobically with C 0 2 were much larger than those produced 
aerobically. The numbers and colony size of the majority 
of the other bacteria present on aerobic cultures were 
reduced or absent when cultured anaerobically. Anaerobic 
incubation with added C 0 2 did not show a numerical 
advantage over aerobic incubation with C 0 2 but proved to be 
a simple and effective selective procedure that enhanced
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recognition both by the production of large mucoid 
pneumococcal colonies and by the suppression of many of the 
mixed flora commonly seen in cultures of respiratory 
specimens.
3.1.2 The isolation of pneumococci under different gaseous 
conditions
The atmosphere employed and the eight capsular 
serotypes tested are given in Table 3.1. None of the 
strains grew after diluting 1 in 100 with water. The 
Pseudomonas culture, the negative control organism for 
anaerobiosis, grew in both the N 2 and the H 2/ C 0 2/ N 2 
atmospheres indicating that some 0 2 remained in these jars.
The N 2 atmosphere showed no advantage over aerobic or 
candle jar. The H 2/C02/ N 2 mixture alone gave similar 
yields to H 2.
The results (Table 3.2) of dilution in PBS and T-H broth 
showed that the serotype 06 strain gave similar results in 
PBS and T-H under both incubation conditions. After 
dilution in water however anaerobic culture, with C 0 2, gave 
higher yields than the aerobic atmosphere. The serotype 18 
culture gave scant growth anaerobically with C 0 2 and failed 
to grow under aerobic conditions regardless of the diluent.
The results of the repeat gaseous test of serotypes 18, 
19, 23 and a further strain serotype 19 are given in Table 
3.3. All cultures grown anaerobically with C 0 2 gave larger 
colonies and comparable or higher viable counts than in the 
other environments, except for
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TABLE 3.1
Pneumococcal growth on Columbia blood agar plates
under different gaseous atmospheres. A
Pneumo.Type
Colony count and size after incubation in
h 2/c o 2 h 2 n 2 H 2/C02/ N 2 o 2 CJ
19 2 2 - - - -
06 8 20 15 8 8 15L M S S S S
04 10 7 107 10 7 107 107 107L M S S S S
18 107 107 10s 107 10 1 107L M S M S S
03 107 107 107 107 105 10 3L L L L L L
23 107 107 107 10 7 107 107L M S M S S
19 107 107 105 105 107 107L M S M S S
H 2 = hydrogen L = large colonies
n 2 = nitrogen M = medium colonies
c o 2 = carbon dioxide S = small colonies
0 2 = oxygen CJ = candle jar
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TABLE 3.2
Anaerobic and aerobic culture after dilution in
water, phosphate buffered saline or Todd-Hewitt broth of
two pneumococcal cultures
Density of growth after dilution in
Serotype Atmos Water PBS Todd-Hewittbroth10 50 100 10 50 100 10 50 100
A n02+C02
++ ++ + 80 ++ + 30
06 o2 + ++ + 80 ++ + 30
AnO 2 +C02
10 9 4 1 12 4 2
18 o2 . . . ' "
Atmos = atmosphere used for culture
A n 0 2 = anaerobic atmosphere with 10% C 0 2 +C02
0 2 = aerobic atmosphere
++ = moderate semi-confluent growth 
+ = less confluent growth 
- = no growth
The figures in the A n 0 2+C02 and the 0 2 rows indicate the number of colonies recorded.
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TABLE 3.3
Pneumococcal growth on Columbia blood agar plates
under different gaseous atmospheres. B
Pneumo.Type Colony count and size after incubation in
h 2/c o 2 h 2 n 2 h 2/c o 2/ n 2 ^ 2 CJ
19 10 7 105 10 5 10s 107 107
18 10s 103 10 3 10s 0 107
23 107 10s 10 7 10 7 105 107
19 107 10 5 105 107 106 106
H 2 = hydrogen L = large colonies
N 2 = nitrogen M = medium colonies
o o ro II carbon dioxide S = small colonies
o 2 = oxygen CJ = candle jar
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the serotype 18 strain. This strain was of further 
interest with its need for C 0 2, it failed to grow or gave 
reduced viable counts in those atmospheres without C 0 2 i.e. 
aerobic, hydrogen or nitrogen.
3.1.3 Direct isolation and gaseous environment
The results from the specimens of patients suspected 
of carrying pneumococci (Section 2.4.5), incubated under 
different atmospheres, gave moderate or heavy mixed growths 
of other respiratory flora as well as pneumococci. None of 
the pneumococcal isolates (Table 3.4) grew aerobically 
without extra C0.2. The pneumococcal colonies produced by 
culture in a H 2 atmosphere, from serotypes 18 and 06 gave 
the same viable count as under anaerobic conditions with 
C O 2 although the colony size was greatly reduced. Two 
serotype 09 isolates required increased C 0 2 levels for 
growth even when the 0 2 tension was reduced since they 
failed to grow in either a H 2 or a N 2 atmophere. The 
extent of the C 0 2 requirement merited further study.
3.2. THE REQUIREMENT FOR CARBON DIOXIDE
The essential requirement for C 0 2 shown by certain 
pneumococci was investigated to establish its importance in 
the isolation of clinical strains.
3.2.1 Carbon dioxide requirement of individual strains 
grown on Columbia blood agar
None of the four strains, serotypes 03, 09, 19 and
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TABLE 3.4.
The effect of different culture atmospheres on the
isolation of pneumococci from clinical specimens
Pneumo.Type Viable count (cfu/ml) after incubation in
h 2/c o 2 h 2 n 2 h 2/c o 2/ n 2 C 0 2 o 2 CJ
06 107 107 4 107 I07 0 10 7
18 10 7 107 10 3 107 I07 0 107
09 o 1—1 0 0 105 I0*7 0 107
09 10 5 0 0 10 s I07 0 107
H 2 = hydrogen L = large colonies
N 2 = nitrogen M = medium colonies
o o M II carbon dioxide S = small colonies
0 2 = oxygen CJ = candle jar
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33, grew aerobically without C 0 2, but all strains grew in 
the other three environments (Section 2.4.6). The 
pneumococcal colonies grown in the C 0 2 incubator were 
larger and more convex than the smaller more collapsed 
colonies seen in the candle jar cultures. The improved 
colony appearance after candle jar culture over aerobic 
culture could have been produced by the reduction in 
oxygen within the jar as the candle burnt rather than the 
increased C 0 2 level produced by the combustion. Therefore 
the tests were repeated but with a further series of 
plates for a second candle jar which included a bottle of 
40% KOH solution to absorb the C 0 2 produced. The absorbed 
candle jar plates gave only small numbers of minute 
colonies (less than 0.5 mm in diameter) with serotypes 09, 
19 and 33; the serotype 03 strain failed to grow. When 
the absorbed candle jar plates were reincubated 
anaerobically with C 0 2 for a further 18 h at 37°C the 
serotype 03 strain still did not grow; the other three 
strains gave a heavy growth of large mucoid colonies, 
larger than those seen after 18 h incubation anaerobically 
with C 0 2. The requirement for C 0 2 could be even more 
apparent on primary isolation rather than after subculture 
on laboratory media and the repeat nasal swabs obtained 
from the two patients previously shown to carry 
pneumococci were obtained to examine this aspect of 
pneumococcal isolation. The pneumococcus isolated from 
one of the patients (Patient A) was present on CBA in 
moderate numbers after anaerobic incubation with C 0 2, in
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small numbers anaerobically without C 0 2 and failed to grow 
aerobically either with or without C 0 2. A similar pattern 
was observed on HBA except that smaller numbers of colonies 
were seen anaerobically with C 0 2 and only scant numbers 
when cultured anaerobically without C 0 2.
In the second patient (patient B) pneumococci were present 
in larger numbers anaerobically with C 0 2 and smaller 
numbers and reducing colony sizes were observed in a 
progression down to aerobic culture without C 0 2. A similar 
pattern was found on HBA but with lower numbers 
anaerobically progressing down to no growth aerobically 
without C 0 2. Pneumococcal colonies on HBA that had been 
incubated anaerobically did not show the characteristic 
greening and bleaching observed on that medium when 
incubated aerobically.
Growth on CBA and Sheep blood Todd-Hewitt/liver digest agar 
(ST-HL) of these four strains, under the same atmospheres, 
showed that one of the sertype 09 strains could grow 
aerobically without extra C 0 2 on ST-HL but not CBA. This 
strain also failed to grow on CBA plates when sheep blood 
replaced the horse blood.
3.2.2 The requirement for C 0 2 related to pneumococcal 
capsular serotype
The four strains used in Section 3.2.1, belonging to 
serotypes 06, 09 ( two isolates) and 18 all failed to grow 
aerobically without extra C 0 2 even after 10 subcultures on 
artificial media. The simple method adopted for assessing
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the C 0 2 dependance of recently isolated cultures (Section 
2.4.6) was used from April to July 1979 on 103 strains of 
which 14 (13.6%) were shown to need extra C 0 2 for growth in 
vivo. Of these 14 strains, 11 were either serotype 09 or 
16. When the survey was extended (Table 3.5) from October 
1979 to November 1980, a further 27 C 0 2 requiring cultures 
were found in the 298 strains tested, 11 of which were of 
these two serotypes. Further details of C 0 2 dependance and 
serotype are included in Section 5.
3.3 THE EFFECTS OF MEDIA ON GROWTH
Growth in a number of media and their modifications
was undertaken to improve recovery of the pneumocococci
from clinical samples and viability of the organisms for
identification and characterisation studies.
3.3.1 Growth in Reinforced Clostridial broth
The strains of serotypes 06, 08, 14 and the two
cultures of serotype 03 all grew in the two RCM formulae 
without dye but not in the. medium with methylene blue. The 
dye containing broths were blue in the upper 5-10 mm 
(oxidised) and colourless (reduced) below this level. The 
broths without agar gave a diffuse light turbidity and the 
medium with agar a 3-5 mm wide band of heavy growth 
approximately 7-12 mm below the surface of the fluid. The 
depth of this band corresponded to the depth at which the 
methylene blue was reduced in the dye containing medium.
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TABLE 3.5 
Distribution of C 0 2 requirement
related to pneumococcal serotype
Serotype Total number of strains tested CO 2dependant strains
09 24 18
01 4 1
18 17 2
42 1 1
19 76 7
16 6 4
23 64 2
03 20 1
28 1 1
I 4 1
15 14 1
06 85 1
04 15 1
Others 69 0
Totals 401 41
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Methylene blue appeared to be inhibitory to the 
pneumococci tested; this phenomenon was further studied in 
Section 4 .
3.3.2 Growth enhancement using liver digest
Heavier growth of the serotype 03 strain occurred in 
each of the media with LD than in the corresponding medium 
without this supplement. The amount of LD necessary for
optimal enhancement, examined by double dilution, showed 
that turbidity of the broths increased progressively from 
the control tube without LD to the tube containing 1% LD. 
Thus 1% was taken as the routine amount of supplement for 
broth cultures.
3.3.3 The effect of pH change on pneumococcal growth
i)Todd-Hewitt and Reinforced Clostridial media: the
initial pH values of T-HL and RCML were 7.8 and 6.8
respectively. After 24 h incubation with a serotype 03 
strain, isolated from a patient with an ear infection, 
these values had fallen to 6.6 and 5.4 and after 72 h to
6.4 and 5.1 respectively. The T-HL had become almost clear 
within 72 h and the RCML remained very turbid. The 
supernates titred against serotype 03 protein-A reagent 
gave values of 3000 after both 24 and 72 h in the T-HL 
culture and 2000 and then 6000 from RCML. The deposits of 
both broths gave titres of 100 after 72 h.
A further four cultures, serotypes 03, 04 and 14 (two
strains), obtained from respiratory sites, and the above
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serotype 03 strain, were incubated for 48 h in RCML and 
the appearance of growth, the pH and glucose remaining 
recorded. The following results were obtained in three 
strains (serotypes 03, 04 and 14) diffuse turbidity, a 
final pH of 6.6 and absence of glucose, when tested with 
Dextrostix, were produced; in the other serotype 14 
culture the growth was granular and settled out with a 
final pH of 7.0, a large amount of glucose remained. The 
initial serotype 03 strain produced a diffuse turbidity as 
did the respiratory serotype 03 isolate, but the former
gave a final pH of 5.8 with some glucose remaining and the
latter a pH of 6.6 with all the glucose exhausted,
ii) The effect of the pH of T-H, RCM and Columbia agars
on the growth of the three cultures, serotypes 01, 03 and
31 on the eight media (Section 2.6.3) was to give reduced 
colony size (<0.5 mm) on T-H and RCM at pH 6.8. At pH
7.3, on T-H and CA media, moderate sized colonies, 
approximately 1.5 mm were observed; large colonies, 
approximately 2-3 mm formed on RCMA with serotypes 01 and 
31 and the serotype 03 strain gave moderate sized 
colonies. The T-H and RCM. media at pH 7.8 gave small 
colonies < 1 mm. No growth was found on either T-H or RCM 
agars at pH 7.8 containing bromothymol blue which had been 
included to demonstrate acid production from the glucose 
in the formulae. This finding was further investigated and 
is reported in the dye inhibition section (Section 4."*.). 
The colonies of the serotype 03 strains were generally 
reduced anaerobically when compared to aerobic culture, in
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contrast to the other cultures in which colonies were much 
larger anaerobically.
3.3.4 Yield and viable count on broth and plate culture 
The viable counts and optical density tests (Section
2.^.4) showed that although the turbidity of T-H was only 
0.03 to 1.0 unit less than that of the plate culture the 
viable count was only a quarter to a half of the plate 
viable count. The values found at 260 nm were too small 
for this absorbance to be used for further strains. The 
growth after plate culture was adopted for study following 
18 h incubation at 37°C since the viable count was
significantly higher.
3.3.5 The effects of cysteine and sodium bicarbonate on 
growth in Todd-Hewitt broth
Turbidity was evident in all tubes (Section 2.6.5) at 
5 h. At 18 h the row of broths containing both cysteine 
and bicarbonate were more turbid than their respective
tubes in the cysteine row. With cysteine only the 0.25% 
broth was the most turbid,.this density gradually decreased 
to the 0.03% tube; this last tube was still more turbid 
than the control tube.
The control tube and those with cysteine only were strongly 
positive and the bicarbonate tubes very weakly positive for 
glucose. Viable counts and final pH of the control tube, 
0.025% cysteine and the 0.025% cysteine with bicarbonate 
broths were 4 x 106 cfu/ml, pH 6.5; 2.5 x 108, pH 7.2; 2 x
108
10®, pH 8.3 respectively.
3.3.6 Neutralised cysteine and sodium bicarbonate.
The serotype 23 strain performed equally well in all 
4 T-H media; the growth of the serotype 08 culture was 
inhibited by bicarbonate (T-HB) and enhanced in T-HC 
(neutralised cysteine); the serotype 19 strain was 
inhibited by cysteine and bicarbonate in combination, 
T-HCB.
No advantage was found for these strains except that the 
medium plus bicarbonate had a pH of 7.4 - 8.0 and was
consistently depleted of glucose; in T-HLH the pH was less 
than 6.8 and only 2 of the 6 organisms removed all the 
glucose; in T-HC this only occurred with the serotype 11 
strain.
3.4 SELECTIVE CULTURE METHODS
i) Sodium azide (0.01%) and gentamicin (0.4 ug/ml) 
included in T-H broths for the isolation of six 
pneumococcal strains when mixed with a suspension of Staph, 
aureus (Oxford strain, SOX) gave the results in Table 3.6. 
Gentamicin inhibited the SOX but was also inhibitory to
four of the pneumococcal strains tested, at the 
concentrations used. Sodium azide did not inhibit the SOX 
but restricted the growth of four of the pneumococcal
strains. The serotype 04 pneumococcal culture was
inhibited by the SOX in the T-HL broths and one of the
serotype 14 strains showed a reduction in growth. Reduced
109
TABLE 3.6
Pneumococcal recovery from mixed culture with Staph, aureus
using sodium azide and gentamicin selective broths.
Serotype
P
Density of growth on medium
T-HL S ATP -HLS P GT-HL S
ContrP
03 ++ ++ ++ ++ + +++
03 ++ ++ ++ ++ ++ - +++
14 +++ ++ - ++ - - +++
14 ++ +++ + +++ +++ - +++
03 +++ +++ +++ +++ +++ - +++
04 - +++ - +++ - - +++
T-HL = Todd-Hewitt broth containing 1% liver digest; 
AT-HL = T-HL containing 0.01% sodium azide;
GT-HL = T-HL containing gentamicin 0.04 ug/ml.
Contr = positive control of growth;
P = pneumococcal growth;
S = SOX growth.
Growth was scored from - = no growth
to +++ = heavy growth.
1
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growth by these strains and the other serotype 14 strain 
was more pronounced in the azide medium whilst serotypes 
03, the second serotype 14 and the serotype 04 gave reduced 
growth in the gentamicin medium and contrasted with the 
heavy growth of the pneumococci in pure culture.
ii) The inhibition zones produced with gentamicin, fucidin, 
kanamycin and nitrofurantoin discs against the nine 
pneumococci and four non-haemolytic streptococci (NHS) 
showed that all strains were sensitive to nitrofurantoin 
with zones exceeding 35 mm, except for one strain from each 
group that gave a zone of 10 mm. Inhibition zones of all 
isolates were <10 mm with kanamycin and gentamicin discs 
and 10-12 mm with fucidin. None of the discs were suitable 
for selective purposes with the organisms tested.
iii) Gentamicin blood agar;
a) The gentamicin minimal inhibitory concentration (MIC) of 
the nine pneumococci, taken as the plate containing the 
lowest concentration of gentamicin not permitting growth, 
showed that one of the pneumococci was inhibited by 4 US* 
the other 8 grew in the presence of 8 ug/ml; the control 
SOX had an MIC of 0.25 ug/ml.
b) Gentamicin blood agar (GCBA) seeded with 59 consecutive 
throat and nasal swabs gave eight samples positive for 
pneumococci under anaerobic conditions, five when incubated 
aerobically with C 0 2 and four on the aerobic (without C 0 2) 
GCBA plates. Growth was present on 17 of the aerobic GCBA, 
24 of the C 0 2 GCBA and 44 of the anaerobic CBA plates.
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The short series of 12 routine swabs cultured on CBA
aerobically with and without C 0 2, anaerobically with and 
without C O 2 and on GCBA anaerobically with C 0 2 gave 2
samples positive for pneumococci on CBA and GCBA incubated 
anaerobically. One of the negative swabs yielded a 
beta-haemolytic streptococcus on the anaerobic CBA but not 
on the GCBA or the other CBA plates.
Eight further swabs cultured on GCBA under aerobic and 
anaerobic conditions yielded three specimens positive for 
pneumococci after aerobic culture; four of the remaining 
five samples gave no growth. Anaerobic culture on GCBA
showed five positives (equivalent to number found on the
original CBA plates). All of the remaining plates showed 
some growth.
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3.5 DISCUSSION
Pneumococci can be difficult to isolate from serious 
infection sites for a number of often interrelated reasons 
and it is essential that the artificial environment 
employed for their recovery is optimal for their exacting 
requirements. The culture method commonly used is rapid 
transfer of the sample, obtained before the commencement of 
antibiotic therapy, on to enriched agar with aerobic 
cultivation in an atmosphere containing 10% C 0 2. This has 
been shown to be unsatisfactory in many surveys of 
respiratory isolation in which the pneumococcus was 
recognised in Gram stained smears of the specimen, but 
grown in only 50 to 70% of cases (Lepow et a l ., 1968;
Spencer and Phillips, 1973; Rein et a l ., 1978 and Sarchik, 
1979). Following the introduction of an improved anaerobic 
technique (Collee et a l 1971; 1972) , pneumococcal
isolations in this laboratory appeared to have increased. 
A study by Howden (1976) showed that more than twice the 
number of pneumococci were isolated by the new anaerobic 
procedure which included extra C 0 2 than by aerobic 
incubation. The advantage of anaerobiosis with C 0 2 over 
aerobic incubation without C 0 2 was quite clear but the 
effect of permutations of 0 2 and C 0 2 concentrations on the 
recovery of pneumococci was not examined. Qualitative and 
quantitative experiments of a range of gas conditions on 
colony size and viable count confirmed that growth of 
almost all strains was enhanced by anaerobiosis with added
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C O 2 . The main exceptions were colonies of serotype 03 
strains, which although large after anaerobic incubation, 
remained smaller than the huge mucoid colonies seen after 
aerobic culture. Other gas mixtures were less than optimal 
for some of the strains tested. Certain isolates grown 
anaerobically without added C 0 2 gave results comparable to 
aerobic incubation with added C 0 2. In others growth in 
nitrogen was similar to aerobic culture without added C 0 2. 
The two major factors which combined to give increased 
pneumococcal isolation from clinical material were reduced 
0 2 and increased C 0 2 levels. In a more easily defined 
group of strains no growth occurred in air unless extra C 0 2 
was available. These C 0 2 dependent cultures predominantly 
belonged to serotype 09. Following an extended survey of 
the proportion of dependant strains related to serotype it 
was seen that 10% of all isolates required extra C 0 2 (Table 
3.5). Although these strains were most prevalent in 
serotypes 09, 16 and 19 other serotypes showed one or more 
examples and in two serotypes i.e. serotypes 28 and 42, 
these were the only isolates seen of that serotype. This 
degree of C 0 2 dependence would have meant that more than 40 
samples each year could have been incorrectly reported as 
negative for pneumococci. At least some of these false 
negatives could have been from patients with septicaemia or 
meningitis, confirming the essential nature of C 0 2 in the 
isolation of pneumococci.
The marked differences in pneumococcal colony size after 
aerobic (Fig 3.1) and anaerobic incubation (Fig 3.2) may be
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FIGURE 3.1 Colonies of S. pneumoniae after aerobic
culture (without added C 0 2) on Columbia blood agar.
®r
FIGURE 3.2 Colonies of S. pneumoniae after anaerobic
culture with added C 0 2 on Columbia blood agar.
a combination of a number of effects. The pneumococcus, 
unique amongst aerobes, is unable to synthesise either 
catalase or peroxidases (MacLeod, 1921) such that when 
grown in air accumulates hydrogen peroxide. This is 
probably a product of oxidative reactions by the organisms 
flavoprotein enzymes and leads to the characteristic 
greening or bleaching around colonies formed on blood agar 
rendered catalase deficient by heating. Under anaerobic 
conditions hydrogen peroxide should not accumulate and an 
enzyme deficiency would not, in vivo, be a problem. This 
lack of peroxide was confirmed in vitro by the absence of 
changes around colonies grown anaerobically on heated blood 
agar.
Anaerobic culture has a further advantage for the isolation 
of pneumococci by suppressing other commonly encountered 
bacteria, for example the neisseriae, diphtheroids and 
staphylococci. The Gram negative bacilli, particularly the 
pseudomonads, are also adversly affected by anaerobiosis 
since they either fail to grow or the colonies produced are 
reduced in size. The majority of the organisms listed can 
be associated with the pneumococcus in infection but most 
commonly are commensals that contaminate samples during 
collection. Oppression of aerobes gives the pneumococcus 
the opportunity to form colonies which are also enhanced in 
size and appearance (Fig 3.2) facilitating their easy 
recognition in mixed culture. This is in sharp contrast to 
the small easily overlooked "draughtsman" colonies (Fig 
3.1), amongst the many colonies produced by aerobic
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culture.
The role of C 0 2 in the increased colony size is uncertain; 
it has been shown that other streptococci in continuous 
culture have a reduced lag phase if a particular C 0 2 level 
is provided (Valley 1927; Walker 1932 and Kempner 1942). 
Carbon dioxide depletion experiments suggested that a 
similar mechanism exists in the pneumococcus since strains 
incubated initially without C 0 2 gave only minute colonies 
but when C 0 2 was introduced and incubation continued
characteristic large mucoid colonies resulted. This
supports the belief that lack of C 0 2 extends the lag phase
of pneumococcal growth. Some carboxyphilic pneumococci 
were able to grow on Todd-Hewitt (T-H) agar but not on 
Columbia agar without extra C 0 2 being present. The
bicarbonate ions in the T-H medium were probably the factor 
that allowed these strains to overcome their dependance on 
gaseous C 0 2. This independence did not apply to all the 
C 0 2-requiring isolates but whether this was a qualiatative 
or quantitative effect would require further study. The 
increased colony size after anaerobic incubation with extra 
C 0 2 is probably a combination of increased viablity of the 
organism, in part by a reduction in peroxide formation and 
inhibition of autolytic enzyme release and greater 
production of capsular material.
Carboxyphilic streptococci are most frequently recognised 
as initially anaerobic strains which on subculture become 
aerotolerant if extra C 0 2 is provided. In a similar 
fashion some pneumococci were seen to be initially
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intolerant of an aerobic atmosphere unless an excess of C 0 2 
was present. In other isolates the lack of C 0 2 could be 
overcome if cultures were incubated anaerobically in an H 2 
only atmosphere.
The narrow band of pneumococcal growth, 10 mm below the 
surface of a broth, containing a small amount of agar to 
reduce convection currents, was similar to the growth of 
microaerophilic organisms in this kind of medium. Failure 
of artificial culture conditions to provide optimal 
concentrations of pneumococcal growth factors would appear 
to be depend nt upon both gaseous and medium constituents. 
Enriched agar bases with horse or sheep blood are used for 
pneumococcal isolation but these have largely been 
developed with stock laboratory strains and compared with 
now acknowledged inferior media. The commonly used medium, 
Columbia blood agar base, considered superior to previously 
used blood agar formulae (Elner, 1966) may only represent 
an improved medium and not the ultimate pneumococcal 
culture base. Todd-Hewitt agar for example proved superior 
to Columbia agar in the recovery of C O 2-depend«nt strains 
and RCM agar gave larger colonies with non-fastidious 
cultures. Liver digest, a source of essential amino acids 
and vitamins, further enhanced pneumococcal growth. 
Although T-H broth culture is less practical for a routine 
clinical laboratory than Columbia blood agar, it was 
sucessful in the recovery of the organism from respiratory 
samples when the plate culture was negative. Whether this 
was through osmotic support or supply of nutrients is
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unknown but it was not possible to extrapolate the findings 
from T-H broth to growth on agar. Simple alteration of the 
pH in T-H, RCM or Columbia agars significantly affected 
pneumococcal viability, autolysis and the amount of 
capsular material formed. The optimal pneumococcal culture 
pH . on agar was 7.3, with marked reductions in growth 
either at 6.8 or 7.8, and was pH 7.8 in T-H broth. Growth 
in T-H broth was enhanced both by cysteine, an antagonist 
of oxidation and hydrogen peroxide; and by sodium 
bicarbonate, a pH buffer or possible source of bicarbonate 
ions. The extended metabolism produced in the broths 
containing both cysteine and bicarbonate had the 
disadvantage that the growth curve reached a plateau more 
quickly and the organisms were therefore in decline after 
20 h incubation. However, extended glucose metabolism 
consequently gave higher capsular polysaccharide titres and 
was independant of the serotype of the isolate, fall in 
initial pH of the medium and viability of the culture. 
Inhibition of pneumococcal growth by methylene blue and 
bromothymol blue was an unexpected finding, which was 
further expanded in Section 4.7.
Recommended selective agents were also unreliable when 
pneumococci with an MIC of greater than 4 ug/ml to 
gentamicin were inhibited by 0.4 ug/ml of gentamicin 
included in a broth medium. Similarly the sodium azide at 
the concentration used should not have reduced the growth 
of many of the pneumococcal strains tested but should have 
inhibited the staphylococci. These practical difficulties
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in applying theoretically suitable selective agents to the 
isolation of small numbers of bacteria confirms the view 
that anaerobic culture with added C 0 2 is the method of 
choice for the recovery of pneumococci from clinical 
samples.
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IDENTIFICATION AND CHARACTERISATION
4.1 CAPSULE SWELLING
The capsule swelling test, performed on 10 
pneumococcal strains, was difficult to interpret because 
the increase in capsule size was not easily recognised with 
the microscope available; the method was therefore 
discontinued.
4.2 IMMUNODIFFUSION
All the four methods of antigen extraction (Section 
2.5.2) gave similar specific precipitation lines; T-H broth 
culture supernate (method a) was adopted for routine use. 
Culture supernates from 151 consecutive clinical isolates 
tested, initially against the pooled sera, by 
immunodiffusion showed specific reactions with 91 strains, 
but 60 cultures did not react. This gave the following 
distribution:-
Pool A 9 cultures
Pool B 18 cultures
Pool C 2 cultures
Pool D 10 cultures
Pool E 1 cultures
Pool F 7 culture
Pool G 6 cultures
Pool H 37 cultures
Pool I 1 culture
Unidentified 60 cultures
Immunodiffusion was not sui
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detection.
4.3 IMMUNO-ELECTROPHORESIS
4.3.1 Studies to establish an optimal method for 
electrophoresis
Precipitation lines were not seen under any of the 
conditions (Section 2.5.3.i) when the serogroup H strain 
antigen was tested in agar/agar or indubriose in Veronal 
buffer. When the parallel series (Section 2.5.3.ii), with 
the substitution of Tris buffer was performed, the results 
were also negative and the gel distorted after the current 
had been passed for 15 min. At a constant current of 100 
ma in agar/agar (Section 2.5.3.iii) with Veronal or Tris 
buffers the former was negative and the latter gave blurred 
lines; the gel again becoming distorted after 15 min. 
Faint non-specific lines were seen with 50 ma constant 
current in agar/agar with Tris buffer and faint specific 
precipitation was observed using indubriose as the support 
medium (Section 2.5.3.iv). Agar distortion caused by 
overheating was reduced by placing a frozen platten under 
the slides before starting each electrophoresis test. A 
constant voltage of lOOmv for 30 min across cooled 
indubriose in Tris buffer (Section 2.5.3.V) showed strong 
precipitation lines with Omni-serum and weak lines with 
pool H serum and pool B.
Fresh group H antigen prepared in T-H broth tested at lOOmv 
for 30 min in Tris buffer and indubriose gave specific 
reactions with Omni and pool H sera (Section 2.5.3.vi).
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The source of this artefact, investigated by 
electrophoresis of pneumococcal cultures in tryptone soya 
broth (TSB) and T-H with and without 1% liver digest and/or 
1% haemoglobin (Section 2.5.3.vii) showed faint specific 
lines with all T-H based media and blurred non-specific 
lines with the TSB media. Todd-Hewitt medium was therefore 
used for all subsequent broth culture tests.
Sources of antigen (Section 2.5.3.viii), in whole culture, 
whole culture lysed with sodium deoxycholate and culture 
supernate both with and without alcohol precipitation, 
under the conditions used for detection of the artefact 
showed similar antigen titres for all extracts; the
precipitin lines formed however were still weak.
The Veronal buffer system when retested (Section 2.5.3.ix) 
with antigens from cultures of serotypes 06, 23 and group E 
identified by slide agglutination at a constant current of 
20 ma for 30 min against Omni, pool B, pool H, pool E, 
serotype 06 and serotype 23 antisera in indubriose and also 
agar/agar gave strong precipitin lines with serotypes 06 
and 23. The group E strain gave a weak line with
Omni-serum only.
Sensitivity of the system (Section 2.5.3.x) assessed with 
neat, 1 in 3, 1 in 6, 1 in 12 and 1 in 24 dilutions of
serotypes 06 and 23 antigens in both gels under the same
conditions showed equivalent titres for both agars. The 
precipitin lines in indubriose, in contrast to agar/agar 
were initially thicker and closer to the well and became 
more central after dilution.
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The reactions given by pneumococcal cultures in T-H, 
previously tested by immunodiffusion and stored at 4 C, 
when tested by CIE at 20 ma per slide for 30 min in Veronal 
buffer are shown in Table 4.1. The pool sera were negative 
by CIE except for the strains of groups A and D, and one of 
the three group C cultures.
The interwell gap, previously 5 mm, when tested at 2 and 3 
mm with 10 strains of groups A, D and F showed specific 
positive reactions with the A and F sera. Three of the four 
group D strains, negative immediately after electrophoresis 
showed precipitation lines after cooling and staining. The 
3 mm distance was chosen for further study because the 
lines formed were more central between the wells; both gaps 
showed strong precipitation. Agar/agar and indubriose gel 
tested at pH 8.6 and pH 6.6, using the 10 serotypes A, D 
and F antigens, at 30 ma constant current for 30 min, gave 
central clear and stronger lines at pH 6.6 on the 
indubriose slides.
Sensitivity of the acidic gel for pool antisera tested 
against neat and 1 in 12 diluted antigens of groups A, B, 
C, F, G and H showed that Groups A, C, F and G cultures 
were positive at both concentrations. Group B cultures 
showed two strains positive at both levels, 18 at 1 in 12 
and six negative. Group H c showed 16 strains at both 
levels and the remaining 13 at 1 in 12 only.
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TABLE 4.1
Crossed-immuno-electrophoresis of pneumococcal cultures,
previously tested by immunodiffusion
Group CIE Not Not Untyped by ID
/Pool Results Tested typable Typed by CIE
A 9 0 0 0
B 38* 1 0 20
C 2 2 0 0
D 8 1 1 0
E 1 0 0 0
F 7 0 0 0
G 2 0 4 0
H 30* 4 9 7
I 1 0 0 0
Negatives 41** 0 27 27
Totals 139 12 14 27
■k = includes cultures positive by ID that were positive
by CIE and cultures non-reacting by ID that were positive
after CIE.
* * = includes cultures negative both by ID and CIE and 
strains previously positive by ID that were negative by 
CIE.
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4.3.2 Detection of antigen in body fluids
Patient A : the acute CSF sample, which yielded a
serotype 06 pneumococcus, and a second CSF, taken two days 
later, tested against Omni, serotypes 06 and 35 antisera in 
indubriose (pH 8.6) gave a strong line from the first 
sample and a faint line from the second, only with serotype 
06 serum; the other sera were negative on both samples. 
Patient B : sputum, from which a pneumococcus serotype 19 
had been isolated, tested against Omni, serotypes 19 and 06 
showed precipitin lines with Omni and serotype 19 but not 
serotype 06.
Patient C : blood and CSF obtained at post-mortem reacted 
with serotype 03 sera but not Omni or pool B; a serotype 03 
pneumococcus was grown from the middle ear swab from this 
patient.
Patient D : serum from a patient suspected of having
pneumococcal septicaemia was negative by electrophoresis 
and also blood culture.
4.4 CO-AGGLUTINATION
4.4.1 Production of protein-A suspension
Comparisons of bacterial yields on CCY, and tryptone 
soya (TS) and Columbia (CB) agars with and without CCY 
supplements showed that CCY agar, TS with supplement and CB 
with or without additions gave equivalent growth, heavier 
than TS without supplement. Production of protein-A for 
co-agglutination was modified to growth on CB agar followed
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by the scrape/wash method.
4.4.2 Non reaction of pool reagent
Two strains, serotypes 04 and 09, which had shown 
weak agglutination when tested against pool
co-agglutination reagent (PCR) but specific reaction with 
their individual PCR had been cultured in T-H broth. When 
the reactions of these strains were tested after growth in 
TS, RCM, CCY and T-H broths with and without 10% serum 
(Section 2.5.4), the serotype 04 isolate did not 
agglutinate satisfactorily with pool A PCR, in any of the 
media. The serotype 09 isolate gave a positive result 
against pool D PCR, with all the formulae tested, except 
CCY medium (Table 4.2).
Extraction and concentration treatments were negative for 
serotype 04 strain and pool A reagent, and positive for 
serotype 09 strain and pool D reagent.
4.4.3 Modification of sensitisation of protein-A reagent 
Weak or negative pool reactions observed with Omni,
pool D and serotype 03 strains, using co-agglutination 
reagent at a final dilution of 1 in 28 and examined by the 
modifications described in Section 2.5.4 gave the following 
results at sensitising dilutions (SD 1 to 3) and use 
dilutions (UD 1 to 4):-
a) Omni serum when tested as reagent SDl gave positive 
results with serotypes 04, 11, 14, 15 and 21; doubtful
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TABLE 4.2
Co-agglutination reactions, against pool antisera
by two pneumococcal strains 
grown in eight broths.
Serotype Media tested
TS TSS RCM RCMS CCY CCYS THL THLS
04
growth +++ + + +++ + + +++ +++
Pool A W 0 0 0 0 0 0
09
growth +++ +++ +++ + + +++ +++
Pool D P P P W P P P
TS = tryptone soya broth;
CCY = CCY broth;THL = Todd-Hewitt broth plus 1% liver digest; RCM = reinforced clostridial medium;
Suffix "S" = the medium with 10% horse serum added.P = positive; agglutination W = slow/weak; agglutination.
0 = no agglutination.Growth was scored from - = no growth to +++ = heavy growth.
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agglutination with serotype 19 and was negative with 
serotypes 03, 06, 09 and 23. Reagent preparations SD2, SD3 
and UD2/SD1 were negative with all strains tested,
a) Pool A:
SDl UD3 SD2 UD3
Serotype 01 +/- + + +
Serotype 01 +/- + +/- +
Serotype 04 + + + +
Serotype 18 + + + +
b) Pool B: strains of serotypes 03, 06, 08 and 19 tested at 
SD1 and SD2 and UD4 showed SDl to be slightly quicker for 
all strains and stronger for one of the serotype 03 
cultures.
c) Pool C:
SDl UD2 SD2 UD2
Serotype 07 + + + +
Serotype 27 + + + -
Serotype 31 + + + +
Pool D:
SDl UD2 SD3 UD2
Serotype 09 + -/+ + -
Serotype 09 -/+ - - -
Serotype 11 + - + -
Serotype 11 - - -/+ -
Serotype 11 + - + -
Serotype 16 + -/+ -/+ -
Serotype 37 + + + +
-/+
-/+
-/+
+
UD2
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e) Pool E:
SDl SD‘3 UD2 UD3 SD2 UD4
Serotype 10 - - - - + +
Serotype 21 - - -/+ - + +
Serotype 21 + + + -/+ + ++
Serotype 33 - - - - + +/-
Pool F:
SDl UD2 SD3 UD2 SD2 UD2
Serotype 17 + + + + + +/-
Serotype 17 +/- -/+ + + + +/-
Serotype 17 +/- -/+ + + +/- -/+
Serotype 22 + -/+ + + + +/-
Pool G:
SDl UD3 SD2 UD3
Serotype 34 + + + +
Serotype 35 +/- - + -/+
Serotype 35 + + + +
Serotype 35 -/+ - + +/-
Serotype 35 + + + +
h) Pool H: strains tested of serotypes 13, 14, 15, 23 and 
28 gave equivalent reactions at SDl, SD2, SD3. The UD4 
dilutions of SD2 gave much stronger reaction than the other 
UD4 reagents.
i) Pool I:
SDl UD2 SD2 UD2
x" + + +
y" +/- + +
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j) Serotype 03:
SDl SD2 SD3
Strain M + -/+
Strain N + + +
Strain R + + +
Titre
Strain R 1:25 + + +
1:100 + + +
1:150 + +/-
1:200 + +/-
1:250 + -/+
1:625 + -
The results from the above tests were used to modi:
reciprocal dilution of each stage of the preparation
particular pool antisera PCR:-
Sensitising Use
Dilution Dilution
Omni 2 0
Pool A 2 2
Pool B 2 3
Pool C 2 2
Pool D 2 0
Pool E 14 4
Pool F 7 2
Pool G 14 3
Pool H 14 4
Pool I 14 1
Serotype 03 2 0
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4.4.4 Detection of antigen by co-agglutination and
immunoelectrophoresis
Overnight broth cultures of serotypes 01, 04 and 18 
(group A ) , and a serotype 19 strain (group B) were double 
diluted in PBS from 1 in 10 to 1 in 320. Testing of the 
group A strains against pool A antisera and their 
individual antisera by co-agglutination and
immuno-electrophoresis in veronal buffer at pH 6.6 and 8.6, 
30 ma constant voltage for 30 min gave the results in Table 
4.3. The serotype 19 culture was a negative control of the 
pool A antiserum. The PA reagent was approximately one 
dilution less than immuno-electrophoresis at pH 6.6 but 
roughly equivalent at pH 8.6.
4.4.5 Extraction of serotype 03 antigen
The antigen preparations obtained by the extraction 
procedures detailed in Section 2.5.4 were titred against 
serotype 03 PA reagent and the results expressed as per 
plate or per 10 ml broth:-
a) lysed with 1% sodium deoxycholate, boiled and 
precipitated with alcohol - 1300
b) as for a) except acetone was used to precipitate the 
antigen - 1300
c) plates lysed in situ with the deoxycholate treated as a) 
- 500
d) as for c) except that acetone was the precipitant - 500
e) RCM treated as in a) - 1000
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TABLE 4.3
Co-agglutination and immuno-electrophoresis titres of
three pool A antigens and a negative control, serotype 19.
Titres of the antigens tested
Antigen Antisera Electrophoresis * 
pH 6.6 pH 8.6
Co-agglutination
01 160 80 8001 pool A 320 160 160
04 160 160 160
04 pool A 320 80 160
18 160 80 160/32018 pool A 160 80 80
19 pool A 0 0 0
the results seen after cooling and staining
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f)RCM as in b) - 2000
g)RCM boiled, alcohol precipitated without lysis - 2000
h) as in g) except acetone was used - 2000
A serotype 06 culture, used as a negative control of 
serotype 03 reagent, was negative with all preparations.
4.4.6 Survival of antigen
Strains grown on T-H broth and on CBA plates to test
loss of antigenicity were serotypes 01, 03, 06, 17, 19, 20, 
22, 23, 33, 35, and group I. The reaction of each strain
grown in T-H broth and grown on CB agar when tested against
their respective pool and individual PCR gave specific
co-agglutination on the day of incubation. After 7 days 
storage at RT or 4°C the broth and the growth from the CBA 
culture plate, suspended in PBS at 4°C, gave the following 
results:-
Serotypes 06 and 17 positive reaction with type but not
pool reagents however stored.
Serotypes 22 and 23 positive reaction with type but not 
pool reactions stored in broth, but with both reagents if 
stored in PBS.
Serotypes 01, 30, 35 and group I reacted with both pool and 
type reagents however stored.
Serotype 20 reacted with both reagents and antigens if
stored at 4°C but not at RT.
Serotypes 03 and 19 were positive with type reagents
however the antigen was stored but doubtful results with
the pool reagents were seen when stored in broth.
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The loss of pool reaction resulted in subsequent serotyping 
of strains being performed from plate cultures.
4.5 ENZYME STUDIES
4.5.1 Carbohydrate fermentation
i) Pneumococci tested for carbohydrate fermentation 
in enriched serum-free CTA medium, without 1% liver digest 
did not support the growth of the seven pneumococcal 
cultures; the strain of S. faecalis did grow. When 20% egg 
yolk emulsion was added to the CTA formula three of the 
pneumococcal cultures grew but detection of fermentation 
was masked by the yellow colour of the medium. Yeast 
extract and liver digest when included permitted slow 
growth and four of the seven strains showed a weakly acid 
pH change in the depth of the mannitol medium, after 2 days 
incubation.
ii) Defined Gonnococcal broth examined for pneumococcal 
fermentation studies as the base alone, as the base plus 
supplements and as the base plus 0.5% mannitol gave the 
growth and approximate final pH results noted in Table 4.4, 
with the strains used in Section 4.5.1,i). Heavier growth 
was more generally produced by the supplemented base, which 
included glucose, than in the base alone, but was only 
slightly heavier than in the medium with mannitol. Acid 
production in the medium with mannitol and with supplement 
but not in the base alone was seen with strain T122 only; 
T52 and T69 failed to produce acidity.
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TABLE 4.4
Growth and fermentation in Gonnococcal culture broth
and CTA medium
Serotype GC base GC base/ mannitol GC base/ supplements CTA/mannitol
growth PH growth pH growth pH PH
13 ++ K ++ K ++ N A
23 ++ A +++ A +++ A A
06 ++ K +++ A +++ A N
06 ++ A +++ A +++ A A
06 + N + N ++ A N
06 ++ A ++ A +++ A A
03 + K + K ++ N N
S.f +++ A +++ A +++ A A
GC base = defined gonnococcal culture basal medium;S .f = S. faecalis A = acid;
K = alkaline;N = neutral.Growth was scored from + = light turbidity to +++ = heavy 
turbidity.
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iii) Four media modified from Todd-Hewitt broth containing 
either glucose, mannitol, salicin or sucrose tested with 
four pneumococcal cultures and the Staph. aureus (SOX) 
strain gave the results shown in Table 4.5 after 18 h and 
42 h incubation. Growth of the pneumococcus was poor 
except in the glucose medium. The SOX culture produced 
heavy growth in all the media tested.
iv) Growth and acid production in Columbia agar by the 
seven pneumococcal strains and the culture of S .faecalis in 
that medium alone, and with horse serum or finely powdered 
chalk are recorded in Table 4.6. The formula containing 
chalk did not show any advantage over the basic medium in 
growth or acid production and gave reduced colony size. 
Strain T 408 produced clearing around the colonies on chalk 
medium and opacity on serum agar. Serum added to the basic 
formulae yielded the heaviest growth and largest colonies 
but failed to support the growth of strain T 291.
4.5.2 Basal sugar testing medium.
i) Trypticase-yeast-liver-succinate broth (TYLS): 
Growth in TYLS and CB broths with and without haemoglobin 
and cystein showed light growth in TYLS both with and 
without the additives for five of the six strains, T1512 
failed to grow in TYLS with additives. Turbidity in CB 
without the additions was equivalent to that in TYLS, but 
growth was enhanced to moderate turbidity in the medium 
with additives for three of the six strains,
ii) Streptococcal basal medium for carbohydrate tests.
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TABLE 4.5
Modified Todd-Hewitt broth as a base for
carbohydrate fermentation studies
Growth after 1 and 2 days in
Serotype
Basal Man 1tol Glucose Salicin Sucrose
1 2 1 2 1 2 1 2 1 2
22 -/+ - - +++ +++ - -
03 -/+ - - +++ +++ + + -
19 + + + -/+ +++ +++ - -
23 - - - +++ +++ +++ + -
Staph +++ +++ +++ +++ +++ +++ +++ +++ +++ +++
Man'tol = mannitol- = no growth;-/+ = scant growth;+ = poor growth;+++ = moderate to heavy growth. Staph = Staph, aureus
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TABLE 4.6
Columbia agar with and without serum and chalk 
as a base for fermentation studies
Sero
type
Basal Serum Chalk
growth pH growth PH growth pH
22 +/- K - K - K
03 + A ++ A +/- A
19 H—h A ++ A + A
23 ++ A ++ A ++ A
01 + A ++ A + A
16 ++ A *++ A kk++ A
03 ++ A ++ A ++ A
S.f ++ A ++ A ++ A
A = acid;
K = alkaline
k = marked opacity of the medium around the colonies
•k k = clearing of the medium around the colonies
S .f = S. faecalis
Growth was scored from - = no growth to ++ = moderate growth.
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a) Growth of the eight strains in streptococcal broth (SB), 
RCM and T-H was heaviest in RCM, less in T-H and least in 
SB. Strain T2860 failed to grow in SB and T-H but grew in 
the RCM broth.
b) Streptococcal basal Agar (SBA) used to culture the eight 
strains used in a) above gave similar numbers of colonies
on both media under aerobic, aerobic with C 0 2 and anaerobic
with C 0 2 atmospheres. Strains T2645, T2744 and T2860
(serotypes 09, 16 and 19 respectively) failed to grow in
aerobic culture without C 0 2 on either medium i.e. those 
strains were carboxyphilic. The major difference between
the media was that smaller colonies were produced on SBA 
under all three conditions; colonies on SBA after anaerobic 
incubation were approximately the size of colonies on CBA 
incubated aerobically without added C 0 2.
c) The addition of agents to the Streptococcal basal medium 
was carried out in an attempt to improve the growth of the 
four pneumococcal strains. Serotypes 14, 15 (two isolates) 
and 19, gave the results shown in Table 4.7. Glucose 
stimulated growth for all four strains equivalent to the 
turbidity seen in T-H; glucose, detected by the Clinistix 
test, was still present in the broth after 18 h incubation.
Choline and agar marginally improved the growth of two of 
the strains compared to the blank medium. None of the 
other agents noticeably improved growth, bicarbonate and 
arginine inhibited all four strains, haemoglobin inhibited 
three and ornithine two strains. Moderate to heavy growth 
was seen on subculture independently of the turbidity of
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Table 4.7
The effect of additives on the growth of pneumococci 
in Streptococcal basal medium.
Additives
Serotype
15 14 19 15
acetate +/- + +/- +succinate -/+ +/- + +
bicarbonatephosphates -/+ +/- + +
ornithine _ +/- _ +arginine - - - -
choline +G +G +G +Gglucose ++G ++S ++S ++S
haemoglobin — - - —agar + + + +
control +/- +/- + +
T-H broth ++ ++ ++ ++RCM + + + +
Growth was graded as turbidity from:- = no growth, to ++ = moderate turbidy.
G = granular appearance of turbidity;S = smooth even turbidity.T-H = Todd-Hewitt medium.RCM = Reinforced clostridial medium.
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of the initial broth for all media except that containing 
glucose. One of the serotype 15 strains did not grow when 
subcultured from the glucose containing broth and the other 
three cultures only yielded 15-20 colonies.
d) Assimilation studies of the four strains, serotypes 14 
(T2989), 15 (T2860 and W2077) and 19 (T2645) in
Streptococcal basal agar plates containing glutamic acid, 
pyruvic acid, thiamine, L-histidine, tryptophan and aneurin 
showed no visible growth with any of the strains after 24 
h. After 48 h only the serotype 19 culture showed a halo 
of growth around the haemoglobin and aneurin wells.
4.5.3 Fermentation of high concentration substrates in 
microtitre plates.
i) High concentrations of fructose, inulin, maltose, 
raffinose, rhamnose, sucrose, trehalose, xylose and 
aesculin in microtitre plates gave a yellow to red colour 
change (positive) result with fructose, maltose and sucrose 
with seven of the eight strains tested (serotypes 03, 06, 
09, 16, 17, 23 and 33). The other isolate (serotype 19) 
gave negative results with all substrates. All strains 
gave negative results with inulin, raffinose, rhamnose, 
xylose and aesculin and only the serotype 23 strain was 
positive with trehalose.
ii) The effect of suspending medium on microtitre 
fermentation tests gave the results presented in Table 4.8. 
Positive results (acid reaction) were seen with all media 
containing fructose, melibiose and sucrose. Columbia broth
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TABLE 4.8
Fermentation reactions of pneumococci suspended in
Columbia base, Streptococcal basal and Bacteroides basal 
broths using the microtitre plate method.
"Sugars"
tested Columbia
Broths used 
Strep/base 
Serotype
Bacte/base
9 6 17 9 6 17 9 6 17
Fructose + + + + + + + + +
Inulin + - - - - - - - -
Melibiose + + + + + + + + +
Raffinose - + + D + D - + D
Rhamnose - - - - - - - -
Sucrose + + + + + + + + +
Trehalose - + + - + - - + +
Xylose - - - - - - - -
Aesculin - - - - - - - - -
Control - - - - - - - - -
Strep/base = Streptococcal basal medium 
Bacte/base = Bacteroides basal medium+ = red colour change (positive);- = yellow colour (negative);D = orange colour change (doubtful); control = basal medium only.
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gave a posiive reaction with inulin for the serotype 09 
strain which was negative in the other two broths; CB and 
BM were positive for the serotype 17 strain that was 
negative when tested in SB. Raffinose results were 
inconsistent in SB and BM. However the colour changes from 
yellow (negative) to orange (doubtful) to pink/red
(positive) with the other compounds tested appeared clearer 
and brighter on SB than on CB or BM.
iii) The repeat microtitre fermentation results in
Streptococcal basal broth of serotypes 06, 14, 17, 19 and
23 showed that all strains examined fermented fructose,
melibiose, sucrose and lactose, and none fermented inulin, 
rhamnose, xylose or mannitol. Three cultures, serotypes 
06, 17 and 19, gave positive reactions with trehalose; the 
serotype 19 culture was also positive with raffinose.
iv) The extended series to examine the fermentation of 
arabinose, dulcitol, fructose, galactose, inulin, mannose, 
maltose, melibiose, raffinose, salicin, sorbitol and 
trehalose in microtitre plates gave the following results 
with the eight isolates tested, serotypes 03, 04, 09, 14 
(two strains), 19 and 23 (two strains). All strains gave 
positive reactions with fructose, galactose, maltose and
mannose. Negative results were seen for all strains with
arabinose, dulcitol, inulin, raffinose and sorbitol. The
serotype 19 culture was the only strain that did not
ferment melibiose; the serotype 09 isolate was the only
strain that did not ferment trehalose. Positive results 
were only seen with one of the serotype 23 strains and the
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serotype 03 strain and doubtful results were given with one 
of the serotype 14 strains and the serotype 19 isolate in 
the salicin containing wells.
4.5.4 The APIZYM system
The standardisation experiments for the three 
variables, bacterial dose, duration of and suitable gaseous 
conditions for incubation were as follows
i) Growth standardisation
a) bacterial mass measured by centrifugation of a broth
culture in a haematocrit centrifuge at 10,000 rpm for 5 min 
gave a deposit of <1% and was therefore unsuitable for 
routine estimations.
b) Photometric estimation, in the range 380-700 nm, of the 
growth from two strains examined as whole culture in broth, 
as the centrifuged supernate and as the suspension obtained 
from the colonies on a CBA plate gave the results in Table 
4.9. Growth on agar gave a straight line graph of
absorbance against wavelength and in broth gave a sigmoid 
curve with a peak absorbance at 540 nm.
When scanned in the spectrophotometer the lawn of growth 
from a CBA plate, suspended in PBS and lysed by sodium 
deoxycholate gave absorbance peaks at 260 and 350 nm 
against a blank of PBS containing an equivalent amount of 
deoxycholate.
A repeat of equal • areas of growth prepared as lysed and
whole suspensions measured for absorbance at 350 and 660
nm, and viable count at the latter absorbance are given in
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TABLE 4.9
Photometric estimation of growth on Columbia agar and in
Todd-Hewitt broth
Strain Wavelength (nm)
380 420 460 500 540 580 620 660 700
Plate
X 1.24 1.10 1.02 1.08 0.92 0.87 0.77 0.80 0.69
y 1.06 0.94 0.86 0.83 0.75 0.71 0.64 0.60 0.52
Broth (whole)
X 0.35 0.32 0.45 0.47 0.44 0.37 0.43 0.40 0.40
y 0.25 0.30 0.39 0.47 0.44 0.35 0.37 0.37 0.37
Broth (supernate)
X 0.04 0.03 0.03 0.05 0.04 0.05 0.05 0.04 0.04
y 0.04 0.04 0.06 0.07 0.07 0.08 0.07 0.05 0.04
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TABLE 4.10 
Pneumococcal growth measured as
turbidity, viable count and absorbance.
Strain
Wavelength Culture Viable
count660 350 neat 1:25 1:625
Experiment A.
59 0.61 1.80 ++++ +++ 400 c 1.25x10683 0.36 1.40 ++++ +++ 100 c 0.31x10649 0.48 1.20 ++++ +++ 200 c 0.63x10615 0.48 1.52 ++++ +++ 100 c 0.31x106
Experiment B.
55 0.61 1.53 80 c 0.30xl0649 0.50 1.30 80 c 0.30x10 615 0.71 1.60 80 c 0.30x10 6
Experiment C.
49 TH 1.02 1.94 H—(-+ + +++ ++ 7.00x10 7RCM 0.18 1.31 - - - 0
15 TH 0.73 1.59 ++ + ++ 200 c 6.30x10 5RCM 0.20 0.99 20 c 2 c 1 c 1.00x102
TH = Todd-Hewitt medium;RCM = reinforced clostridial medium; c = colonies;Growth was graded from
- = no growth, to ++++ = confluent growth.
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Table 4.10, experiment A. Further repeat measurements
performed at 660 and 260 nm for plate culture, experiment 
B, and in T-H and RCM broths, experiment C, gave the 
results shown in Table 4.10. The RCM broth did not support 
the growth of strain number 55 nor active growth of the
other strains unless 1% liver digest had been added. The 
results of RCM, T-H broth and CBA assayed for viable count 
and absorbance at 660 and 260 nm, after lysis, are given in 
Table 4.11, experiment D. Measurement of turbidity at 660 
nm appeared the more practical method for standardising
inoculum density related to viable count.
The higher viable count after 18 h incubation on CBA,
experiment D, led to the adoption of a plate method in the 
preparation of organisms for APIZYM studies in preference 
to broth culture.
c) The suspension, at 1.0 absorbance unit, of strain 55, 
neat and diluted 1 in 2 and 1 in 4 in three APIZYM strips 
gave the results, recorded in Table 4.12 (experiment A), 
after 4 h incubation at 37 °C. The intensity of the 
colours, produced after the addition of APIZYM reagents A 
and B, were scored from 0 to 5, using the colour chart 
supplied with the strips (Appendix B ) .
The APIZYM strip results of the same strain, at 1.0 
absorbance unit and concentrated to 2.0 and 2.5 units, when 
tested under the same conditions are given in Table 4.12, 
experiment B.
ii) The effects of gaseous environment on the APIZYM 
reactions of four strains (under the standard test
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TABLE 4.11
Pneumococcal growth measured as 
absorbance and viable count, Experiment D.
Wavelength (nm)
Strain 660 260 Viable(xlO Count5)
CBA T-H RCM CBA T-H RCM CBA T-H
49 0.46 0.56 0.35 0.13 0.16 0.07 12.5 6.3
15 0.73 0.64 0.29 0.27 0.18 0.03 19.0 4.7
55 0.66 0.63 0.36 0.19 0.25 0.12 12.5 4.7
CBA = Columbia base agar;
T-H = Todd-Hewitt medium;RCM = reinforced clostridial medium;
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TABLE 4.12
The effect of bacterial dosage on APIZYM results.
Dose Cupule *Number
Experiment A.
2 3 4 6 7 8 10 13 14 16 18
Neat 0 0 4 5 4 0 4 4 5 5 5
1:2 0 0 2 4 2 0 0 2 2 4 4
1:4 0 0 0 3 0 0 0 0 0 3 3
Experiment B.
Neat 0 1 4 5 5 1 5 5 5 5 5
x 2 .0 0 1 4 5 4 0 5 5 5 5 5
x 2 .5 1 1 4 5 5 0 5 5 5 5 5
cupules 5, 9, 11, 12, 15, 17, 19 and 20, the control cupule was negative in each test.
Figures given under the. cupule number are the colour, 
produced by APIZYM reagents A and B, scored by the comparative chart (Appendix B ) from:-0 = no colour change to 5 = maximum colour change.
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conditions, both aerobically, with and without extra C 0 2 
and anaerobically with 10% C 0 2) gave comparable enzyme
results; aerobic incubation in the C 0 2 incubator was
therefore adopted as the standard method.
iii) Incubation of the strips for 4, 5 and 6 h before
colour development with the same four strains showed no 
advantage for continued incubation; the standard length of 
incubation for the strips was taken to be 4 h.
iv) The results of 101 strains tested by the standard 
APIZYM method (Section 2.7.4) are summarised as cultures
showing the same enzyme profile patterns (Tables 4.13 and 
4.14) and analysed by serotype (Tables 4.15) and by source 
of isolate and serotype (Table 4.16).
4.5.5 Nitrophenyl enzyme substrates
Nitrophenyl substrates when attacked by specific 
enzyme released the yellow coloured nitrophenyl group in 
the test methods except when used impregnated into paper 
discs.
The following results were obtained:-
i) Glass capillary tubes containing the organism and test 
substrate gave positive (yellow colour) release with 
alpha-galacto'sidase, alpha-glucosidase and N-acetyl 
glucosaminidase substrates with the four strains tested.
ii) Paper discs impregnated with the same nitrophenyl 
substrates placed directly on to pneumococcal colonies 
grown anaerobically on CBA plate did not produce a colour 
change after 2 h further incubation.
152
TABLE 4.13 
The first 20 APIZYM profile codes
obtained from 101 pneumococcal strains.
Number Cupule number of Profileof Substrates attacked CodeStrains ----------------------------------------
15 3 4 6 7 10 13 14 16 18 01
11 6 7 10 13 14 16 18 02
10 3 4 6 7 10 14 16 18 03
9 6 7 10 14 16 18 04
7 6 7 10 16 18 05
6 3 4 6 16 18 06
5 3 4 6 7 13 14 16 18 07
3 6 7 10 16 08
3 3 4 6 7 10 14 16 09
3 3 4 6 7 14 16 18 10
4 4 6 7 10 13 14 16 18 11
1 6 7 16 18 12
1 6 16 18 13
1 6 7 13 14 16 18 14
3 3 6 7 10 14 16 18 15
2 4 6 10 13 14 16 18 16
1 6 7 10 13 14 16 18 17
2 4 6 7 10 13 14 16 18 18
1 6 10 13 14 16 18 19
1 3 4 6 7 10 13 14 16 17 18 20
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1
1
1
1
1
1
1
1
1
1
1
1
TABLE 4.14
The remaining 12 APIZYM profiles 
obtained from 101 pneumococcal strains.
Cupule number of ProfileSubstrates attacked Code
4 6 7 13 14 16 18 21
3 4 6 7 10 14 16 17 18 22
4 6 7 10 14 16 18 23
3 4 6 10 13 16 18 24
3 4 6 13 14 16 18 25
3 4 6 7 14 16 18 26
3 . 4 6 10 14 16 18 27
6 7 10 16 18 28
3 6 7 10 14 16 17 29
6 7 10 13 14 16 30
6 7 10 14 16 31
3 4 6 13 14 16 32
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TABLE 4.15 
Relationship of Pneumococcal serotype
to APIZYM enzyme profile code
Number NumberSerotype of of Enzyme profile codesstrains codes ---------------------------
tested seen
06 25 14 If 2, 3, 4, 5, 1 
10, 11, 12, 20, 
23, 28, 30, 32.
19 19 9 1, 2, 7, 8, 14, 
16, 18, 19.
18 8 8 3, 7, 8, 11, 13 
18, 22, 25.
23 7 4 - 1, 3, 6, 19.
03 7 5 1, 2, 5, 21, 27
09 6 3 3, 4, 9.
31 6 3 2, 11, 24.
11 5 3 3, 4, 15.
Others 21 13 2, 3, 4, 5, 6,
11, 15, 29, 31
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TABLE 4.16
Relationship of the source of sample to serotype 
and APIZYM profiles.
Sample Organisms
Source Number Serotype Enzyme code
Sputum 14 3, 6, 8, 11, 13, 1, 2, 3, 4, 10
19, 23, 33 15, 26, 27
Ear 9 1, 3, 6, 9, 18, 1, 2, 3, 8, 11
19, 33 15, 25
Eye 8 NC, 6, 11, 15, 1, 3, 4, 7, 9
18 20, 29.
*Nasal 6 6, 11, 18, 31, 37 3, 4, 7, 8, 24
30
Wounds 4 1, 11, 17, 31 3, 10, 11, 18
Nasal swabs, not associated with discharge, provided a further 51 samples; throat swabs were the source of 14 isolates.NC = non-capsulate strain.
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iii) Spectrophotometric assay of the products from the
pneumococcus grown in the beta-galactosaminide substrate
showed a peak absorbance at 410 nm. The sensitivity of the
method assessed by ortho nitrophenyl galactosaminide
+•solution incubated with approximately 10.! cfu of organism, 
had an absorbance of 0.96. Dilutions of the substrate at 1 
in 2, 1 in 4 and 1 in 8 tested against a suspension of the 
same strain at a concentration of approximately 10® cfu 
showed absorbances of 0.72, 0.54 and 0.35 respectively,
iv) Alpha-galactosidase, alpha-glucosidase and N-acetyl 
glucosaminidase solutions tested in 0.2 ml volumes against 
four pneumococcal strains showed yellow colour changes in 
alpha-glucosidase and N-acetyl glucosaminidase and no 
change in alpha-galactosidase within 2 h. When incubation 
was continued for 18 h the negative tubes became positive.
4.5.6 Neuraminidase
Neuraminidase was demonstrated by:-
i) Pan-agglutinability of human blood group 0 red cells 
with AB antiserum was not possible since the red cells 
lysed during exposure to either an overnight T-H broth 
culture or a deoxycholate lysed broth. Sodium 
deoxycholate, which had been used to lyse the pneumococci 
in the culture broths, when diluted from 0.4% to 0.02% in 
saline, lysed untreated red cells within 3 min at each 
concentration. The control was not lysed and did not show 
agglutination. If the deoxycholate was diluted in 5% 
saline, lysis did not occur at levels below 0.02% during
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the 30 min incubation period. Pan-agglutination was not 
demonstrated in this modified method.
ii) Pneumococcal neuraminindase content, measured by the
WHO method (Section 2.7.2), for three T-H broth cultures 
(strains W, T and C) and the turbidity of the broths at 660 
nm were recorded and expressed as a ratio:-
Strain Turbidity (T) Neuraminidase (N) N/T ratio
Code at 660 nm activity
W 0.59 0.78 1.32
T 0.33 0.68 2.06
C 0.40 0.54 1.35
4.5.7 Proteinase activity
Proteinase production by the three strains of 
pneumococci, serotypes 03, 06 and 23, and the clinically 
isolated culture of Serratia marsecens, was indicated if 
zones of clearing on Columbia milk agar (CBM) were 
produced. Prior stimulation in three of the four milk 
containing broths, Tryptose liver digest broth (MTL), TL 
without salt but in PBS (MPTL) and Reinforced Clostridial 
broth (MRCM), showed clotting and partial clearing of the 
milk with all three pneumococci. No changes were seen in 
the fourth medium, Todd-Hewitt broth (MT-H) or in any of 
the broths with the Serratia culture. Pneumococci were 
recovered from each of the subcultures of the control 
broths, without milk, but not from the test broths with 
milk. The Serratia strain gave moderate turbidity in TL, 
no apparent growth in PTL, T-H or RCM but was recovered on
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subculture from all of the broths. A zone 5 mm greater
than the well size was produced on the CBM agar by the
Serratia strain after culture in MTL only. None of the
pneumococcal culture broths produced zones of clearing in
the milk containing agar after prior culture in any of the 
four broths.
ii) The Serratia strain when grown on the milk agar plates 
prepared from the MPTL and MTL formulae produced clearing 
on aerobically cultured plates but not on anaerobic plates.
On both agars after anaerobic but not aerobic culture the 
pneumococci and the Cl. perfringens gave minimal clearing 
of the medium in the initial well but not around individual 
colonies. Colonies on MPTL were relatively smaller than on 
MTL and this was reflected by slightly smaller zones of 
clearing.
Repeat tests on 2% milk TL agar gave a similar effect of 
clearing and sparse growth as seen in i). The pneumococcal 
cultures in TL and MTL broths, added to wells in MTL and 
MPTL agar, gave no change in the medium and a 5 mm zone of 
clearing around the well was seen with the Serratia strain.
4.5.8 Haemolysis
i) Sodium azide induced haemolysis: 
a) Four horse blood containing media, Columbia agar base, 
with and without 0.02% sodium azide and tryptose blood agar 
base, with and without 0.02% sodium azide, seeded with 
pneumococcal strains were incubated anaerobically with C 0 2 
for 18 h. The plate was removed from the anaerobic culture
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jar and stored at 4°C for 3 h and observed for zones of 
haemolysis against an illuminated background. Although 
colony size and viable count was greatest on CBA only 
tryptose blood agar with azide showed haemolysis around 
colonies. The results can be summarised as:-
Columbia Columbia- Tryptose Tryptose
azide azide
Haemolysis +
Growth +++ + ++ +
Both tryptose and azide were therefore essential for 
production and/or release of the haemolysins.
ii) Reductions in the azide content of the medium to 
increase colony size but still promote haemolysis showed 
that culture of the eight test strains on tryptose agar 
with 0.005% azide gave larger heamolytic colonies than at 
0.02 and 0.01% levels. This concentration reduced the 
tendancy of red cells to autolyse in azide medium during 
storage.
iii) Culture on Todd-Hewitt agar prepared both with 0.005% 
azide (T-HA) and without (T-H), azide blood agar (TAz) and 
CBA for the eight strains gave the results in Table 4.17. 
Although the haemolysis produced on T-HA was equivalent to 
that on TAz the double haemolytic zone was only seen on the 
latter medium. Collapsed "draughtsman" colonies were 
commonly seen on all media except TAz.
iv) Haemolysis of sheep and horse red cells by the 12
pneumococcal strains cultured anaerobically with C 0 2 on 
Tryptose base agar plates, with and without 0.005% sodium
TABLE 4.17
Haemolysis on Todd-Hewitt and Tryptose blood agars,
containing sodium azide
Media tested
Sero­type Columba
Todd -H AzideTodd-H TryptoseAzide
Shape MediaEffect Shape MediaEffect Shape MediaEffect Shape Media Effect
16 D a D 2H D 4H F 4H Dz
09 F a F 2H F 4H F 4H Dz
01 C a F 2H F 4H F 4H Dz
NC C ap C 2H C 4H F 4H Dz
I C ap F 2H F 4H F 4H Dz
23 D a F 2H F 4H F 4H Dz
14 C a C 2H F 4H F 4H Dz
19 C a D 2H D 2H F 4H Dz
Todd-H = Todd-Hewitt agar;
C = convex colony; a = alpha haemolysis;D = draughtsmen colony; ap = alpha prime haemolysis;F = flat topped colony;2H = twice the haemolysis zone produced on CBA;4H = four times the zone of haemolysis;Dz = double zone of haemolysis;(absence of Dz in the media effect column indicates that Dz was not produced).
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azide, and 5% of sheep or horse red cells and on CBA with 
5% horse blood showed zones only on the azide containing 
media. The zones on horse blood were slightly smaller and 
not as sharply defined as those on sheep blood which also 
differed in producing a greenish central area around the 
colonies.
Cultures of the six strains on the above five media 
incubated aerobically, aerobically with C 0 2 and 
anaerobically with C 0 2 showed that the T-H agar with azide 
produced haemolysis of both sheep and horse red cells. The 
haemolytic activity in azide medium was not influenced by 
incubation in C 0 2; anaerobiosis tended to reduce the degree 
of haemolysis.
v) Haemolysis of human and horse red cells. The cultures on 
human blood tryptose agar base without azide gave 
moderate-sized colonies without haemolysis; with azide 
smaller colonies having a double zone of haemolysis were 
produced. Horse blood plates without azide showed similar 
colony sizes and a single haemolysis zone and with azide a 
double zone. A faint extra zone of haemolysis was shown by 
all strains on the human blood plates with azide, but these 
plates appeared to contain less haemoglobin than the horse 
blood media.
vi) The Camp reaction. was positive only with the C . 
perfringens control culture after anaerobic incubation, the 
pneumococci were negative after both aerobic and anaerobic 
incubation. The plates spread with azide did not show the
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double zone of haemolysis produced on horse blood 
containing agar.
4.6 DYE INHIBITION STUDIES
4.6.1 Inhibition of cultures in Todd-Hewitt broth.
The results of the first tests for dye inhibition of 
the serotype 33 strain in broth culture (Section 2.8.1) 
showed complete inhibition of growth in the bromothymol 
blue solution (BTB) 1% but not at 0.1 or 0.01%. Inhibition 
was produced by methylene blue (MB) and toluidine blue but 
only in the aerobic zone, a 10 mm blue region at the top of 
the broth tube. Bromocresol purple did not affect growth 
at the three concentrations tested.
4.6.2 Inhibition studies by the agar slope method.
i) Initial testing of sixteen dyes: the results
obtained from the four strains, serotypes 09 (T891), 16
(T895) and 34 (T904 and -T918) in the dye inhibition tests 
by the agar gradient method (Section 2.8.2, i) are given in 
Table 4.18.
Bromothymol blue (BTB), methylene blue (MB), toluidine blue 
(TB), neutral red (NR), janus green (JG), nile blue (NB), 
malachite green (MG), coomassie blue (CB) and crystal 
violet had shown some degree of inhibition and were 
selected for further study.
ii) Inhibition tests of nine from the initial sixteen and a 
further nine dyes.: the six test strains, tested against
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TABLE 4.18
Growth inhibition studies of 16 dyes
by the agar slope method.
Results obtained with serotypes
Dyes 34 34 09 16 SOX
BB + + + + +BP + + + + +CR + + + + +CO + + + + +NR + + + + +MR + + + + +SF + + + + +CB + + + + +PR + + +. + +
PP + + + + +NB + 15 15 15 +JG + + 10 10 +CV 15 15 15 15 IMB 40 40 70 40 ITB 5 I 5 I IMG I I I I I
+ = growth along the length of the streakI = no growth SOX = Staph, aureus (Oxford strain).
The figures represent the length of growth of the teststrains along the streak, in mm.
The dyes were included at the following concentrations: BB,CR, MR, PR at 0.002%; RR, NR, JG, NB, CV, MB, TB and PP at0.001%; SF and CB at 0.005% and 0.0002% for MG.
BB = bromothymol blue; PR = phenol red;
BP = bromocresol purple; PP = phenolphthalein;RR = cresol red; NB = nile blue;CR = congo red; JG = janus green;NR = neutral red; CV = crystal violet;MR = methyl red; MB = methylene blue;SF = saffronin; TB = toluidine blue;CB = coomassie blue; MG = malachite green;
164
the eighteen dye concentrations given in Section 2.8.2, ii, 
gave the inhibition patterns shown in Table 4.19. 
Potentially useful differential effects were seen with BTB, 
TB, JG and EY.
iii) Inhibition studies of ten dyes, selected from the 
twenty-five previously tested, on the six test strains, at 
the dye concentrations given in Section 2.8.2, iii, are 
recorded in Table 4.20. These findings suggested possible 
dye concentrations for agar plates containing a single dye 
level.
iv) Agar slope inhibition studies of nine dyes against four 
strains under aerobic and anaerobic conditions on the four 
pneumococcal cultures, at the concentrations given in 
Section 2.8.3 are recorded in Table 4.21. In general the 
organisms were more dye sensitive anaerobically than 
aerobically, e.g. the inhibition of strains T918 and T895 
by BB, JG, NB and MG. It was not possible to compare the 
effect of dyes on T891, under the two conditions, as this 
culture failed to grow aerobically.
4.6.3 Paper strip method.
Of the 21 dyes tested by the impregnated paper strip 
method (Section 2.8.4) luxol fast blue, nigrosin, naphthol 
yellow, orange G, rhodamine B, saffron, Best's carmine, 
celestin blue, and brilliant blue showed no inhibitory 
effect. Acridine orange gave slight inhibition of strains 
if the bacterial dose was light; alcian blue inhibited one 
strain and eosin yellowish inhibited all but one of the six
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TABLE 4.19
Repeat agar slope inhibition tests of eighteen dyes.
Dye Test strain
T891 T895 T904 W894 T918 T966
AO n d d n d dAB + + + + + +
EY + I I + I nBB I + I I I n
MB + + + + + +TB I + I I I +
NR + + + + + nJG + + I I I n
NB + + + + + +MG + + + + + +
COB + + + + + +
CV I I I I I I
OG + + + + + +LB + + + + + +
BC + + + + + +CEB + + + + + +
BRB + + + + + +RB + + + + + +
I = growth inhibited;d = doubtful result - reduced colony size produced;+ = no inhibition of growth;n = no growth on the culture control plate.AO = acridine orange; AB = alcian blue;
BC = Best1s carmine; BRB = brilliant blueCEB = cestin blue; EY = eosin yellowish;LB = luxol blue; OG = orange G;RB = rhodamine blue.The dyes were included at the following concentratios:-
0.0010% - MB, TB, NR, NB, COB, CV,LB, BC, CEB , BB AND RB.0.0020% - AO, AB, MG, AND JG.
0.0005% - BTB AND EY.
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TABLE 4.20
Further inhibition studies of ten dyes
by the agar slope method.
Dye Test strains
T891 T895 T904 W894 T918 T966
NB I 12 10 15 6 10
CV I 35 40 35 40 35
TB I I I I I I
BTB I 2 10 10 10 I
JG I 10 15 15 15 2
MG I 5 30 30 35 30
MB I I I I I I
EY 30 + d ' d d +
AB + + + + + +
AO I 30 30 25 30 30
I = inhibition of all growth along the streak;+ = no inhibition of growth;d = doubtful result - reduced colony size produced;’
Figures used are the length of growth along the streak, in 
mm.
The dye agar base contained dyes at the following concentratios:-0.0010% - BTB, TB, NB, JG and EY.0.0020% - AB.0.000 5% - MB and AO.
0.000002% - MG.
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TABLE 4.21
Inhibition studies of nine dyes 
on strains grown on Columbia agar 
under aerobic and anaerobic cultural conditions
Dye Atmos Strains tested
T904 T918 T891 T895
BTB A I I I I
0 I + + +
MB A I I I I
0 I I n I
TB A I I I
0 I I n I
NR A + + d +0 + + n +
JG A I I I I0 I n +
NB A I I I0 I I n +
MG A I I + I0 + + n I
CB A + d + d0 + + n +
CV A I I I I0 I I n I
A = anaerobic incubation with added C 0 2;0 = aerobic incubation without C 0 2;1 = inhibition zone >5 mm;d = doubtful result- inhibition zone <5 mm;+ = no inhibition of growth;n = no growth on the control plate;Atmos = cultural atmosphere.The dyes were included at the following concentrations: BB,at 0.02%; NR, JG, NB, CV, MB, TB and at 0.01%; CB at 0.05%
and 0.002% for MG.
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cultures used. Only bromothymol blue, malachite green and 
janus green, from the nine dyes of the initial sixteen 
tested, gave satisfactory results.
4.6.4 Inhibition studies by the dye containing agar plate 
method
The dye concentrations and the pneumococcal strains 
used in these experiments are given in Tables 2.6-10. The 
investigation of dye inhibition was a series of progressive 
biological titrations of initially ten and subsequently 
eight dyes. The results of each experiment were used to
determine the conditions for the next, which in turn 
modified the next stage. The modifications were chosen 
specifically for each dye at every stage and are therefore 
given collectively in Tables 2.6-7 for Stages 1-8, and in 
Tables 2.8-9 for Stages 9-19. The many stages of the 
modifications to dye concentrations produced, however, a 
large number of results; these are given in Tables 4.22-43 
and summarised below.
Stage 1 : The results of the eight cultures tested against 
the ten dyes prepared at two concentrations are given in 
Table 4.22. Comparable results at both dye levels were
seen with NB, BTB, JG and TB. The higher dye levels of CV, 
MG, AO, MB and EY inhibited all cultures and the results
given in the table are those seen with the lower
concentrations. The majority of dyes inhibited or greatly 
reduced pneumococcal growth at the concentration used.
Stage 2 : The results for the eight strains used in Stage
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TABLE 4.22
Inhibition studies by the
agar plate containing method. Stage 1.
Dye Test strains
T891 T895 T904 W894 T918 T966 T1214 T1217
NB I I I I I I I I
BTB I I I I I I I I
JG I I I I I I I I
CV* d I d I d d I I
MG* I I I I d I I I
AO* d d d I d d I I
TB I I I I I I I I
MB* I I I I I + I I
EY* + d d d d d d +
AC* + + + + + + + +
I = inhibition of growth; d = reduced colony size;+ = no inhibition of growth;* = the results given are for the more dilute platefor these dyes; the higher concentration gave total inhibition. Those dyes without the * gave the same results at both dilutions.Dye, concentration (%) and volume (ml) added
Bromothymol blue 0.02 
(1.0, 0.5) Janus green 0.01 (1.0, 0.5)
Nile blue 0.10 
(1.0, 0.5) Methylene blue 0.10 (0.5, 0.2)
Acridine orange 0.10 
(1.5, 1.0) Malachite green 0.002 (1.5, 1.0)
Crystal violet 0.01 
(1.0, 0.5) Toluidine blue 0.10 (0.5, 0.2)
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1, when tested on the modified dye concentration plates, 
containing 1.0 and 0.5 ml of each dye, gave the results 
shown in Table 4.23. If comparable results were obtained 
at both the levels tested only one result is listed. The 
levels were not optimal but promising inter strain 
differences were indicated.
Stage 3 : The results of testing the eight test at the new 
dye levels are given in Table 4.24. Dye concentrations 
were chosen from these results for the testing of 40 
pneumococcal strains for inhibition patterns (Stage 4). 
Stage 4 : The results of the 40 strains tested against the 
eight dyes are given in Tables 4.25-26. Patterns of 
inhibition were seen with a number of strains and the two 
pairs of isolates of the same, serotypes from the same 
patients gave reproducible results. The reactions of MG 
and JG were not sufficiently discriminatory and variations 
to these and the other dyes were sought to further refine 
the method.
Stage 5 : The results of the revised dye concentration
plates against the ten test strains are given in Table
4.27. The concentrations were in general too inhibitory. 
Stage 6 : The results of testing levels modified after the 
results of stage 5 are recorded in Table 4.28. These 
values were generally not sufficiently inhibitory and again 
modifications were sought.
Stage 7 : The results of the inhibition tests made in
parallel for the five cultures and the single tests for the
six other strains are given in Table 4.29. Comparable
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TABLE 4.23
Inhibition studies by the
agar plate containing method. Stage 2.
Dyeagarplates
Test strain
T891 T895 T904 W984 T918 T966 T1214 T1217
BTB i I I I I I I I Iii ii + + + + + + + I
JG i + + I I I + I IM ii + + + + + + + +
NB + + + + + + + +
CV + + + + + + + +
MG + + + + + + + +TB + + I I + + I I
AO i + + + I + + I I
i i ii + + + I + + + +
EY i d d d d d d d d
i i ii + d d d d d d d
MB i + d d I + + I Iii ii + + d I + d d I
I = inhibition of growth; d = reduction in colony size;+ = no reduction in growth.Dye, concentration (%) and volume (ml) addedBromothymol Nile Acridine Crystalblue blue orange violet
0.02 0.20 0.033 0.033Janus Methylene Malachite Toluidinegreen blue green blue0.20 0.01 0,002 0.01i = 1.0 and ii = 0.5 ml of dye/15ml agar plate) Where i and ii are not specified in the table the same results were obtained at both concentrations.
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TABLE 4.24
Inhibition studies by the
agar plate containing method. Stage 3.
Dye Test strain
T891 T895 T904 W984 T918 T966 T1214 T1217
NB i + + + I + + I I
t i ii + + + + + + + +
C V i + . + + d + + I I
i i ii + + + + + + d d
MG i + I + I + I I I
i i ii + I + d + d d d
BTB i I I + I + + I I
i i ii I + + I + + d I
MB i d d I I d d I I
i i ii + d d I d I I I
TB i d d I I I I I I
i i ii + + d I + + I I
JG + + + + + + d d
AO + + + d + + I I
I = inhibition of growth; d = reduced colony size;+ = no inhibition of growth;
Dye, concentration (%) and volume (ml) addedBromothymol Nile Acridine Crystalblue blue orange violet0.02 0.10 0.033 0.01(0.8, 0.6) (0.3, 0.1) (0.8, 0.6) (0.8, 0.5)Janus Methylene Malachite Toluidinegreen blue green blue0.02 0.01 0.002 0.01
(0.8, 0.6) (1.5, 1.2) (0.7, 0.5) (0.8, 0.6)(i = first volume, ii = second volume ml of dye/15ml agar plate)
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TABLE 4.25
Inhibition studies of 20 of the
40 pneumococcal strains by the agar plate method. Stage 4.
TestStrainSerotype
Dye agar
BTB AO TB MG JG CV NB MB
01 I I I I I d I +
03 I I I I I + I +03* I I I I I I I I03* I I I I I I I I
06 I I I + I + I I06* d I I + I d I I06* d I I + I d I I06 I I d + I I I I06 I I I + I + I I06 d I I + I + I I
07 + I I + I + I d
09 + + + + I + d +09 I + I + I + d +09 + I + + I + d d
09 d + d + I + I d09 d + d + I + I d
14 + I I + I + I +14 + I I + I + I I
15 d I I + I d I I
15 d I I + I + I d
I = inhibition of growth; * = paired isolates,d = reduction in colony size; NC = non-capsulate strain;+ = no reduction in growth; PI = serogroup I strain.Dye, concentration (%) and volume (ml) addedBromothymol Nile Acridine Crystalblue blue orange violet0.01 0.025 0.04 0.002Janus Methylene Malachite Toluidinegreen blue green blue
0.02 0.01 0.002 0.01(0.80) (0.70) (1.0) (0.80)
(1. 0 ml was taken from each dye)
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TABLE 4.26
Inhibition studies of the remaining 20 of the
40 pneumococcal strains by the agar plate method. Stage 4.
TestStrain Dye agar
Serotype BTB AO TB MG JG CV NB MB
16 + I I + + I +16 I ' + d I + I +
16 + + + + + d I
19 + I I + + I I19 I I I + + I I19 + I I + + I I19 + I I + + I I
22 d I d + I I I
23 + + I + + I +23 + + + + + I I23 I + I + + I I
31 d I I + I I31 d I I + d I I
33 I + + I + d +33 d I d + d I I
34 I + I + + I +
34 d + d + + I d34 I + I + + I I
NC I d I d d I IPI + I I + + I +
I = inhibition of growth; 
d = reduction in colony size; NC = ‘non-capsulate strain; + = no reduction in growth; PI = serogroup I strain.Dye, concentration (%) and volume (ml) addedBromothymol Nile Acridine Crystalblue blue orange violet
0.01 0.025 0.04 0.002Janus Methylene Malachite Toluidinegreen blue green blue0.02 0.01 0.002 0.01(0.80) (0.70) (1.0) (0.80)(1.0 ml was taken from each dye)
175
TABLE 4.27
Inhibition studies by the agar plate method. Stage 5.
Test Dye
otype BTB AO TB MG JG CV NB MB
03 I I I I d + I I
19 I d I I d + I I
03* I I I I I I I I
03* I I I I I I I I
16 d d I I d + I I
14 d I I I I d I I
PI I I I I I d I I
23 d d I I d + I I
14 I I I I I I I I
19 I I I I I + I I
* = isolated from two sites on the same patient. I = inhibition of growth; d = reduced colony size;+ = no inhibition of growth;
Dye, concentration (%) and volume (ml) addedBromothymol Nile Acridine Crystalblue blue orange violet0.01 0.10 0.04 0.002(0.80) (0.30) (1.04) (0.80)Janus Methylene Malachite Toluidinegreen blue green blue0.01 0.10 0.002 0.10(1.0) (0.90) (0.70) (1.0)
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TABLE 4.28
Inhibition studies by the agar plate method. Stage 6.
Teststrain
serotype
Dye
BTB AO TB MG JG CV NB MB
19 + + I I + + + +
16 + + + I + + + +
14 + + + I + + + +
PI + + + I + + + +
23 + + + I + + + +
14 + I I I I I I I
19 + I I I + d + +
The three strains of serotype 03 failed to grow on the 
control plate.
I = inhibition of growth; 
d = reduced colony size;+ = no inhibition of growth;
Dye, concentration (%) and volume (ml) addedBromothymolblue0.01(0.90)Janus
green0.02(0.40)
Nileblue
0.09(0.40)Methylene
blue0.01(0.40)
Acridineorange0.04(0.40)Malachite
green0.00002(0.80)
Crystalviolet0.002 (1.2)Toluidine
blue0.01(0.40)
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TABLE 4.29
Inhibition studies by the agar plate method. Stage 7.
Teststrain
serotype
Dye
BTB AO TB MG JG CV NB MB
PI I + + I + d + +PI* I d + I + d + +
23 + + d I + d + d23* I + + I + d + +
14 + + d I + d + d14* I + + I + d + +
19 I + I I + d + I19* I d I I d d + I
16 + + + I + + + +16* + + + I + + + +
09 + + d I + + + d01 + + + I + + + +NC I + d I + I + d14 + I + I d d + +
03 + d + I + d + +06 I I I I + d + I
I = inhibition of growth; d = reduction in colony size;+ = no reduction in growth;* = repeat cultures of the above strain.
Dye, concentration (%) and volume (ml) addedBromothymol Nile Acridine Crystalblue blue orange violet0.0033 0.0035 0.008 0.001Janus Methylene Malachite Toluidinegreen blue green blue0.0028 0.0014 0.000005 0.002(3 .0 ml was taken from each dye)
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patterns were seen with the tests for the five pairs. 
Inter-strain differences were more apparent with plates 
prepared by adding 3 ml volumes of dye instead of fractions 
of 1 ml; further modifications were considered necessary. 
Stage 8 : The results of the dye inhibition studies of
slightly different amounts of dye than those tested in 
stage 7 are given in Table 4.30. The results were not 
suitable for routine testing of strains.
Stage 9 : The effect of the two levels bacterial dosage 
(approximately 10s and 103cfu/ml) on pneumococcal 
susceptibility to dyes are given in Table 4.31. The lower 
bacterial dosage increased the senstivity of strain 6 
(serotype 03) on BTB, strains 7 (type 14) and 8 (type 19) 
on JG and on TB, and strains 3 (type 23) and 5 (type 04) on 
AO and strain 7 on MB. The inhibition results shown by the 
majority of dyes were unaffected by the concentration of 
pneumococci present. The dosage used was standardised 
after the results of Stage 10.
Stage 10 : The eight strains, grown into the log phase and 
diluted for use, gave viable counts of approximately 
105cfu/ml and the patterns of inhibition in Table 4.32. 
Stage 11 : The tolerance of the eight strains to the
adjusted dye levels following standardisation of the 
bacterial dose are given in Table 4.33.
Stage 12 : The results of growth on the further adjusted
dye agar plates are given in Table 4.34.
Stage 13 : The results of the parallel testing of the eight 
strains on agar plates containing narrow ranges of the dye
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TABLE 4.30
Inhibition studies by the agar plate method. Stage 8.
Teststrain
serotype
Dye
BTB AO TB MG JG CV NB MB
14 d d I I d d d I
PI d + I d + d + I
23 d + I d + d + I
14 d + I I + d I I
19 d + I d + d + I
03 d + d I + I + +
16 d + d I + d + +
NC d d I I d I + I
I = inhibition of growth; 
d = reduction in colony size;+ = no reduction in growth;
Dye, concentration (%) and volume (ml) added
Bromothymol Nile Acridine Crystalblue blue orange violet0.0033 0.0035 0.008 0.001(3.40) (3.60) (3.40) (3.4)Janus Methylene Malachite Toluidinegreen blue green blue
0.0028 0.0014 0.000005 0.002(3.40) (3.40) (2.60) (3.40)
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TABLE 4.31
Inhibition studies at two bacterial concentrations 
by the agar plate containing method. Stage 9.
SeroType
Dye
TB BB AO MB
L H L H L H L H
14 d d I I I I d d09 d d I I I I d d23 I I + + d I I I23 d d I I d d I I04 d d + + d I I I03 I I I + + + I I14 I d + + + + I d19 I d + + + + I I
JG NB CV MG
L H L H L H L H
14 + + + + ■ + + + +
09 + + + + + + + +23 d + + + + + + +23 + + + + + + + +04 + + + + + + + +
03 d + + + + + + +14 I + + + + + + +19 I + + + + + + +
I = inhibition of growth; d = reduction in colony size;+ = unrestricted growth;L = low pneumococcal dose (103 cfu/ml);H = high pneumococcal dose (10s cfu/ml).
Dye, concentration (%) and volume (ml) addedBromothymol Nile Acridine Crystalblue blue orange violet0.003 0.003 0.013 0.001Janus Methylene Malachite Toluidinegreen blue green blue
0.0027 0.0013 0.000005 0.0013(3.0 ml of each dye was added to 12 ml of agar)
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TABLE 4.32
.ng
Stage 10.
Serotype
Dye
TB BB AO MB JG NB CV MG
14 I + I I d + + I
09 I + I d d + + +
23 I + I I I + + +
23 I + d + + + + +
04 I + I d + + + +
03 I + I d I I + +
14 I + I I d + + +
19 I + + I + + + +
I = inhibition of growth; 
d = reduction in colony size;+ = unrestricted growth;
Dye, concentration (%) and volume (ml) added
Bromothymol Nile Acridine Crystalblue blue orange violet0.00375 0.001 0.00325 0.0008
Janusgreen0.0038
Methyleneblue0.00043
Malachitegreen0.000005
Toluidine
blue0.00325
(3.0 ml of each dye was added to 12 ml of agar
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TABLE 4.33
Inhibition studies by the agar plate containing method.
Stage 11.
Serotype
Dye
TB BB AO MB JG NB CV MG
14 I + + + I + I +
09 I + + + d + I +
23 I + + + I + I +
23 d + + + + + I +
04 I + + + I + I +
03 I I + + I I I +
14 I + + + I I I +
19 I + + + I d I I
I = inhibition of growth; d = reduction in colony size;+ = unrestricted growth;
Dye, concentration (%) and volume (ml) added
Bromothymol Nile Acridine Crystalblue blue orange violet0.005 0.0015 0.0044 0.00026
Janus Methylene Malachite Toluidinegreen blue green blue0.00348 0.00052 0.000010 0.00026(3.0 ml of each dye was added to 12 ml of agar)
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TABLE 4.34
Inhibition studies by the agar plate containing method.
Stage 12.
Sero
type
Dye
TB BB AO MB JG NB CV MG
14 d I + + + I + +
09 + + I + + + + +
23 d + + + + I + +
23 + I + + + + + +
04 + + + + + + + +
03 I I + I + I + +
14 d + + d + I + +
19 d I + d + I + +
I = inhibition of growth; 
d = reduction in colony size;+ = unrestricted growth;
Dye, concentration (%) and volume (ml) addedBromothymol Nile Acridine Crystalblue blue orange violet0.005 0.0015 0.0046 0.00040Janus Methylene Malachite Toluidinegreen blue green blue
0.0036 0.00059 0.000025 0.00028(3.0 ml of each dye was added to 12 ml of agar)
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solutions are given in Table 4.35. The BB results were 
comparable with those seen in Table 4.34 but the repeat NB 
concentration inhibited all of the test strains. Suitable 
inhibitory levels of MG and MB appeared to be between the 
concentrations tested. The CV, TB, AO and JG patterns were 
either not reproducible from the previous stage or the 
inhibition seen was not suitable for differentiation.
Stage 14 : Further testing of dye inhibition at narrow 
concentration ranges gave the results in Table 4.36. More 
suitable patterns appeared to be produced at these levels 
for NB, GV, AO and JG. Less satisfactory results were 
shown by MB, BB and TB in which non-reproducible or 
difficult discriminatory inhibition was seen.
Stage 15 : Adjusted dye concentrations following stage 14
gave the discriminant patterns of inhibitions, given in 
Table 4.37, except for the CV concentration which was not 
sufficiently inhibitory.
Stage 16 : Modified dye studies and testing of potassium 
tellurite inhibition gave the results in Table 4.38. 
Discriminant results were suggested by most of the dyes 
tested except for CV, which was at a too inhibitory level. 
Stage 17 : Testing of inhibition on the same batch of agar 
plates on three consecutive days and plates prepared from 
dye solutions autoclaved in the agar, gave the results in 
Tables 4.39 and 4.40. Variation in inhibition patterns 
were seen over the three days with all dyes and with a 
range of strains, and little evidence of deterioration of 
dye activity. Autoclaving the dye in the agar reduced the
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TABLE 4.35
Inhibition studies by the agar plate containing method.
Stage 13 •
Dye anddilutiontested
Strain used
1 2 3 4 5 6 7 8
MB a I + + + + I I Ib + + + + + + + d
AO a I I I I I I d db I I I I I I d d
CV a I I I I I I I Ib I I I I I I I I
c I d + I I I I I
TB a I d d d I I I Ib I d I d d I I Ic I d d d d I I I
MG a + + + + + + + +b I + + I I I I I
JG a I d I d I I I Ib I d I d I I I I
c I d I d I I I I
BB I + + I + I + I
NB I I I I I I I I
I = inhibition of growth; d = reduction in colony size;+ = unrestricted growth; 
a, b, c = progressively more dilute solutions as below
Dye, concentration (%) and volume (ml) added
Bromothymolblue0.005
Janus green 
0.0038, 0.0036 0.00348
Nile blue 0.0015
Methyleneblue
0.00059
Acridine orange 
0.0043, 0.0046 Malachite green 
0.000025 
0.000050
Crystalviolet
0.00040.0006Toluidineblue0.000325, 0.00028 
0.00026
(3.0 ml of each dye was added to 12 ml of agar)
186
TABLE 4.36
Inhibition studies by the agar plate containing method.
Stage 14 •
Dye anddilution
tested
Strain used
1 2 3 4 5 6 7 8
AO a I I I d I I I +b d d + + + + + +
CV a I I I I I I I Ib + + + I + d + I
TB a d d I + d I d Ib d d I + + I d I
NB a I I I I I I I Ib + + + + + I I +
MG a + + + I d I + +b I I + I I I I I
JG a I d I + d I d Ib I + I + + I d I
BB I I I I I I I IMB + + + + + d I d
I = inhibition of growth; d = reduction in colony size;+ = unrestricted growth; 
a, b = progressively more dilute solutions as below
Dye, concentration (%) and volume (ml) added
Bromothymolblue0.005
Nileblue0.00150.0010
Acridineorange0.00430.00325
Crystalviolet0.000440.00026
Janus
green0.00348
0.0027
Methylene
blue0.00059
Malachitegreen0.0000350.000050
Toluidineblue0.0002360.000216
(3.0 ml of each dye was added to 12 ml of agar)
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TABLE 4.37
Inhibition studies by the agar plate containing method
Stage 15 •
Sero
type
Dye
TB BB AO MB JG NB CV MG
14 + + + d d + + +
09 + + I I d I + + .
23 + + + d d + + +
23 + I + + + + + +
04 + + + + d + + +
03 I I + I I I + I
14 I + I I I I + I
19 + I + I I I + +
I = inhibition of growth; 
d = reduction in colony size; + = unrestricted growth;
Dye, concentration (%) and volume (ml) added
Bromothymol Nile Acridine Crystalblue blue orange violet
0.0043 0.00107 0.00406 0.000296
Janus Methylene Malachite Toluidinegreen blue green blue
0.00225 0.00060 0.000040 0.000163
(3.0 ml of each dye was added to 12 ml of agar)
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TABLE 4.38
agar plate containing method • Stage 16.
Serotype
Dye
TB BB AO MB JG NB CV MG PT
14 + I I I I I I I I
09 + + I I d I I + +
23 + + + I . I + I + +
23 + I + + + + I + +
04 + + d I d I I + +
03 I I d I I I I I I
14 d + d I I I I + +
19 + I + I I I I + +
I = inhibition of growth; d = reduction in colony size;+ = unrestricted growth;
Dye, concentration (%) and volume (ml) added
Bromothymol Nile Acridine Crystalblue blue orange violet0.0043 0.00107 0.00406 0.000296
Janus Methylene Malachite Toluidinegreen blue green blue0.00225 0.00060 0.000040 0.000163
(3.0 ml of each dye was added to 12 ml of agar)
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TABLE 4.39
agars prepared by autoclaving with the dye. Stage 17 A.
Dye and Strain used
Day
tested 14 09 23 23 04 03 14 19
TB 1 I I I + + I I I2 I + I + + I d I
A I d d + + I I I3 + d d + + I I I
BB 1 I + I I + I + I2 I + + I + I + I
A I + + I + I + I3 I + + I + I + I
AO 1 + + + + + I + +2 I I + + + d I +
A I + + + + I d +3 + d + + d d I +
MB 1 I I I I + I I I2 I I I I I I I I
A I I I + I I I I3 d d d d d I I I
AI
d+
Dye, concentration Bromothymol blue 0.0043
= dye solution autoclaved, Day 2.
= inhibition of growth;= reduction in colony size;
= unrestricted growth;(%) and volume (ml) added Nile Acridine Crystalblue orange violet0.00107 0.00406 0.000245
Janusgreen
0.00225
Methyleneblue
0.00060
Malachitegreen
0.000040
Toluidine
blue0.000163
(3.0 ml of each dye was added to 12 ml of agar)
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TABLE 4.40
Inhibition studies of a batch of dye containing agars and
agars prepared by autoclaving■ with the dye. Stage 17 B.
Dye and Strain used
Day
tested 14 09 23 23 04 03 14 19
JG 1 d d d + + I d +2 I d + + d I I I
A + d + + I I + +3 d d d + d d I I
NB 1 + I + + + I I I2 I I + + d I I I
A + + + + + I I +3 + I + + d I I I
CV 1 I + + I + I I I2 I + + I + I I I
A I + + + + I + I3 d d d d + + I I
MG 1 + + + + + I + +2 + + + + + + + +
A + + + + + d + +3 + + + + + + + +
A = dye solution autoclaved, Day 2.I = inhibition of growth; d = reduction in colony size;
+ = unrestricted growth;
Dye, concentration (%) and volume (ml) addedBromothymol Nile Acridine Crystalblue blue orange violet
0.0043 0.00107 0.00406 0.000245
Janusgreen0.00290
Methyleneblue0.00060
Malachitegreen0.000040
Toluidine
blue0.000163
(3.0 ml of each dye was added to 12 ml of agar
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inhibitory effects of JG, NB and CV for a significant
number of strains, AO and MB each with a single culture,
whilst the TB and BB results were unaffected.
Stage 18 : The results of testing 18 recent isolates and
the standard eight strains against the dye levels modified
from the previous stage's results and the tellurite levels
used in stage 16 are given in Table 4.41. Inter— strain
differences in dye susceptibility were seen for all
serotypes to some degree. All the serotype 19 strains
except one gave the same inhibition pattern.
Stage 19 : The results of testing 36 strains for dye
susceptibility, C 0 2 requirement and colonial appearance on 
Mitis-salivarius agar (M-S) are given in Tables 4.42-43.
Differences were seen amongst serotypes 03 and 06 both with
dye inhibition and colonial appearance on M-S agar. Only
three of the 36 strains were C 0 2 dependant. The two
serotype 09 cultures differed in that the C 0 2 dependant
strain was not inhibited by, and the non-dependant strain
was inhibited by CV. All of the five cultures of serotype
19 gave similar dye inhibition patterns including the two
C 0 2 requiring isolates; differences within this serotype
were only seen on M-S agar. Little difference was seen in
the serotype 14 cultures except that two strains were not
inhibited on TB agar, one of these failed to grow on M-S
agar. The serotype 23 strains gave similar patterns on dye
and M-S agars except that two of the eight strains tested
were tolerant of BB. •
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TABLE 4.41
Inhibition studies of dyes and potassium tellurite
on 26 pneumococcal strains
by the agar plate containing method. Stage 18.
Serotype Dye
TB BB AO MB JG NB CV MG PT
23 a + + d d + + + + +II b I I I I I I I + +II c + I I + + + I + +II d + I d + + + I + +
14 a d I I I I d + + +ii b I I d I I I I + +ii c + I d d + + + + +it d I I I I I I I + +
19 a I I I I I I d I Iii b I I d I I I d + +ii c I I I I I I I + +ii d d I d I I d I + +ii e I I d I I I I + +ii f I I d I d I I + +ii g I I d I d I I + +it h I I d I d I I + +ii i I I d I d I I + +
03 a I I + I I I I + +ii b I I d I d d + + +ii c I I d I d d + + +
09 a I + I I d I I + +ii b I I I I d I I + +
11 I I d I I d d d +
06 a I I I I I I I + +ii b I I I I I I d + +ii c I I d I I I I d +
i i d + I + d d + d + +
I = inhibition of growth; d = reduction in colony size;+ = unrestricted growth;Lower case letters denote examples of that serotype. The dye levels were the same as in Table 4.40.
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TABLE 4.42
Inhibition studies, C 0 2 requirement 
and colonial appearance on Mitis-salvarius agar 
of 36 pneumococcal strains. Stage 19.
Serotype
M-S
agar
Dye
BT AO TB MG JG CV NB MB PT
03 G I I I + I I I I +03 G I I d + + + I I +03 BR + + + + d + + d +
03 n I I d + d I I I +03 G d + d + d d I I +
06 BR + I I + I I I I +06 R I I I + d + I I +06 R I d d + d + I d +06 R I d d + d + I I +
15 R + I d + d + I d +15 R d I d + d d I I +
11 n I I d + d d I I +
08 n I I I + I I I I +
09 R + I d + d I I d +09o R + I d + d + I d +
19d sc I I I + I I I I +19 a R I I I + I I I I +19 R I I + I I I I +19 R d I I + I I I I +19 R I I I + I I I I +
I = inhibition of growth; d = reduction in colony size;+ = unrestricted growth; n = failure to grow;□ = C O 2 requiring strain. sc = small negative colonyBR = bluish irridescence colony;DB = dark blue coloured colony;
G = greyish colony.GR = greenish irridescent colony;R = irridescence colony;The dye levels used were the same as in Table 4.40.
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TABLE 4.43
Inhibition studies, C 0 9 requirement 
and colonial appearance on Mitis-salvarius agar
of 36 pneumococcal strains. Stage 19 B.
Serotype M-Saga r Dye
BT AO TB MG JG CV NB MB PT
23 R I I I + I I I I +23 R I I d + d I I d +23 R + I d + d I I d +23 R I I d + d I I d +23 R I I d + d I I d +23 R + I d + d d I d +
23 R I I I + I I I I +23 R I I I + I I I I +
14 DB + I d + I I I I +14 n + d n + I I I I +14 DB + d n + I I I I '+
14 DB + I I + d I I I +14 DB + I I + + I I I +14 DB + I I + I I I I +
14 DB + d d + d + I I +14 DB + I I + d I I I +
I = inhibition of growth;
.+ = unrestricted growth; d = reduction in colony size; n = failure to grow;
BR = bluish irridescence colony;DB = dark blue coloured colony;G = greyish colony.GR = greenish irridescent colony;R = irridescence colony; sc = small negative colony.
The dye levels used were the same as in Table 4.40.
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4.6.5 Colonial forms on Mitis-salivarius media
i) The growth on Mitis-salivarius and TYC agars of 11 
pneumococcal strains, serotypes 01, 14, 17, 19 (three
cultures), 23 (three cultures) and 34, showed that very 
small colonies were produced on TYC. These strains however 
on M-S agar gave larger colonies showing a number of 
distinctive colours and sizes. The observation of the 
phenomena depended upon examining the culture under the 
plate microscope after positioning the substage mirror to 
direct oblique light through the colonies. Under these 
conditions the observed characters were divided into three 
types: large irridescent colonies (I), smaller dark blue
colonies (B) and large grey colonies (G). The 11 strains 
were divided into four groups:-
Colony-type I (Ct I): five cultures, two each of serotypes 
23 and 19, and a serotype 34;
Colony type B (Ct B ) : one culture, serotype 14;
Colony type G (Ct G ) : one culture, serotype 19;
Colony type 0 (Ct O ) : five strains, which failed to grow on
M-S, serotypes 06, 17, 19 and 23.
ii) Growth of the six strains on M-S and M-S-s (M-S without 
sucrose) produced five Ct I and one Ct B on M-S and on 
M-S-s four Ct I and two cultures unclassified because the 
colonies produced were too small.
iii) The results of the 24 pneumococcal strains cultured on 
M-S, M-S-s, T-H agar with trypan blue (T-Htb), RCM agar 
with trypan blue (RCMtb) and CA agar are given in Table 
4.44. Irridescence was shown by 16 strains on M-S, 14
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TABLE 4.44
Growth of 24 pneumococcal strains 
on Mitis-salivarius, with and without sucrose, 
and on T-H and RCM agar with trypan blue.
Strain Medium
Type M-S M-S-S T-Htb RCMtb CBA
23 R R d R M23 0 0 0 0 023 R 0 d R M23 R R R R M23 R R d d M '23 R R d d S
14 B B _ 0 S14 B B - - s
14 B B - - s14 B B - - M
19 R R _ R M19 R R d R M19 R R R R M
19 R R d d M19 R R d 0 M
06 R R d d M
06 R R d d M06 R d R R M
09 * d d _ M17 R R R R M01 * R R R M34 R d . - - M
gi G G d - M08 0 R d d M
R = irridescence, Ct I; d = doubtful Ct I;B = d a r k  blue colonies; G = greyish colonies;
- = colourless colonies; 0 = no growth;
* = culture gave blueish irridescent colonies, Ct lb;M = medium sized colonies; S = small colonies;M-S = Mitis-salivarius agar; CBA = Columbia base agar;M-S-s = Mitis-salivarius agar without sucrose;T-Htb = Todd-Hewitt agar with toluidine blue;RCMtb = reinforced clostridial agar with toluidine blue.
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strains on S-M-S, six strains on T-Htb and nine strains on 
RCMtb. Growth on CA, the control plate, produced medium 
sized colonies with 19 cultures, small colonies with four 
strains and one culture, serotype 23, failed to grow on all 
media. Seven strains on M-S did not produce irridescences; 
four gave Ct B colonies and were all of serotype 14; the 
other three cultures, serotypes 01 and 09 and the serogroup 
I strain appeared as large bright blue colonies. Repeat 
testing of these seven strains confirmed the results for 
five strains, the four type 14 and the serogroup I 
cultures. The two other isolates, serotypes 09 and 01 both 
gave blueish irridescenct colonies and were classified as 
Ct lb, variants of Ct I.
iv) The results of growing 70 consecuetive pneumococcal 
isolates on M-S showed 55 cultures of Ct I which included 
two isolates, both serotype 08 having a pink blue 
irridescence. The other 15 non-irridescent strains were 
divided into 10 Ct B cultures, consisting of eight serotype 
14 and two non-capsulate isolates; four greyish colonies, 
Ct G, belonging to serotypes 03 (two cultures), 37 and 19, 
and one whiteish colony, Ct W, a serotype 37 strain. These 
results were summarised as:-
55 strains Ct I: mixed serotypes;
10 strains Ct B: serotype 14 (eight strains),
non-capsulate (two strains);
4 strains Ct G: serotype 03 (two strains),
serotypes 19 and 37;
1 strains Ct W: serotype 37.
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v) Examinations for irridescence of pneumococci grown in
M-S broth, and colonies transferred from M-S agar to 
microscope slides were negative. The suspension of 
colonies from M-S agar in PBS was initially negative but 
during observation on the microscope slide with the 
consequent drying a weak irridescence was seen.
vi) Testing of 60 strains, two years after the first 
experiments, confirmed the colonial effects and showed 45 
cultures were of Ct I, two of which were of Ct lb, both 
serotypes 19. The other 15 strains were divided into seven 
of Ct B, six serotype 14 and one non-capsulate variant; 
five were of Ct G, serotypes 03 (two strains), serogroup I 
(two strains) and serotype 19, and two of Ct W, serotypes 
01 and 03.
A further 40 pneumococci, tested for growth characteristics 
on M-S as part of a larger investigation of differential 
factors, also showed the distinct colonial types; the 
detailed results are included with the Dye inhibition 
studies, Tablet4.42-3.
vii) The growth of eight strains on the two M-S agar 
formulae, with and without potassium tellurite showed that 
four strains were unaffected by the concentration of 
tellurite, three cultures were inhibited by the tellurite 
and one strain did not grow on M-S. The inhibition of 
pneumococci by tellurite was further investigated in the 
Dye inhibition studies, Tables 4. 4-1 “to 4.4-3.
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4.7 ANTIBIOTIC SENSITIVITY TESTS.
4.7.1 Media and atmosphere effects on inhibition zones 
produced by penicillin, tetracycline, trimethoprim and 
co-trimoxazole
The results of testings the two pneumococcal strains 
on the sensitivity test agars (Section 2.9) against the 
above antibiotics are recorded in Table 4.45. On 
iso-sensitest (IS) and Mchocolate"-IS (CIS) plates zone 
diameters for penicillin and tetracycline for sensitive 
strains were larger after aerobic than after anaerobic 
incubation. On blood-iso-sensitest agar (BIS) little 
difference was seen. Trimethoprim when tested on IS and 
BIS incubated anaerobically gave reduced zones but on CIS 
anaerobic culture gave larger zones. Co-trimoxazole zones 
were larger on IS and CIS under anaerobic conditions and 
smaller on BIS. The larger inhibition zones produced by 
co-trimoxazole in comparison could be the result of the 
sulphonamide fraction of this combined anti-microbial 
agent.
4.7.2 Sensitivity testing of 22 pneumococcal strains 
against tetracycline and trimethoprim by the disc and agar 
containing methods
The testing of 21 strains resistant to trimethoprim 
by the plate method and four cultures resistant by the disc 
technique by both the plate and disc methods gave the 
following results. Tetracycline gave comparable results by
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TABLE 4.45
Media and atmosphere effects on
penicillin, tetracycline, trimethoprim and co-trimoxazole
inhibition zones on three versions of Isosensitest agar.
Strain Atmosphere Pen Tet Trim Co­trim
Isosensitest agar (IS)
1 o 2 30 24 16 20A 0 2 40 34 12 302 o2 30 10 16 20
a o 2 40 10 12 30
Heated blood IS (CIS)
1 0 2 30 14 10 20
a o 2 40 30 14 242 0 2 30 0 10 20AO 2 40 10 14 24
Blood IS (BIS)
1 o2 30 24 12 24
a o 2 30 24 10 20
2 0 2 30 0 12 24
a o 2 30 0 10 20
0 2 = aerobic incubation with added C 0 2; A 0 2 = anaerobic incubation with added C 0 2; Pen = penicillin, 2 units;
Tet = tetracyclin, 5 ug;Trim = trimethoprim, 2.4 ug?
Co-trim = co-trimoxazole, 25 ug.The figures under the antibiotic columns are the diameter of the inhibition zones in mm.
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either method with the same three cultures showing 
resistance. The control organisms appeared sensitive on 
both the plate and disc methods.
Growth occurred on the trimethoprim containing plates at
2.5 ug for two cultures, a further strain at 1.0 u g #■ 6 more 
at 0.75 ug and 11 cultures grew only on the control plate 
without antibiotic.
Repeat testing of the resistant strains on trimethoprim 
agar after initial culture for 4 h in RCM broth showed that 
none grew at 2.5 ug but all did so at 1.0 and 0.77 ug. 
Further tests on four of the sensitive strains from the 
first experiment showed growth at 1.0 and 0.75 but not at
2.5 ug.
Resistance or drug tolerance to trimethoprim could be a 
product of both the dose of the agent and the viability of 
the organism. This problem was not seen with tetracycline 
in which the repeats of the plate containing method gave 
comparable findings.
4.7.3 Extended series of antibiotic disc diffusion 
senstivity tests
All 13 strains tested, except for the known resistant 
culture, gave zones of inhibition greater than the control 
organism, i.e. zone diameters 22-35 mm. Chloramphenicol 
and trimethoprim gave zones smaller than the control (15-18 
m m ) . A comparison of a resistant and a representative 
sensitive strain are given in Table 4.46. The resistant 
culture generally gave smaller zones with all antibiotics
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TABLE 4.46
Antibiotic inhibition diameters of an antibiotic tolerant 
and a representative sensitive strain
Sensitivestrain Resistantstrain
Penicillin 35 20
Cloxacillin 30 15
Erythromycin 30 25
Chloramphenicol 15 17
Piperacillin 40 30
Mecillinam 22 8
Trimethoprim 18 17
Cefotaxime 40 30
Mezlocillin 40 32
Azlocillin 40 30
Ceftazidine 28 22
Cefuroxime 40 30
Cefamandole 35 22
Ticaricillin 35 25
Figures given are the inhibition zone diameters in mm. The concentrations in the discs were the recommended blood level for each antibiotic (see Table 2.11).
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and markedly reduced zones were seen for cloxacillin and 
mecillinam. Cloxacillin has been suggested as a suitable 
test disc for penicillin tolerant strains but the finding 
with mecillinam was not expected.
The repeat testing for mecillinam and cloxacillin for the 
routine isolates gave zones >25 mm for Cloxacillin. The 
three resistant strains (the previously tested strain and 
the two Colindale cultures) gave zones <18 mm with 
cloxacillin and <12 mm when tested against mecillinam, 
compared to >22 mm sized zones with the routine cultures.
4.7.4 Sensitivity testing for tetracycline and trimethoprim 
by the disc method
The 50 cultures tested by the disc diffusion method 
against tetracycline and trimethoprim were considered 
sensitive to the antibiotic if an inhibition zone >18mm was 
produced.
Four strains, one of the four serotype 06 cultures and 
three of the eight serotype 14 strains tested, were 
resistant to tetracyclin. None of the 50 strains tested 
were resistant to trimethoprim.
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4.8 DISCUSSION
The studies included in this chapter form two 
separate but interrelated parts for the differentiation and 
characterisation of the pneumococcus. These consist of 
firstly, serological typing of the organisms' capsule, and 
secondly, attempts to distinguish within and between the 
capsular serotypes by other means, such as the presence of 
enzymes and growth inhibition by dyes.
Identification of pneumococcal capsules is, of necessity, 
by elimination, since there are 83 known serotypes. Four
methods of performing this elimination process are
described, capsule swelling, immuno-diffusion (ID), crossed 
immuno-electrophoresis (CIE) and co-agglutination (CA), 
each of which were assessed for specificity, speed and 
simplicity of the technique. The Quellung reaction for 
capsular typing, the apparent swelling of the pneumococcal 
capsule when mixed with homologous antisera (Neufeld, 
1902) , has a long and distinguished history in the
identification of pneumococci (Armstrong, 1932 and Logan 
and Smeall, 1932) and as a prelude to serum-therapy 
(Austrian, 1968). Attempts to use this rection were not 
successful because either poor technique or equipment 
failed to give clear evidence of capsule swelling. Strains 
tested by this method had been cultured anaerobically and 
gave large mucoid colonies with presumably a large capsule 
which may not have been suitable for capsule swelling. 
Immunodiffusion, the precipitation of antigen and antibody
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at optimal concentrations in an agar gel was applied as an 
interim procedure in this study prior to the arrival of 
electrophoresis equipment. Although ID has been used to
detect microbiological antigens it appeared to be neither 
sensitive nor rapid enough for typing the pneumococcus in a 
clinical laboratory. Identification by ID required a 
minimum of two days; obtaining a result with the pool 
antisera occupied the first and the individual antisera
tests the second day. Only 91 of the 151 culture
supernates tested were positive by ID, which may in part be 
explained by the findings of El-Rafie and Dulake (1975)
that ID required 5-10 times more antigen to produce
precipitation by this method than by CIE. Although more 
sensitive and more rapid than ID, difficulties were
experienced in applying CIE to pneumococcal typing. The 
CIE method, derived from procedures for detecting Hepatitis 
antigen, has been described as either a discontinuous or 
continuous electrophoresis of the antigen and antibody.
This reaction has been performed in barbital based buffers 
with a variety of agarose gel supports at a particular 
current or voltage for 30-60 min (Coonrod and Rytel, 1972; 
Tugwell and Greenwood, 1975 and El-Rafie and Dulake, 1975).
The problems experienced with the initial test antigen,
eventually found to contain non-specific precipitants, 
hindered the assessment of the relative merits of buffers, 
agar gels and electrical system in CIE. The composition of 
the buffer used is critical because the mobility of 
pneumococcal capsular polysaccharides in an electrical
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field is affected by pH and ions present. An alkaline pH 
value of 8.2, or more commonly 8.6, should detect the 
negatively charged pneumococcal polysaccharides (Michaels 
and Poziviak, 1976). However two of the serotypes, 
frequently isolated from serious disease, serotypes .07 and 
14, are said to have either neutral (Anhalt and Yu, 1975) 
or positively charged capsules (Michaels and Poziviak, 
1976) and in any event are not detectable in the usual 
technique according to most authorities (Kenny et al., 
1972; El-Rafie and Dulake, 1975 and Michaels and Poziviak, 
1976). Tugwell and Greenwood (1975), in their Nigerian 
studies, did however detect these serotypes by CIE. In 
contrast El-Rafie and Dulake (1975) showed that an acidic 
buffer system (pH 6.6) was a more sensitive method for all 
serotypes, except serotype 14, and that any precipitate 
formed centrally between the wells was therefore more 
easily recognised. Once a fresh antigen preparation had 
been obtained more specific and reproducible lines were
obtained which confirmed the advantages of the acidic
buffer over the alkaline system. Strong precipitation 
lines were formed centrally between wells, in an indubriose 
support gel, at pH 6.6 but not in the same gel at pH 8.6,
when the gap between the antigen and antibody wells had
been reduced from 5 mm to 2 mm. Application of CIE to
serotyping, at pH 8.6, was unable to serotype 41 cultures,
which was little better than the 60 strains untyped by ID. 
All the typeable strains by ID were serogroup positive,
only strains of serogroups A and D reacted with their pool
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antisera by CIE. When CIE was performed in a pH 6.6 buffer 
(Section 4.3>.*>) , with antigens neat and at a 1 in 12 
dilution, pool reactions, at both concentrations, were seen 
with all of the serotypes tested, with the exception of
some of the pool B and H strains previously untyped by ID. 
This was in general agreement with El-Rafie and Dulake
(1975) who showed prozone to be more pronounced in alkaline 
than in acidic buffers systems. Other difficulties
experienced with CIE concerned speed and simplicity of the 
method, for as other workers have shown (Coonrod and Rytel, 
1973; Tugwell and Greenwood, 1975 and El-rafie and Dulake, 
1975) precipitation lines were not always visible 
immediately after electrophoresis, and usually required 
leaving for four hours or overnight at 4°C and/or staining 
with Coomassie blue before reliable results were seen.
Immuno-electrophoresis when applied to the detection of 
antigens in samples from patients suspected of meningitis, 
septicaemia or pneumonia, presented problems, especially as 
it was performed on an irregular basis requiring reagents 
such as buffers and agar to be prepared immediately before 
each test. The positive results that were seen by CIE in 
the clinical situation were obtained retrospectively
because the samples arose during the evening and the 
serotype of the isolate was known before the patients's 
sample came to be tested. No extra clinical information
was offered by CIE, in this small survey, to warrant
persistence with this generally slow and unreliable method 
and it was subsequently abandoned in favour of
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co-agglutination. Co-agglutination had been developed from 
the observation that staphylococcal protein-A can attach to 
the Fc structures of antibody molecules (Forsgren and 
Sjoquist, 1966; Kronvall and Williams, 1969 and Kronvall 
and Frommel, 1970) to leave the Fab-located antigen 
combining sites exposed and produce a sensitised particle 
able to demonstrate the combination of antigen and antibody 
as a slide test. Preparation of the protein-A carrier 
particle, as originally described by Kronvall (1972), 
recommended growth of the staphylococcus on CCY medium 
(Ardvison et a l ., 1971) a relatively complicated broth
which requires two vitamins and four minerals as 
supplements. Tryptic soy broth was used by Edwards et al. 
(1980) to prepare the reagent but growth on Columbia agar 
base (Section 2.5.4) was found in this study to be superior 
to the two broths. Harvesting of this growth was found to 
be easier from a plate culture than from large volumes of 
broth recommended in the original method. Sensitisation of 
the stabilised protein-A, by formalisation and heat was 
achieved using the Danish Serum Institute's pneumococcal 
antiserum, but Lund (personal communication) underlined 
that these sera were only for the capsular swelling 
reaction and not for CIE or agglutination. Anhalt and Yu
(1975) and Coonrod and Rytel (1972) advocated the 
production of a serum especially for CIE when they found 
weak precipitation and cross reaction with S. viridans by 
their techniques. Poor results had been found with 
Omni-serum and serotype 03 sera with CIE (Coonrod and
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Rytel, 1972; Kenny et al., 1972 and Anhalt and Yu, 1975) 
and this also occurred initially with CA reagents. The 
titres of Omni-serum components are lower than those in the 
pool antisera, and serotype 03 strains are known to produce 
an excess of capsular material which may cause prozone 
effects with antiserum. Experiments were performed 
(Section 4.4.2) to overcome the slow or weak reactions seen 
with these and other early CA reagents in order to obtain 
more rapid results than the recommended 2 min for 
agglutination to appear after adding the reagent (Kronvall, 
1972 and Edwards et al., 1980). After modifications in
reagent preparation (Section 4.4.3) CA with Danish serum 
gave satisfactory co-agglutination results in less than 15 
seconds, in contrast to the time taken for ID and CIE. 
Omni-serum was the least satisfactory by CA, but after 
identification of the test strain by bile solubility and 
colonial appearance, testing proceeded to the pool reagents 
and only rarely was Omni reagent used. Serotype 03 
pneumococci were further examined to determine the optimal 
antigen extraction method (Section 4.4.4) and showed that 
culture in RCM broth, after boiling and precipitation of 
the capsular material by either alcohol or acetone, gave 
the highest titres. The reduced titres found in pneumococci 
scraped from CB agar plates, when lysed by deoxycholate, 
before boiling and precipitation, were much higher than the 
results obtained when the plate growth was lysed in situ, 
possibly because the polysaccharide released during growth 
adheres to or diffuses into the agar. The advantage of
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broth culture for the release of serotype 03 antigen was 
lost when capsular polysaccharides from this and ten others 
strains grown in broths and on blood agar plates were 
tested after storage for one week. Antigen reactions were 
more reliably detected from the growth on an agar plate, 
suspended in PBS and held at 4°C, than the same strain 
cultured in broth and similarly stored (Section 4.4.5). 
The antigenicity of the capsule, in broth, had been 
destroyed or considerably reduced in a short time and may 
explain why some strains, stored in T-H broth at 4°C for 
many weeks, between testing by ID, CIE or CA, failed to be 
serotyped. The CA method proved to be superior for 
serotyping than capsule swelling, ID or CIE both for 
accuracy and speed of reaction and CA was adopted for the 
epidemiological survey of serotypes after identifying 265 
(90%) of the 293 strains available between April and 
October 1976, the majority of which had been stored in T-H 
broths.
Once the identification of the capsular serotypes was 
resolved the second stage, pneumococcal characterisation, 
began with a search for "sugar" fermentation test media. 
Pneumococcal fermentation studies, previously by serum agar 
slopes, have largely been abandoned because of a failure to 
provide rapid or useful information. Modern media can more 
reliably supply nutrients and the need for serum in 
carbohydrate test media should be superfluous, particularly 
since the effect of serum on the pneumococcus is largely as 
a pH buffer (Holt, 1962). Some of the more recent
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fermentation substrates and methods have been tested 
(Sections 4.2.3-5) for their ability to demonstrate 
pneumococcal enzymes, in an attempt to provide quicker and 
more relevant results. Suitable serum-free media were not 
found, neither CTA medium nor a modified T-H medium 
(prepared without glucose), were suitable for pneumococcal 
growth as a basic medium for fermentation. Defined 
Son ococcal medium although slightly better than CTA in 
promoting growth was no more suitable for fermentation 
studies since pH changes were seen both with and without 
fermentable additives (Table 4.4). Growth produced on 
Columbia agar with sucrose was not very heavy, and when 
supplemented by chalk, to demonstrate and contain acid 
production in the streptococci, the colonies formed were 
much reduced. Only the addition of serum gave moderate 
sized colonies for seven of the eight pneumococcal strains 
tested. These media failures were largely overcome when 
dense suspensions of the test organism were mixed with high 
concentrations of substrates in microtitre plates. 
Fermentation reactions were slightly affected by the 
suspending medium used but the results were generally 
clearly evident after 4-6 h in contrast to 4-6 days by the 
serum agar slope method.
An alternative approach to enzyme detection, the commercial 
version of the Auxotab method, the APIZYM system also 
detects enzyme reactions within 4 h. The 19 APIZYM cupules 
contain substrates for carbohydrate splitting enzymes, 
esterases, phosphatase and protein peptidases, each
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selected to recognise particular enzymes rather than the 
gross effects demonstrated in conventional bacteriological 
fermentation tests. The APIZYM system, as a controlled set 
of enzyme substrates, could form the basis of a 
standardised intra and inter-laboratory scheme to 
characterise pneumococci by their enzyme profiles. This 
could be done in a similar manner to the differentiation of 
Enterobacteriaceae and streptococci by the API20E and 
APISTREP strips (API Products) respectively, but 
potentially may give patterns associated with clinical
infections. To produce a reproducible enzyme detection 
scheme it was first necessary to standardise enzyme 
preparation by first considering the growth conditions. 
Pneumococci can be difficult to characterise because
vigorous growth is difficult to obtain (Section 4.5.1-2). 
Cultures in broths (Section 4.5.4) did not give the highest 
yields probably because the growth curve had passed to the 
decline phase through the action of inhibitory metabolic 
products, acidic pH shift by glucose fermentation and
peroxide accumulation. The excess capsule release in the 
latter stages of metabolism may trigger pneumococcal 
autolytic enzyme (Tomasz, 1981) and enhance the decline in 
the organisms viability. This did not appear to be the 
case with strains grown anaerobically with C 0 2 on CB agar 
which, when first removed from the anaerobic jar, showed 
large and convex colonies and only developed the collapsed 
"draughtsman” colonies, characteristic of aerobic culture, 
after the plates had remained at room temperature for
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number of hours. The growth produced by anaerobic culture 
with C O 2 was heavy enough to allow a dense suspension to be 
prepared from one culture plate and sufficiently viable to 
permit between four and ten strong enzyme reactions in the 
APIZYM strip, depending upon the strain tested. 
Pneumococci had not previously been tested in the system, 
although the development laboratory of the French parent 
company of API Products stated that the pneumococcus was 
unreactive in the APIZYM system. The only available 
reports of enzyme reactions of related organisms in the
APIZYM system, were the few Gram-positive cocci tested by
Humble et a l . (1977) in a general paper on the APIZYM
method and the more intensive study of Waitkins et a l .
(1976) on the alpha and non-haemolytic streptococci. All 
the pneumococci tested (Section 4.5.4, ii) showed leucine 
arylamidase and alpha glucosidase activity, the former
shown by most of the streptococci and both shown by S . 
faecalis and some of the other streptococci. Differences 
in enzymes detected were seen in the production of esterase 
lipase, chymotrypsin, alpha and beta galactosidases and 
beta glucosaminidase by the majority of the pneumococci, 
and their absence in the rest of the streptococci. 
Conversely many of the other streptococci had been shown to 
produce acid and/or alkaline phosphatases, cysteine 
aminopeptidase and phosphoamidase, none of which were
detected in the pneumococci tested. The 32 enzyme profile
codes, obtained from the 10 possible APIZYM enzyme-positive 
results found in the pneumococci tested (Tables 4.14-16),
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were randomly distributed amongst the serotypes of the
strains. Amongst each group of serotypes from three
(serotypes 09, 11 and 31) to fifteen profiles (serotype 06) 
were found, and although 63% of the cultures gave enzyme 
codes 1-7 there was no pattern related to capsular serotype 
which indicated a use for this method to differentiate 
within the pneumococcus. The examination of APIZYM
profile, serotype and source of the isolates (Table 4.9)
was less useful as a possible indicator of pathogenicity; 
the four wound site isolates, for example, showed four
codes, only one of which was in the seven most common 
codes. A similar picture was seen with strains from the 
other sites; perhaps more relevant information would be 
obtained from a larger survey. The possession of
neuraminidase, expressed as a ratio to the density of the 
test suspension and detected by the WHO method and not by 
the pan-agglutinability of red cells, also warranted 
further investigation. An inverse ratio of neuraminidase 
activity seen in the two isolates from infection samples 
when compared with the commensal strain (Section 4.2.6, ii) 
was difficult to explain since the invading strains would 
have been expected to more actively attack the 
sialo-mucins, the naturally ocurring substrate for the 
enzyme in the patient. Proteinases, another group of 
potentially aggressive enzymes had been demonstrated in
pneumococci when tested in the APIZYM system but only very 
weak activity was seen even after stimulation in milk agar.
Bacterial pathogenicity can also in part result from the
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organisms' production of haemolysins as observed in the 
streptococci and Clostridia, but in the pneumococcus these 
have been difficult to determine. A double zone of 
haemolysis, best demonstrated on azide containing tryptose 
blood agar (Section 4.5.8), was a reproducible and reliable 
characteristic on this medium only. The "hot-cold" nature 
of the activation of this haemolysin was similar to the 
phenomenon produced by Cl. perfringens which also shares 
possession of a neuraminidase. Slight differences were 
seen on the three red cell species tested with a suggestion 
of an extra zone of haemolysis on human blood agar plates, 
again an area demanding further studies. . The future 
examination of the pneumococcus requires a more flexible 
approach which probably includes using a simpler version of 
the APIZYM system. Only ten of the 19 APIZYM substrates 
were positive for any one pneumococcus and enzyme activity 
could therefore be examined as individual tests, without 
recourse to the expense of the complete APIZYM strip. A 
wide range of carbohydrates and other substrates, including 
many similar to those in the APIZYM series, are available 
linked to a nitrophenyl group and in the small number of 
substrates reported in Section 4.5.5 provided a sensitive 
and rapid enzyme detection method. To complete the 
evaluation of the biochemical testing of the pneumococcus 
parallel study of the nitrophenyl method, the APIZYM system 
and carbohydrate fermentation in microtitre plates with the 
examination of other substrates appear to be promising 
areas for further study.
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Much of this chapter has been occupied with numerous 
experiments examining another promising new approach to the 
differentiation of the pneumococcus that is by its 
susceptibility paricularly to the blue and green dyes. 
Patterns of resistance to dyes and chemicals, to give a 
so-called resistogram have been used in the staphylococci, 
E. coli, the shigella and in the brucella to differentiate 
within the species and between strains that would not be 
possible by biochemical or serological means. The most 
difficult aspect of inhibition methods are the biological 
titrations to find the optimal concentrations of suitable 
inhibitors; pneumococcal inhibition testing was no 
exception. Initial studies with agar slopes established 
general concentrations for investigations in agar plates 
containing each of eight dyes from the 25 screened for 
suitability. It was soon realised that the amount, of dye 
had to be very carefully controlled, within a very narrow 
range, to reduce the inherent error of preparing agar 
plates to contain an exact concentration after a number of 
dilutions from a stock solution. This was started by 
adding 3 ml of a weaker solution to 12 ml of agar rather 
than the previously used volumes of less than 1 ml of a 
more concentrated solution added to 15 ml. The 
mathematical exaggerations inherent in diluting dilute 
solutions, and the time available for this part of the 
study, prevented the definition of optimal levels of the 
dyes tested. The levels used (Section 2.8.5, Table 2.6~10) 
had been gradually finely adjusted but small changes in the
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concentration of the stock solutions gave apparently large 
changes in the plate values and the later stages (Tables 
4.27-43) showed how critical were the dye concentrations. 
Reproducibility of the results obtained from the same batch 
of dye-containing agar plates between repeat tests of the 
same isolate or the same serotype from the same patient 
proved satisfactory (stage 7 and 17). However in the later 
stages in which some of the dyes in consecutive tests were 
at the same concentrations some of the expected results 
differed. A panel of test strains had earlier been 
introduced to remove one of the test variables. From stage 
9 the test pneumococci were used in the log phase of growth 
since active growth should be the most standard and 
sensitive stage of the organisms for inhibition. The last 
four stages (15-19) gave dye inhibition patterns that were 
close to being optimal as differential markers, with the 
probability that closer study of the individual dye in fine 
detail variation tests would give the elusive levels 
indicated in the attempts to study eight dyes at the same 
time. To bring this work to completion would need the 
selection of pure standardised internationally coded dye 
powders, probably obtained from one supplier and the 
precise weighing of the light dye powder. This, combined 
with the selection of stock concentrations for careful 
in-use dilution on a larger scale than the one or two 
plates per batch in this study, should average out the 
described pitfalls of the method. If the stock solutions 
were able to be preserved, over a few months, testing of a
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significant number of strains using one batch of solutions 
could enable standardisation of the technique. Once this 
had been achieved a panel of pneumococcal cultures could be 
chosen from these strains and maintained to control 
subsequent batches of dyes by biological titrations. 
Differentiation of the pneumococcus in Mitis-salivarius 
agar (M-S) has not previously been reported although the 
medium was developed for the selective isolation and 
colonial forms of the oral streptococci, S. mitis and S . 
salivarius.
The distinctly coloured colonial forms produced on M-S agar 
by the pneumococci studied (Section 4.r6.s) was only partly 
the product of two of the components of the medium, trypan 
blue dye and sucrose. The effect seemed to be a 
combination of these two components and the shape of the 
colony produced on this particular formula. Simple and 
reproducible colonial differentiation was available when 
viewed under the critical microscopic conditions (Section
2.8.6). The majority of strains comprised one group which 
produced large irridescent colonies unrelated to serotype. 
Other strains gave colony forms more often associated with 
serotype, e.g. the dark blue colonies of serotype 14 and 
the non-capsulate variants, and the greyish colonies 
produced by a significant number of the serotype 03 
isolates. Potassium tellurite, a required additive in the 
original M-S formula, gave inhibition patterns when 
included in this medium but was unsatisfactory when 
included in T-H agar (Tables 4.38 and 4.41-2).
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The final section of the chapter was in response to the 
changes in the clinical and laboratory reports concerning 
the reduction in the susceptibility of the pneumococcus to 
antibiotics. The incidence of pneumococci, seen in this 
laboratory, that were resistant to tetracycline was higher 
than would be expected since our patients are all under the 
age of sixteen and one would not expect that they would 
have been prescribed this drug. The increasing use of 
co-trimoxazole both for urine and respiratory infections 
may explain the other increased incidence of apparent 
antibiotic resistance seen in this laboratory. Disparate 
results were found in bench tests of 22 pneumococci for 
resistance to trimethoprim (the antibiotic component of 
co-trimoxazole) (Section 4."7, ii) . The disc diffusion 
method showed only four resistant cultures but in the agar 
incorporation plate 21 strains grew in the presence of 1 
Ug/ml of the drug. Studies of agar incorporation between 
0.75 and 2.5 ug/ml were made again using lysed blood 
containing sensitivity agar without reproducible results 
unless the organism had been grown in broth for four hours 
before the plates were seeded with the strain. In general 
the incorporation tests gave an MIC between 1.0 and 2.5 but 
the disc diffusion method gave zone diameters of inhibition 
>15 mm. The discrepancies were not seen when tetracycline 
was tested in a similar manner and serves to highlight the 
known difficulties of laboratory testing of trimethoprim 
(and co-trimoxazole) susceptibility. When a further 50 
strains were tested on heated blood agar plates by the disc
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diffusion method for both tetracycline and trimethoprim, no 
cultures were seen which showed resistance to trimethoprim 
but four were tolerant of tetracycline. The major concern 
with the pneumococcus is the emergence of 
penicillin-tolerant strains which are difficult to 
recognise by routine disc diffusion tests using a 1.0 or 
1.5 unit disc since the reduction in inhibition size is so 
slight as to be easily mixed in a busy department. 
Cloxacillin (5 Mg) discs have been recommended to detect
the penicillin-tolerant variants as the fall in zone size
around this disc is greatly reduced in an antibiotic
tolerant strain. The results produced by the three 
resistant strains tested (Section 4.7, iii) confirmed this 
opinion and showed an almost constant reduction in zone 
diameter in all the sixteen drugs tested. Mecillinam
proved to be at least as sensitive an indicator of 
penicillin-tolerance as cloxacillin in the very limited 
number of cultures available.
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A total of 1736 pneumococcal isolations were made between 
November 1976 and October 1980 from 1361 patients at the 
Children's Hospital. The results are presented in Table 
5.1. During 1976/7 the monthly isolations were highest 
during November, February and March and at their lowest in 
August, September and October. In 1977/8 total isolations 
were reduced; the highest monthly total was seen in July 
and the lowest during August and September. The highest 
return in the four periods was made in 1978/9 in which all 
months showed a general increase with December and January 
providing the most and August and September again the least 
number of isolations. A more evenly distributed year with 
winter counts similar to the summer returns was seen in 
1979/80; March 1980 gave the highest monthly total for the 
four years.
When the isolation rates were examined against the patient
types i.e. In-patient, Out-patient, Accident and Emergency
and post-mortem (Table 5.2) the proportion of In-patients
yielding pneumococci increased markedly from 220 in 1977/8
to 375 in 1978/9 with a corresponding fall in isolations
from 137 down to 106 in the other categories of cases.
Distribution of pneumococci amongst patients by age and sex
(Table 5.3) showed an excess number of male patients (56%)
but this was in line with the ratio seen for all admissions
(59%). Age distibution showed a higher incidence of 
pneumococcus positive patients in children less than 5
years old and a lower incidence in those greater than 5
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TABLE 5.1
Pneumococcal isolations by month and year (1976-80) 
at the Children's Hospital, Sheffield.
Month
Number of isolations in the given month in
1976/7 1977/8 1978/9 1979/80 Total
November 51 35 40 31 157
December 32 38 55 26 151
January 30 32 56 33 151
February 62 21 38 41 162
March 59 21 50 79 209
April 37 17 42 35 131
May 43 35 49 51 178
June 29 27 38 36 130
July 27 51 41 41 160
August 21 24 17 22 84
September 12 23 23 37 95
October 19 33 31 45 128
Totals 422 357 480 477 1736
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TABLE 5.2
Source of pneumococcal positive samples 1976-80 
at the Children's Hospital, Sheffield
Number of isolates from the given source in
Source 1976/7 1977/8 1978/9 1979/80 Total
IN/pt. 303 220 374 371 1268
OUT/pt. 59 74 50 44 227
A+E 43 45 42 53 183
P/M 17 18 14 9 58
Total 422 357 480 477 1736
IN/pt. = In-patient;OUT/pt. = Out-patient;A+E = Accident and Emergency Department; P/M = Post-mortem.
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TABLE 5.3
Age and sex distributions of pneumococcal patients 
against all patients admitted to the 
Children's Hospital, Sheffield (1976-80).
Number (%) of isolations from patients aged
<1 1-5 6-10 11-15 total Q.*©
Pnuemococcal patients
Females 205 335 113 50 703 44
Males 290 509 167 67 1033 56
Totals 495 844 280 117 1736
(28) (49) (16) (7)
All admissions (aver./yr)
Females 290 777 847 633 2547 41
Males 383 1020 1339 895 3637 59
673 1797 2186 1528 6184
(11) (29) (35) (25)
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years, when contrasted to the expected value for all 
admissions.
The number of isolates related to the hospital medical 
departments and the number of respiratory sample culture 
requests are given in Table 5.4. The four medical 
consultants were considered in one group and all other 
departments as a second group. The increase in medical 
requests for bacteriological culture of respiratory 
specimens and the number of In-patient isolations both 
occurred in 1978-80.
Association of the most frequently isolated serotypes with 
hospital ward are given in Table 5.5. The medical units 
(Wards 3, 4, Isolation, and Ground floor, Thornbury Annexe) 
provided 721 (41.5%), surgical units (Wards 5, 10, 11 and
First floor, Thornbury) 324 (18.6%), Plastic surgery (Wards 
2, 8 and 9) 95 (5.5%), mixed surgical and medical wards (1, 
6, 7, Intensive Care unit, Conservatory, Thornbury and the 
Ryegate Annexe) 128 (7.4%) and Out-patients, Accident and 
Emergency, and post-mortem departments 468 isolates (27%) . 
The distribution of serotypes over the period (Table 5.6) 
showed that the 1736 strains belonged to 34 serotypes, 
serogroup I and non-capsulate variants. Serotypes 06, 19
and 23 were represented by 823 cultures (47.4%), and 
serotypes 03, 09, 11 and 14 provided 321 strains (18.5%).
Strains of the serotypes represented in the Pneumovax
vaccine (Thomas Morson Pharmaceuticals, U.S.A.) accounted 
for 1226 (71%) of all the isolates. Of the 24 blood 
culture or CSF positive patients 16 yielded vaccine
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TABLE 5.4
Distribution of pneumococcal isolations by consultant per
year and the total number of respiratory samples received
Number from the of isolates given source
Consultant 1976/7 1977/8 1978/9 1979/80 Total
Medical*
A 65 58 107 128 358
B 18 26 29 Ret. 73
C 66 31 91 104 292
D 44 46 90 60 240
Total 193 161 317 292 963
Others**
229 196 163 185 773
Totals 422 357 480 477 1736
Respiratory samples
3590 3761 5548 5744 18643
Ret. = retired from Hospital practice.
•k = The four main medical firms;
•k :k = All the other consultant firms.
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TABLE 5.5
Distribution of the frequently 
isolated pneumococcal serotypes by Ward.
WardorUnit
Number of the from a given serotypes isolated Ward or Unit Total
03 04 06 09 14 19 23 Others
Medical
Three 9 5 28 14 11 23 20 44 154
Four 6 4 47 8 10 44 25 52 196
Isol 3 3 35 8 8 26 30 55 168
G/f 5 7 45 8 19 44 27 48 203
Surgical
Ten 3 2 11 1 1 5 7 22 52
Eleven 2 2 4 2 2 8 4 22 46
F/f 10 2 37 14 12 23 20 48 166
Two 1 0 9 3 4 9 6 28 60
Mixed surgical 
27 22
and medical 
31 7 9 31 26 70 223
Totals 66 47 247 65 76 213 165 389 1268
Non-admission patients provided 469 isolates. F/f = First floor ward, Thornbury Annexe;G/f = Ground floor ward, Thornbury Annexe; Isol = Isolation ward, Thornbury Annexe
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TABLE 5.6
Distribution of serotype isolated 1976-80.
Serotype Numbers isolated
06 31319 29423 21614 9909 8603 7711 59
15 5618 4904 4517 4031 3535 33
33 2910 2801 23
22 2921 20
08 1716 1434 1420 10 02, 05, 07, 12,13, 27, 28, 37, 3740, 42
Serogroup I 15Non-capsulate 45Un-typed 53
Total 1736
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serotypes were isolated. Vaccine serotypes were recovered 
from 79/89 (88.8%) ear swabs, 107/153 (69.9%) sputa, 52/68 
(76.5%) wound swabs and 75/140 (53.6%) of the eye swabs 
received.
Culture reports as pneumococci alone or mixed with other 
organisms are recorded in Table 5.7. Pneumococci only were 
reported in 1283 (73.9%) specimens and Haemophilus was
present in the majority (77.5%) of the 453 mixed culture 
reports and in half of the nasal swabs. The proportion of 
haemophili isolated from sputa was significantly higher 
(P<0.1%) and the seven strains recovered from ear swabs was 
significantly lower than expected (P<0.5%). Presence of 
Staph, aureus with pneumococci in sputa, eyes, ears and 
wound specimens, and beta-haemolytic streptococci with 
throat swab isolates were both significantly raised 
(P<0.5%).
Analysis of isolations from particular sites related to 
capsular serotype (Table 5.8) showed that pneumococci were 
found in 919 nasal swabs (52.9%) of the positive specimens) 
without any serotype showing a significant relationship to 
that site. Serotype 03 with ear swabs and the 
non-capsulate variants with eye swabs were the only strains 
significantly associated with site (P<0.1%).
When serotypes of isolates received from different sample 
sites at the same admission were studied (Table 5.9) the 
majority (96.3%) yielded the same serotype from each 
specimen. In contrast when repeat admission episodes were 
considered mixed patterns of change in serotype between
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TABLE 5.7
Occurrence of pneumococci with other organisms
at particular sites.
Numbers of isolates for a given site
Site Alone Mixed with *
Haem. Staph. BHS
Throat 276 73 3 16 1
Nasal 732 178 1 13
Sputum 72 42 1 12 1 1
Eye 93 35 12 2 0
Ear 63 7 3 l l 1 3
Wounds 20 3 20 1 1
Others 27 0 0 0
Total 1283 353 66 34
* Isolates were mixed with more than one organism. Pneumo = Pneumococci;Haem. = Haemophilus species;Staph. = Staph, aureus;BHS = beta-haemolytic streptococci *
1 = significant at P<0.1%2 = significant at P<0.5%3 = inversely significant at P<0.5%
TABLE 5.8
Distribution of pneumococcal serotypes 
against sample site.
Sero
type
Number of isolates of the given serotype from
Thr Nas Eye Ear W/s Spt Ur Rem Total
01 2 10 1 7 1 2 2303 23 25 3 12 4 9 1 7704 7 25 2 1 2 6 2 45
06 60 184 21 11 7 24 6 31309 17 50 5 4 3 5 1 8610 6 16 1 2 1 1 28
11 13 34 2 1 3 5 1 5914 13 59 10 6 2 6 3 9915 1 38 1 1 9 2 56
17 5 23 1 4 3 4 4018 8 27 1 4 4 4 1 4919 65 139 19 20 17 33 1 294
22 3 16 1 3 1 4 1 29
23 42 128 8 12 6 17 3 21631 6 16 6 1 2 4 35
33 4 16 1 7 1 29
35 4 23 1 1 4 33NC 2 3 40 45
Others 32 87 16 1 10 13 26 180
Total 313 919 138 87 64 154 6 54 1736
Thr = throat swabs;Nas = nasal swabs;W/s = wound swabs;Spt = respiratory sample, not throat or nasal swabSin = sinus samples;Ur = urine.Rem = remainder of sample sites.
NC = non-capsulate strains.
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TABLE 5.9
Pneumococcal isolation from different patient sites 
during the same admission episode.
Site of sample
Number of samples from the given site
Sameserotype Differentserotypes Total
Thr and
Nasal 92 2 1 94
Eye 11 0 11
Ear 1 0 1
Skin 3 0 3
Eye andNasal 13 2 2 15
Others ll3 1 “ 12
Total 131 5 136
1 = a throat swab strain type 03 and nasal swab type 06;
a throat swab type 19 and nasal strain type 14.
2 = one eye swab contained a non-capsulate strain and
the nasal swab type 23, and the other pair was of a type 16 strain in the eye swab and a type 23 isolate in the nasal swab.
3 = nasal and ear swabs; blood and CSF (three patients);blood and throat swab; skin and throat swabs; sputum 
and ear swabs; wound and nasal swabs; ear and throat swabs; vaginal swab and urine; CSF and valve system.
* = a non-capsulate eye swab strain and a type 19 throat swab isolate.
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samples was seen (Table 5.10). The total number of 
patients admitted on more than one occasion was 111 but 
only isolates from 104 patients were serotyped on each 
occasion. In 80 patients the serotype recovered differed 
between visits and from 24 patients the same serotype was 
isolated on more than one occasion. Certain patients had 
three or four admission episodes such that 134 examples of 
either persistence or change in pneumococcal serotype 
isolated was seen. Changes in the serotype isolated often 
occurred within the first month following the initial 
sample, however patterns were difficult to follow because 
of the random nature of the admission intervals. The 
examples given in Table 5.11 are those patients sampled on 
more than three separate occasions. Persistence of the 
same serotype for longer than one or two months was
unusual, the exception was example 12 in which serotype 19
persisted over a three year period.
All specimens obtained in the mortuary from 39 cases,
listed for cause of death, serotype and site of the isolate 
(Table 5.12), contained the same serotype from each
patients' samples. Pneumococci were found in either blood 
or CSF from 15 of the children, nine of whom had died of 
sudden infant death syndrome (cot death).
It was not practical to analyse the small groups formed 
when the 2545 clinical diagnosis codes (International 
Classification of Diseases, WHO) for the 1367 patients were 
referenced against the 205 diagnosis codes obtained from 
the patients laboratory request form. Similarly when the
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TABLE 5.10
Repeat episodes of pneumococcal isolations from the 
same patient at different admission episodes.
Number of samples at 
in months
each interval,
1 2 3 4 5 6 >6 Total
Change of serotype
18 8 8 12 2 6 43 97
Persistence of serotype
15 10 5 1 4 0 2 37
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TABLE 5.11
Examples of serotypes seen in patients providing
three or more samples.
Patient Date Type Date Type Date Type Date Type
1) 3/78 04; 7/78 23; 6/80 06; 8/80 062) 11/76 06; 2/77 23; 1/79 23; 11/79 183) 112/77 08; 12/77 19; 6/78 15; 8/78 15
4) 7/77 19; 8/77 19; 211/77 19; 11/77 17;1/78 19
5) 3/78 17; 11/79 19; 4/80 23; 10/80 156) 12/77 19; 1/78 06; 4/78 R?
7) 6/78 14; 7/79 23; 11/79 15; 1/80 158) 5/78 15; 9/78 15; 12/78 18; 2/79 189) 11/79 06; 3/80 19; 3 7/80 23; 7/80 23
10) 3/79 04; 4/79 04; 6/79 04; 7/79 15;8/79 15
11) 6/78 31; 9/78 31; 11/78 19, 09“12) 1/77 19; 7/77 19; 12/77 19; 9/80 19
13) 5/77 23; 7/77 04; 8/77 15; 1/78 15;1/79 ii; 4/79 0914) 11/77 19; 1/78 22; 12/78 06; 1/79 06;5/79 23
15) 3/77 10; 1/79 19; 2/79 09.
1 = CSF isolate type 08, throat swab strain type 19;2 = nine days interval between admission episodes;3 = twelve days interval between admission episodes;* = nasal swab strain type 19, ear swab isolate type 09;
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TABLE 5.12
Pneumococcal isolations from post-mortem patients
Patient Cause of death Serotype Site
6497 septicaemia 09 mid ear6790 respiratory infection 19 mid ear
6791 respiratory infection 19 mid ear, nose6796 Haemophilus meningitis 03 mid ear6804 Letterer-Siwe syndrome 11 lung6827 bronchopneumonia 19 lung
6840 sudden infant death 17 mid ear6842 repiratory infection 14 lung6855 myeloid leukaemia 18 blood, nose6873 sudden infant death, 0 .M 06 mid ear6874 respiratory failure 15 lung6859 sudden infant death 23 mid ear
6965 sudden infant death, 0 .M 23 C.S.F, mid ear7007 pneumonia 22 blood, lung
7017 sudden infant death 19 blood, mid ear7020 sudden infant death 14 nose7026 respiratory infection, 0 .M 18 mid ear7035 bronchitis 03 lung
7037 respiratory failure 11 C.S.F, mid ear7147 sudden infant death 14 blood7155 respiratory failure 14 lung7156 congen abnormal glands 31 lung7189 chest infection 23 ear7205 chickenpox 14 throat
7240 respiratory infection 19 mid ear7266 respiratory failure 19 mid ear
7286 sudden infant death 14 mid ear7288 bronchopneumonia 33 blood7312 congen hydrocephalus 06 lung, nose7352 respiratory failure 22 mid ear
7356 congen hydrocephalus 23 operation wound7357 bronchopneumonia 23 C.S.F,lung, ear7369 pelvic neoplasm I blood7410 gastroenteritis 22 mid ear7419 bronchopneumonia 01 mid ear7437 sudden infant death 03 lung, mid ear
7493 lung neoplasm 35 lung7536 sudden infant death 23 mid ear7445 sudden infant death 06 mid ear
Total: 39 cases
Sudden infant deaths: 9 cases (3 blood or C.S.F positive)
Other patients either blood or C.S.F positive: 6 cases.O.M. = otitis media; congen = congenital;mid ear = middle ear.
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laboratory details were plotted against the serotypes of 
isolates the groups formed were too small for analysis. 
The clinical detail codes were condensed into 11 groups of 
related conditions and a final group for the remaining 
miscellaneous diagnoses (Appendix D ) . Distribution of 
pneumococcal serotypes amongst these clinical detail groups 
is given in Table 5.13. The significance of serotype 03 
with ear disease and non-capsulate isolates with eye 
infections were confirmed together with the association of 
serotype 03 with patients of the "sore throat" group.
The distribution of tetracycline and co-trimoxazole 
resistant strains amongst pneumococcal serotypes given in 
Table 5.14 are a continuation of the studies presented in 
Section 4.7. This showed tetracycline resistance in 3.7% 
of all isolates, with a high incidence in serotypes 01, 03, 
14 and 21.
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TABLE 5.13 
Distribution of pneumococcal serotypes
amongst laboratory diagnosis codes.
Diagnosis Serotype
groups 03 04 06 09 11 14 15 19 23 R X Total
Nasal 7 21 6 6 6 8 20 14 1 56 145
Eye '2 1 16 6 1 15 3 30 28 102
Lower 2 5 28 4 6 6 14 14 2 51 132
Upper 7 5 76 25 12 19 16 81 73 1 115 430
"Sorethroat"
11 14 4 6 8 3 18 18 2 28 112
Ear 10 3 14 8 3 7 2 21 7 20 95
"Serious"infection 2 5 24
4 4 15 1 22 4 3 37 121
Immunocomprsd 1 7
1 2 2 4 2 2 14 35
Plastic op. pts.
1 10 7 1 4 1 16 12 26 78
Heart op. pts.
1 8 2 4 8 13 13 49
CSF-valve pts •
9 1 1 1 5 1 7 24
Others 32 26 86 20 22 31 10 72 55 6 51 412
Totals 76 45 313 86 59 99 56 294 216 45 446 1736
X = the other serotypes;Imrauno comprsd = immunologically compromised patients; op.pts. = operation patients.For the composition of the diagnosis groups which were 
derived from the clinical details on the laboratory request forms, see Appendix D.
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TABLE 5.14
Distribution of pneumococcal serotypes related to 
sensitivity to tetracycline and co-trimoxazole
Serotype TotalTested
TotalSens
Total
Res
Q.*o
Res Total Resistant Tet Co-tr Tet and Co-trm
06 251 230 21 8.4 9 10 214 71 57 14 19.7 104 401 20 11 9 45.0 84 1
19 232 224 8 3.4 7 123 173 166 7 4.2 4 303 67 60 7 10.2 7
21 13 8 5 38.5 5404 36 32 4 12.5 3 118 37 34 3 8.1 3
31 29 26 3 10.3 2 135 23 21 2 8.7 1 1
15 44 43 1 2.3 1
NC 45 44 1 2.3 1
17 33 32 1 3.0 105 1 0 1 100.0 1
12 3 2 1 33.3 109 60 59 1 1.7 1
34 13 12 1 7.7 1
UTRem 29185 27185
20 6.9 1 1
Total 1364 1272 92 6.7 65 24 3
Sens = sensitive;Res = resistant;Tet = tetracycline;Co-tr = co-trimoxazole;NC = non-capsulate strainsUT = untyped strains;♦ = significant at P<0.1%
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It seems that the pneumococcus, like the poor, will always 
be with us, for even after over a hundred years of study we
are still a long way from determining the basis for its
life-threatening invasion of the lungs, blood-stream and 
cerebro-spinal system. The pneumococcus also continues to 
be an enigma by its ability to change into this systemic 
invader after a varied period as a benign inhabitant of the 
naso-pharyngeal tract. A plethora of information, 
accumulated over many years has provided glimpses of many 
aspects of this complex organism, without revealing the 
crucial infective characteristic which could lead to
preventive measures against the often fatal outcome. 
Pneumococcal disease was such a dominant feature of 
medicine into the late 1930’s that the organism received 
intensive study which eventually led to effective vaccines 
and serum therapy, and to the administration of one of the 
first anti-bacterial agents, optochin. The pneumococcus 
was also however one of the first organisms to show 
resistance to a chemotherapeutic agent and optochin
treatment was soon abandoned. Ultimately successful 
treatment was achieved with the sulphonamides and, during 
the Second World War, with penicillin. Although thirty 
years were to elapse before pneumococcal resistance to 
penicillin became a clinical problem the only pathological 
or epidemiological marker to investigate these resistant 
strains is still serotyping of the organism's capsule, a 
technique available before the First World War (Neufeld, 
1902).
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The aims of this thesis were to collect epidemiological 
information of the pneumococci isolated in the Sheffield 
Children's Hospital following the introduction of the new 
anaerobic culture method (Collee et al. , 1971; 1972) and
to use the improved growth obtained to seek alternative 
ways to characterize this complex organism. This latter 
area eventually formed the largest part of the study with 
the recognition and development of new approaches to 
differentiation, independent of capsular serotype (Sections 
4.5.3-5 and 4.6-7).
Following Mrs. Beeton's instruction for hare pie - "first 
catch your hare", this essential requirement was achieved 
by the introduction of the new anaerobic culture method, 
with added C 0 2, which increased pneumococcal isolation and 
formed the basis for the other studies. Characteristically 
large mucoid colonies (Howden, 1976) and heavier bacterial 
growth, little affected by the lytic action of the 
organism's autolysin, enhanced detection of enzymes 
(Section 4.5) and the other differential methods (Section
4.6). The desire to obtain new information from this 
fascinating organism co-incided with renewed interest in 
the pneumococcus during the early 1970's, resulting from 
the emergence of antibiotic tolerant strains. Another 
development at this time was the detection of bacterial 
antigens in body fluids, initially by CIE. It was 
anticipated that this method would greatly reduce the time 
for and increase laboratory diagnosis of serious 
pneumococcal infections, without the delays inherent in
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artificial culture; particularly when patients had received 
prior antibiotic therapy. Unfortunately CIE was not found 
to be suitable in this laboratory (Section 4.3), in part 
because the method was unreliable and also because too few 
samples were received to maintain a routine service. A 
further application of CIE, the serotyping of isolates, was 
no more successful; neither were the capsule swelling or 
immunodiffusion methods practical for this purpose 
(Sections 4.1-3). All three techniques were either too 
slow or more importantly did not give specific results, and 
often a combination of both. These difficulties were 
overcome by co-agglutination (Section 4.4) a quick,
specific and simple technique, suitable for use in most 
laboratories. A practical system was established to 
serotype all routine isolates (Section 4.4.6), following 
confirmation of the isolate as a pneumococcus by the rapid 
bile solubility test (Howden, 1979). Current practice in 
the majority of clinical laboratories is to confirm suspect 
"draughtsmen11 colonies, produced after aerobic culture, by 
the bile solubility of a broth culture and the
susceptibility of the strain to optochin, both of which 
require overnight incubation before results can be read 
(Lund, 1959). The large mucoid colonies, following 
anaerobic culture with added C 0 2, in conjunction with the
rapid bile test permitted a positive report to be issued
within minutes of the culture plates being examined, 
without the delays inherent in the overnight tests. 
Serotyping of pneumococci was also simplified and quickened
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as positive results could be obtained, again within minutes 
of isolation, by the co-agglutination slide test using only 
one or two of these large colonies. The mucoid colonies 
formed with the new anaerobic culture method with added C 0 2 
were similar to those of serotype 03 strains, previously 
the only characteristically mucoid pneumococcus. 
Strangely, whilst almost all other strains gave larger 
mucoid colonies when grown anaerobically with added C 0 2 the 
colonies of the serotype 0 3 isolates were smaller than when 
grown aerobically, although they retained their extremely 
mucoid appearance. Serological typing confirmed that the 
mucoid isolates were not predominantly serotype 03 and in 
fact belonged to a wide range of capsular types. 
Unfortunately serotype distribution patterns found in the 
survey (Table 5.6) could not be contrasted against earlier 
distributions because serotyping of isolates had not 
previously been undertaken in this laboratory. A day-book 
register of positive samples for earlier years had been 
collected and it was hoped to compare the isolation rates 
before and after the introduction of the improved anaerobic 
culture method, which had occurred in September 1973. 
However, the only laboratory records book missing from a 
series spanning the last 24 years was the one for 1971-2. 
The nearest complete year, prior to commencement of the new 
method, was 1969-70 which showed an isolation rate of 4.8% 
(210 isolates from 4380 respiratory samples). In the eight 
months immediatly before the new method, January to August 
1973, 5% of the 5,340 samples tested were positive (267
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strains). For the two years following improved anaerobic 
culture with added C 0 2 the isolation rate rose to 8.2% and 
10.0%, and the year preceding the survey an isolation rate 
of 8.4% was recorded from a peak number of 7,238 
respiratory specimens. These improved results confirmed 
the view that introduction of anaerobic culture with added 
C 0 2 had at least increased recognition of pneumococci. The 
major source of pneumococcal-positive samples were throat 
and nasal swabs which usually contain a rich microbial 
flora that tends to obscure or inhibit pneumococcal 
colonies in artificial culture. The new method contributed 
to pneumococcal recovery in two ways. Firstly, the 
production of anaerobic conditions inhibited many of the 
competing organisms (Section 3.1), and secondly the extra 
C O 2 encouraged or was essential for the growth of many 
pneumococci (Section 3.2). These factors in combination
produced larger and more readily visible colonies, although 
the value of the two factors, as would be expected in any 
biological system, was found to vary from strain to strain.
Some strains required anaerobiosis, some were
carboxyphilic and in some both conditions were necessary 
for optimal growth (Sections 3.1-2). The advantage of 
anaerobiosis may, in this catalase-negative organism,
simply be a reduction in its production of hydrogen
peroxide, a recognised inhibitor of pneumococci in 
artificial culture (McLeod, 1922 and Holt, 1960). Reduced 
oxygen tension and not necessarily exacting anaerobiosis 
may be sufficient since growth of the pneumococcus in a
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serai-solid broth (containing 0.2% agar) was similar to that 
of micro-aerophilic organisms i.e. a narrow band of 
turbidity was seen approximately 10 mm below the surface of 
the medium (Section 3.3). The study of Wu et al. (1980) 
confirmed the advantage of strict anaerobiosis in 
successful pneumococcal isolation using a GasPak anaerobic 
system (BBL Microbiology Systems, Cockeysville, Maryland, 
America). Baseman and Strand (1984), on the other hand, 
could not confirm this advantage. However their anaerobic 
cultures were performed in a Bio-Bag Environmental 
ChamberA anaerobic system (Marion Laboratories, Kansas 
City, Mo, America) which they speculated could have been 
the cause of their failure through an inability to attain 
suitable anaerobiosis. The role of C 0 2 was also not 
straightforward although it seemed to be essential for a 
high proportion of strains (Section 3.2). It could be, as 
in other carboxyphilic bacteria, that C 0 2 is incorporated 
into the carboxylic acid cycle via the phosphoenol-pyruvate 
pathway (Kapke et al., 1980). The actual mechanism could 
be confirmed by determining those molecules in the 
pneumococcus which accumulate radio-active carbon when 
grown in an atmosphere containing radio-isotope labelled 
C 0 2. A biochemical explanation of the apparent increase in 
capsular material, indicated by the mucoid colonial 
appearance, produced by growth in extra C 0 2is required. It 
could be that a combination of the gas with pyrimidine 
precursors in the organism leads to the production of 
uridine phosphate. The uridine compound, under the control
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of pyrophosphorylase, could combine with
glucose-l-phosphate, released from the anaerobic metabolism 
of carbohydrate, resulting in a cyclic process to form and 
extend polysaccharide chains. The actual process would no 
doubt be more complicated to account for the different 
polysaccharides composing the 83 capsular types (Lee et 
a l ., 1981). Whether these individually recognised pathways 
in the above sequence are applicable to polysaccharide 
formation is another relevant area for biochemical study of 
the pneumococcus. Whatever pathways are responsible for 
C O 2 dependance this requirement is strongly linked with 
certain capsular serotypes. An average 10% of all strains 
recovered by the new method were shown to require extra C 0 2 
even after a number of sub-cultures on artificial ’ media 
(Section 3.2). This requirement increased to 66% of 
serotype 16 strains and to 75% of the capsular serotype 09 
isolates (Table 3.5). The isolation rate following 
anaerobic culture with added C 0 2 had not merely increased 
by 10%, as would be expected from the general level of C 0 2 
dependant isolates, but had in fact increased by over 60%. 
Perhaps pneumococci are even more sensitive to C 0 2 tension 
when first transferred from the host, particularly if this 
transfer is on relatively inhospitable culture swabs, or 
perhaps mucoid colonies are more easily seen.
Isolations with the new method were at a high rate (11.7% 
and 9.5%, Table 5.1) during the first two years of the 
study although the number of samples examined had slumped 
from over 7,000 in the year before to less than 3,700
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(Table 5.4) . When, in the final two years, the number of 
samples increased to over 5,000 the recovery rates fell 
back to 8.7 and 8.3% respectively. it is of interest to 
speculate on the factors involved in the changing patterns 
of sampling before and during the survey. Why was the 
number of samples received before the survey so high and 
why did the total number of requests vary so much? The 
increased number of samples cultured in the second part of 
the study coincided with increases seen in requests from 
particular consultants (Table 5.4). The changes may 
reflect an increase in the number of patients seen by these 
consultants and/or the introduction of policies to sample 
certain patients, for example, all patients on admission. 
The latter seems most likely as the increase in samples 
from three of the medical consultants was in contrast to 
the relatively static number of requests received from the 
remaining consultants. Without a background of previous 
assessment of these and other study, results were greatly 
handicapped. Slowly the value of this type of information 
is now becoming accepted in many laboratories. The depth 
of information collected in the survey (Tables 5.1-14) may 
be impractical for some departments but an on-going record 
of bacteriological, and hopefully relevant clinical 
information, would help recognise trends relevant both to 
the hospital and to the patient. These benefits would 
include the improved management of resources and the 
selection, based on the sensitivity records of recently 
tested strains, of effective antibiotic therapy. Thus both
250
retrospective and prospective evidence could be an aid in 
discerning the clinical significance of one of the more 
difficult aspects of the association of man and the 
pneumococcus. When present in CSF or blood culture samples 
the significance of the pneumococcus is rarely in doubt, 
however, when isolated from respiratory material, for 
example, its importance can be less clear. The respiratory 
tract, particularly the anterior nares, is a reservoir for 
the pneumococcus both as a harmless visitor and as the 
probable starting point for many of the organism's 
infectious forays, e.g. sinusitis, otitis media, pneumonia 
and meningitis. For the clinician the nose provides one of 
the "routine" bacteriological sampling sites for a large 
number of patients. Not surprisingly nasal swabs were the 
source of 919 (55%) of the 1736 pneumococcal isolates
(Table 5.8). How many of these isolates were harmless 
visitors and how many were potential invaders is unknown. 
When recovered from sputa in patients with suspected chest 
infection, the role of the pneumococcus can be even more 
confused. Mere presence in the sample does not confirm the 
pneumococcus as the cause of infection as it may be a 
contaminant of the specimen acquired during transit from 
the lung to the laboratory container. In certain 
situations clarification can be deduced from the clinical 
details, provided on the specimen request form, when taken 
in conjunction with demonstration of the organism in 
purulent material, by Gram's stain, capsule swelling, CIE 
or co-agglutination, and its recovery in "significant"
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numbers on a culture plate. Clinical details if relevant 
and if on the request form can be most helpful, however, 
the reality often falls well below this standard. As was 
shown in Table 5.13 strains of particular types, such as 
serotypes 03 and 14, which have been frequently isolated 
from particular sites in disease states, can also be 
isolated on occasions when their significance is uncertain.
Serotype 03 strains, a common cause of otitis media, were 
isolated from 10% of the 95 patients said to have ear 
infections but were also isolated from 10% of those in the 
"sore throat" group of cases. In another example 
non-capsulate strains were isolated from 30 patients said 
to have eye infections. This was an unexpected finding 
since these variants are considered to be non-pathogenic 
(Lund, 1971). A total of 40 non-capsulate isolates were 
made from eye swabs (Table 5.8) most of which were 
clinically significant as these swabs are generally only 
taken from patients with infected eyes. Again this 
underlines that clinical details on laboratory request form 
can be unreliable. The isolation of these variants from so 
many patients with clinical conjunctivitis warrants closer 
investigation as it is possible that they are an overlooked 
cause of infection. The small colonies produced by the 
non-capsulate strains can easily be missed as they resemble 
colonies of capsulate pneumococci and were similar to those 
produced by those non-haemolytic streptococci generally 
regarded as clinically insignificant. These non-capsulate 
strains also differed from the other pneumococci in having
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a negative rapid plate bile solubility test. They were 
however positive in the broth bile solubility test and were 
sensitive to optochin. Two representative cultures sent to 
Dr. G. Colman, Streptococcal Reference Laboratory, 
P.H.L.S., Colindale, were confirmed as non-capsulate 
pneumococci.
Just as the clinical details supplied to the laboratory 
were not always useful in assessing significance of an 
isolate, demonstration of the organism in material received 
was not always appropriate. This, however, was largely a 
problem of obtaining satisfactory samples, a common feature 
of almost all bacteriological investigations, especially 
those involving children. Sputa, as distinct from saliva, 
was only infrequently obtained during the survey and 
although presumptive pneumococci were occasionally seen in 
direct Gram-stained smears it was not practical to 
demonstrate antigen in these few samples. Similarly the
small number of cases of pneumococcal meningitis seen in
this hospital made the use of CIE unsuitable for the
detection of antigen in CSF, especially as all such cases 
had been detected by Gram-stained film and/or anaerobic 
culture with added C 0 2. The epidemiological survey had 
been based on the need to know the distribution of
pneumococcal serotypes in health and particularly in 
disease. This background information would be essential 
prior to the introduction of vaccination for high-risk 
children. Protection of all young children from 
pneumococcal infections, especially from otitis media, has
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been proposed, although those most at risk are under two 
years old and are also the group least able to produce 
raised antibody titres (Klein, 1981). The most likely 
group in this hospital are immuno-compromised children, 
mainly those with acute lymphoblastic leukaemia, in whom 
pneumococcal bacteraemia is often the terminal event when 
their immune capabilities and white cell count are 
extremely low. Of the 13 pneumococcal blood culture 
isolates six patients (46%) were infected with strains that 
were not included in the commercial vaccine, serotypes 10, 
15, 22, 33 and group I (two strains). This vaccine
contains polysaccharide of serotypes 01, 02, 03, 04, 06, 
07, 08, 09, 12, 14, 18, 19, 23 and 25. A slightly
different picture was seen in those serotypes isolated from 
CSF in which five of the 14 isolates (35%) were non-vaccine 
strains, serotypes 11, 17 (three strains) and a group I
strain (which was from the same patient as one of the group 
I blood culture isolates). The ratio for the 138 eye swab 
isolates taken from the information presented in Table 5.8 
showed that 45% (62 strains) were non-vaccine serotypes, 
although this number included 40 non-capsulate variants. 
Non-vaccine isolates only accounted for 10% (nine of the 87 
strains) of ear infection cases. When the average ratio of 
non-vaccine to vaccine strains was extracted from the total 
isolations, including both commensal and pathogenic cases, 
listed in Table 5.6, non-vaccine strains composed 22% (394) 
of the 1,736 isolates. Other authors who have considered 
the distribution of vaccine strains in serious pneumococcal
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infections have shown that less than 20% of clinically 
significant isolates belonged to the non-vaccine capsular 
types (Broome and Facklam, 1981; Klein, 1981; Hansman, 1983 
and Turk, 1984). Composition of the serotypes included in 
the vaccine was a compromise arrived at from world-wide 
distribution pattern and unfortunately its composition 
could not be tailored to each country's individual serotype 
patterns. The distribution of strains in ear infections 
indicated that vaccination would be effective for this 
group of patients. Vaccination would be of less value in
bacteraemia or meningitis if the serotype distribution
persisted, nonetheless half of these very serious 
infections may have been prevented if the patients had been 
vaccinated. It is an interesting aside to remember that 
despite at least 100 times more deaths from pneumococcal 
infection than from tetanus vaccination against the latter 
is part of normal medical procedure, but protection against 
the pneumococcus is almost never used (Vogel, 1982) .
Serotype distributions of the strain in the survey showed 
that serotypes 06, 19 and 23 represented 46.8% (813) of the 
isolates and serotypes 03, 09 and 14 accounted for a
further 15.1% (262); the remaining 661 strains were divided 
amongst 27 serotypes or groups (Table 5.6). As others have 
found, the pattern of serotypes is unique to the survey 
community, in this case the Sheffield area, but certain 
similarities were shown with other surveys in children 
(Dowling et a l ., 1971; Lcda et a l ., 1975 and Gray et a l ., 
1979). Serotypes 06, 19 and 23 were also the most common
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serotypes encountered in serious childhood infections 
(Morch, 1944; Douglas and Riley, 1979 and Finland, 1981) 
which underlines the double edged sword of pneumococal 
isolations, the ability for the same serotype to occur both 
as a commensal or a pathogen. The presence of serotype 03, 
generally recognised as a severe pathogen, has also been 
found in up to 33% of healthy children. In this survey <5% 
of strains were of this type and associated both with ear 
infection and probable "routine" sample swabs. Serotype 09, 
75% of which in the survey were carboxyphilic, was a major 
cause of systemic disease in an Australian survey (Hansman, 
1983) and may have been less recognised in British surveys 
because of the C 0 2 requirement of so many of these strains.
Turk (CDR 17/84) was surprised to note a significant 
number of this serotype amongst children with severe
pneumococcal disease seen at the Northern General Hospital, 
Sheffield when compared to his earlier findings in his 
Oxford studies (Turk, 1980). This may be another example 
of variation in serotype distribution from community to 
community, or different pathogenicity of serotype 09
strains for children. The carboxyphilic and
non-carboxyphilic strains of this serotype isolated in this 
survey were not tested with subtype sera. This could have 
determined whether this characteristic requirement was 
related to a particular subgroup and to the subgroup
included in the pneumococcal vaccine (subtype 9v), which 
would of course have been relevant to any protection 
afforded by the vaccine.
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The epidemiological evidence (Section 5) whilst providing 
necessary background material for subsequent studies could 
not be expected to provide conclusive evidence for the 
significance of many of the isolates. The investigations 
presented, primarily those in Section 4, gave a number of 
pointers to the development of differential studies. 
Capsular serotyping has been a necessary obsession of 
pneumococcal investigations because of its link with 
pathogenicity. Other methods to recognise invasiveness 
have faltered through lack of suitable methods or the 
extended nature of some investigations. Previous
carbohydrate fermentation testing of the pneumococcus 
needed serum-water media and incubation for at least five 
days (Morch, 194 9). The active growth produced by 
anaerobic culture with added C 0 2 reduced this time to less 
than 5 h, and therefore an extended re-examination of 
differentiation by carbohydrate fermentation reactions
would seem appropriate. Detection of enzyme reactions by 
labelling substrates with indicators, e.g. nitrophenol or 
methylumberriferryl (Maddocks and Grenan, 1976), or
developing coloured products of the reaction (APIZYM) are 
other rapid and sensitive methods to finding characteristic 
pneumococcal or invasive enzymes. Pneumococci in the 
limited number of substrates included in the APIZYM strip 
have shown esterase lipase, chymotrypsin, galactosidase and 
glucoseaminidase activities (Section 4.;S'.i*), which had not 
been found in other streptococci (Waitkins, 1977). It may 
therefore be possible to find further differential
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substrates amongst the array of biochemicals now available.
Significant antibody production against specific 
pneumococcal products, e.g. those against phosphocholine 
(Briles et al., 1981), have been related to infection. 
Specific enzymes if released into body fluids by the 
pneumococcus during tissue invasion could allow early
diagnosis of infection and also end the speculation of this 
organisms' isolation from sputum samples for example. 
Fine-print examinations of pneumococcal enzymes have been 
made in recent years, largely by biochemists using the 
organism as a source of novel enzymes (Kobata and Takasaki, 
1978 and Yamashata et a l ., 1981). To fulfill the promise
of the survey's characterisation results it is essential
that detailed biochemical techniques are applied to the 
pneumococcus to add the meat to the skeleton of
observations reported. As mentioned above the basis for 
C O 2 dependence should be investigated although the results 
of this requirement still provide a simple differential 
test. The production of "hot-cold" haemolysins and 
neuraminidase with their similarities to those of Cl. 
perfringens require further study and in the case of the 
latter test a simplified method. The scientific basis of 
all investigations must be with the premise that the 
pneumococus is a clinically important entity and not a 
biochemical novelty; and tempered by the practical 
application of these in the hospital laboratory. The API 
enzyme substrate strips form an execellent starting point 
for the enzyme studies, with their standardised simple
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procedure providing for collation of results between study 
centres.
Dye inhibition studies may provide an alternative or 
complementary scheme for characterisation, which require 
only the minimal amount of equipment. Determination of the 
critical dye concentrations by biological titrations was, 
as Elek and Higney (1970) had found with other organisms, a 
necessary stage if this type of work is to be reproducible.
From the relatively small amount of work presented, on a 
few of the many hundreds of dyes available for study, a 
vast area of investigation for the pneumococcus was 
revealed. An even simpler differential test, the 
production of coloured colonies on Mitis-salivarius agar 
(Section 4.6.5), also showed an association of certain 
colonial types to capsular serotypes. In the light of the 
many new aspects revealed by this study, a fresh 
examination of the pneumococcus is indicated so that the 
science of biochemistry can be applied to the practise of 
bacteriology.
The results presented here have increased our knowledge of 
the pneumococcus based upon an improved ability to isolate 
the organism and the supplementation of capsular serotyping 
by the introduction of new methods to characterise and 
differentiate this interesting bacterium.
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TABLE A1
The suppliers and order codes of the commercial media.
Name Code Supplier
Amies Transport Medium 
Azide Blood agar base
Columbia agar base Lab 1
DNase agar CM 321
Iso-sensitest agar CM 471
Liver digest powder L 27
MacConkey agar CM 7
Mitis-salivarius agar CM 157
Phosphate buffered saline BR 14a
Proteose peptone
Reinforced Clostridial medium CM 149 
Todd Hewitt broth CM 189
Tryptone L42
TYC agar Lab 35
Dif co 
Dif co 
Lab M 
Oxoid 
Oxoid 
Oxoid 
Oxoid 
Oxoid 
Oxoid 
Dif co 
Oxoid 
Oxoid 
Oxoid 
Lab M
Al
TABLE A2 
The suppliers of media.
API System, S.A.,La Baline Les Grottes,38390 Montalieu Vercieu,
France.
Difco Laboratories,Detroit,Michigan 48201 U.S.A.
L'Industrie Biologique Francais, S.A.9 Genevilliers,France.
London Analytical and Bacteriological Media Ltd. (Lab M ) , Ford Lane,Pendleton,Salford, M6 6PB
Mast Laboratories Ltd.Mast House,Derby Road,Bootle, Merseyside.
Medical Wire and Equipment Co. Ltd.,Potley,Corsham,Wiltshire.
Oxoid Ltd,Wade Road,Basingstoke,Hants.
A2
TABLE A3
The suppliers of chemicals.
BDH Chemicals Ltd,
Poole,Dorset.
Duncan, Flockhart Co. Ltd.,700 Oldfield LaneNorth, Greenford,Middlesex.
Evans Medical,Speke,
Liverpool.
ICI PLC,Alderley Park,Macclesfield,
Cheshire.
Koch-Light Laboratories Ltd., Poyle Estate,Willow Road,Colnbrook,Slough, S23 ODZ
Sigma London Chemical Co. Ltd., Fancy Road,Poole,Dorset.
Statens Serum Institute Amager Boulevard 80 DK -2300 Copenhagen 5,Denmark
A3
TABLE A4
The suppliers of equipment and gases.
Equipment:
Cecil Instruments Ltd.,Green End Road,Cambridge.
Daly Instruments Ltd.Bolney Cross,
Bolney,Sussex.
Gec-Elliott Process Instruments c/o. Baird and Tatlock,P.O. Box 1,
Romford,Essex.
Medcalf Bros. Ltd.
Cranborne Road,Potters Bar,Herts.
Shandon Southern Instruments Ltd., Frimley Road,Crawley,Surrey.
Gases:
BOC Ltd Special Gases,National Accounting,Dept. E5,P.O. Box 12,Worsley,Manchester
Distillers - The Distillers Company, (Carbon Dioxide Ltd),Cedar House,39 London Road,Reigate,Surrey, RH29QE
A4
FIGURE Bl Colour chart for the developed reactions of the 
APIZYM enzyme substrates cupules.
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2 - naphtyl - myristate CJ1o o o
L - leucyl - 2 - naphtylam ide CT>o o o o
L - valyl - 2 - naphtylam ide 'vlo o o o
1 L - cystyl - 2 - naphtylam ide COo o o o
N-benzoyl-DL-arginine-2-naphtylamide CD o o o o
N-glutaryl-phenilalanine-2-naphtylamide o o o o o
2 - naphtyl - phosphate o o o o
Naphtol-AS-BI-phosphodiamide roo o o •
6-Br-2-naphtyl-aD-galactopyra noside COo o o o
2-naphtyl-j3D-ga!actopyranoside o o o o
Naphtol-AS-BI-|3D-glucuronate cno o o •
2-naphtyl-aD-glucopyranoside 03 o o o o
6-Br-2-naphtyl-j3D-glucopyranoside '-J o o o o
1-naphtyl-N-acetyl-j3D-glucosaminide 00 o o •
6-Br-2-naphtyl-aD-mannopyranoside CD o o o o
2-naphtyl-aL-fucopyra noside roo o o o o
Appendix C
Document A for the collection of laboratory details which 
were combined with the patient's details held in the 
Hospital Activity Computer File.
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UUUUntlM I M
FOR ADDING EXTRA DATA TO INPATIENT RECORDS
U n i t  N u m b e r A d m i t  D a t e
i i i i i i i  i i i
P a t i e n t  T y p e  j ^  |
i a g n o s i s  D e t a i l s
I f  d i a g n o s i s  o n  r e c o r d  c o r r e c t  l e a v e  t h i s  b l a n k .
y *
_ __ I------ » i .  J____ L___
.J____ 1____ L... 1 . .  J  .
------ J ................1____1 .. .1 -
, . _ J _  . 1___ I..... _l ,  J
...... I . . . J ___ 1____ 1 J. . . . . .
.. 1 _ „ .  J
Lab. Number
uQ]Site * •Of cSample Type m $
 i—  i— ____
Date 
Ward Taken
— i— — i— i— i—
Post Code
 j.-.j i 1 I l___
LabDiagnosis Test□
Appendix C
Document B for the collection of both laboratory and 
patient details, for patients whose details were not on the 
Hospital Activity Computer file.
C2
DOCUMENT B
FOR ADDING NEW PATIENTS
Unit Number
j i__i— i— l
Admit Date---------
_i_ j__i— i— i— 1
1. Inpatient 4. PM
2. Outpatient
3. Accident and Emergency
Patient Type
Surname Key J L. □
Date of Birth---- ,--- j----i i
— L _ _ j — i— _ j— i—
Age at 
Admission
Consultant/Speciality . .  n
IDiagnosis Details
Lab. Number __J JL
T)<L>Site * ._ , V. mof B_ Type ch a)Sample hh co
1 1
Date
Ward Taken
* * i l_
Post.-Code____|
 ■ i i i i— j
Lab
Diagnosis Test
Appendix Dl
Patients diagnosis groups of laboratory obtained clinical 
detail codes used in Table 5.13.
Nasal:-
Nasal Discharge/Catarrh
Rhinitis
Sinusitis
Eye : -
Blepharitis 
Brused/Infected eye 
Conjunctivitis 
Tear duct Obstruction
Lower (respiratory)
Bronchitis
Bronchoscopy
Bronchopenumonia
Consolidation, right lower lobe
Cystic Fibrosis
Empyema
Pneumonia, pneumococcal 
Pneumonia (unspecified)
Pneumonia, aspiration
Dl
Pneumonia, left lower lobe 
Pneumonia, right lower lobe 
Pneumonia, right upper lobe 
Pneumonia, staphylococcal 
Lung, collapse lobe of 
Lung, consolidation of 
Thick Secretions unspecified 
Tracheostomy
Upper (respiratory)
Apnoea
Asthma
Bronchial asthma
Bronchiolitis
Bronchspasm
Bronchospasm with bronchiolitis
Cold
Cough
Croup
Epiglottitis
Influenza unspecified/query 
Nerve Palsy with cough
Respiratory tract infection, unspecified
Respiratory Tract infection, upper
Stridor
Tachypnoeia
Wheezing
Whooping cough/Pertussis
D2
"Sore throat"
Cervical adenitis
Cervical Lymphodenopathy
Folliculitis/Acute Tonsillitis
Irritable hip
Joint Pains
Knee, painful right
Laryngitis and Tracheitis
Limp
Pharyngitis
Rheumatic Fever
Sore Mouth/Thrush
Sore Throat (unspecified)
Ear: -
Ear Unspecified/Discharge 
Mastoid Cavity Infection 
Otitis Media, bilateral 
Otitis Media, unspecified 
Strabismus
"Serious infections":-
Cerebro-spinal fluid, leaking from head wound
Convulsion/Febrile Episode
Encephalitis
Fever, recurring
Meningitis, haemophilus
D3
Meningitis, E. coli 
Meningitis (unspecified) 
Meningococcal septicaemia 
Pyrexia of Unknown Origin 
Septicaemia (non-specified)
Immuno-compromised:-
Anaemia, aplastic 
Anaemia, iron deficiency 
Angiosarcoma - skull 
Burkitt's Lymphoma 
Haemophilia
Leukaemia, acute lymphoblastic
Leukaemia, acute myeloid leukaemia
Lymphosarcoma
Medulla blastoma
Neoplasm, malignant
Neoplasm unspecified
Neuronblastoma
Tumour, saccrocoxygeal
Tumour, spinal
Plastic operation cases 
Burns, hand 
Burns, Leg 
Burns, face 
Choanal atresia 
Cleft Palate with Cleft Lip
D4
Cleft Palate
Cleft Lip only
Cleft Lip, repair
Excision, naevus
Hypospadias
Paratoid Duct Blocked
Plastic Surgery (unspecified)
Polydactyly
Scalds, chest
Scalds, feet
Scalds, shoulder
Scald, trunk
Scald, unspecifed
Skin Graft
Tongue Tie
Heart operation patients
Atrial Septal Defect
Closed Heart Surgery
Coarction Aorta
Heart Anomaly - unspecified
Open Heart Surgery
Patent Ductus Arteriosus
Transposition of Great Vessels
CSF-valve patients
Bulging fontonelle 
Blocked shunt
D5
Hydrocephalus 
Hydrocephalus unspecified 
Hydroceph with valve 
Hydroceph, ventriculitis 
Myelomeningocoele 
Shunt/Valve system, infected 
Spina Bifida 
Valve insertion
Other diagnoses:- 91 descriptions that did not form groups
of conditions
D6
